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ABSTRACT OF THE DISSERTATION
ELUCIDATING THE ROLE OF MIFS-MIFR TWO-COMPONENT SYSTEM IN
REGULATING PSEUDOMONAS AERUGINOSA PATHOGENICITY
by
Gorakh Digambar Tatke
Florida International University, 2016
Miami, Florida
Professor Kalai Mathee, Major Professor
Pseudomonas aeruginosa is a Gram-negative, metabolically versatile,
opportunistic pathogen that exhibits a multitude of virulence factors, and is
extraordinarily resistant to a gamut of clinically significant antibiotics. This ability is
in part mediated by two-component systems (TCS) that play a crucial role in
regulating virulence mechanisms, metabolism and antibiotic resistance. Our
sequence analysis of the P. aeruginosa PAO1 genome revealed the presence of
two open reading frames, mifS and mifR, which encodes putative TCS proteins, a
histidine sensor kinase MifS and a response regulator MifR, respectively. This twogene operon was found immediately upstream of the poxAB operon, where poxB
encodes a chromosomal ß-lactamase, hinting at the role of MifSR TCS in
regulating antibiotic resistance. However, loss of mifSR had no effect on the
antibiotic resistance profile when compared to P. aeruginosa parent PAO1 strain.
Subsequently, our phenotypic microarray data (BioLOG) and growth profile studies
indicated the inability of mifSR mutants to grow in α-ketoglutarate (α-KG), a key
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tricarboxylic acid (TCA) cycle intermediate, as a sole carbon source. To date, very
little is known about the physiology of P. aeruginosa when provided with α-KG as
its sole carbon source and the role of MifS and MifR TCS in virulence. Importantly,
in the recent years, α-KG has gained notoriety for its newly identified role as a
signaling molecule in addition to its conventional role in metabolism. This led us to
hypothesize that MifSR TCS is involved in α-KG utilization and virulence in P.
aeruginosa. Using mifS, mifR and mifSR clean in-frame deletion strains, our study
demonstrates that the MifSR TCS modulates the expression P. aeruginosa kgtP
(PA5530) and pcaT (PA0229) genes encoding putative α-KG permeases. In
addition, our study shows that the MifSR-regulation of these transporters requires
functional sigma factor RpoN (σ54). Loss of mifSR in the presence of α-KG, resulted
in differential regulation of P. aeruginosa key virulence determinants including
biofilm formation, motility, cell cytoxicity and the production of pyocyanin and
pyoverdine. Involvement of multiple regulators and transporters suggests the
presence of an intricate circuitry in the transport of α-KG and its importance in P.
aeruginosa survival. This is further supported by the α-KG-dependent MifSR
regulation of multiple virulence mechanisms. Simultaneous regulation of multiple
mechanisms involved in P. aeruginosa pathogenesis suggests a complex
mechanism of MifSR action. Understanding the physiological cues and regulation
would provide a better stratagem to fight often indomitable P. aeruginosa
infections.
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Introduction
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In M, M. Babu. (ed.) Bacterial Gene Regulation and Transcriptional Networks.
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Introduction
“Adaptation is the key to survival”, this is particularly true with bacterial cells
as they are often exposed to an array of physiological and environmental changes
during their lifecycle. The evolutionary success of bacteria is a testament to its
intrinsic capability that helps them to keep pace with the frequently changing
environmental conditions, by means of genetic and phenotypic changes. Although
they are considered to be the simplest form of life, bacteria have evolved
sophisticated molecular machinery that orchestrates multiple functions efficiently.
Most bacteria, if not all, live in an extreme and/or dynamic environment, where an
adaptive behavior mediated by quick response to ecological variations is a key to
existence and proliferation. Bacterial cells achieved this by utilizing numerous
signal transduction, information processing systems that incessantly monitor their
surroundings for important changes in order to elicit an adaptive response.
Adaptation to environmental stimuli in bacteria is arbitrated predominantly
through the expression of transcriptional regulators that include serine-threonine
protein kinases (Kalantari et al., 2015), extra-cytoplasmic function (ECF) sigma
factors (Mascher, 2013), and two-component signal transduction systems (TCSs)
(Stock et al., 2000). These regulators function as cellular interpreters where they
directly or with the help of other sensory units, first recognize a specific
environmental stimuli at the cell surface and then transmit that extracellular
information to the cytoplasm with the help of efficient signaling cascade (mostly
phosphorylation and de-phosphorylation reactions) in order to stimulate an
adaptive response, mainly by regulating expression of the target genes (Parkinson,
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1993, Goudreau & Stock, 1998, Cashin et al., 2006). Amongst these signaling
devices, TCS is the predominant signaling mechanism that empowers bacteria
with an ability to efficiently sense, respond, and adapt to a wide variety of
environments, stressors, and growth conditions (Stock et al., 2000).
Two Component Regulatory Systems
Two-component systems (TCS) are sophisticated signaling mechanisms
marked by a highly modular design that have been adapted and integrated into a
wide variety of cellular signaling circuits. They are one of the primary means by
which bacteria sense and respond to variations in their environments, both intraand extracellular. The archetypical TCS is composed of a membrane integrated
sensory histidine kinase (HK) and a cytoplasmic response regulator (RR) (Figure
1.1). The HK contains a periplasmic N-terminal domain that detects specific stimuli
(sensing domain) and a C-terminal cytoplasmic transmitter domain that is
comprised of a dimerization domain, a conserved histidine, and an ATP catalytic
domain (Raghavan & Groisman, 2010). HKs can have two or more transmembrane
domains with little or no periplasmic domain while others are completely
cytoplasmic. The cognate response regulator (RR) contains a conserved receiver
domain and a variable output domain (Stock et al., 2000). Upon receiving a signal,
two HK monomers dimerize and cross-phosphorylate at the conserved histidine
residue, the phosphate subsequently being transferred to an aspartate residue in
the receiver domain of the cognate RR. The phosphotransfer is catalyzed by the
receiver domain and results in a conformational change that activates the output
domain, which often binds DNA and modulates gene expression or enzymatic
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activity (Stock et al., 2000, Mascher et al., 2006, Gooderham & Hancock, 2009).
Variations to this model occur in phosphorelays where a sensor kinase first
transfers the phosphoryl group to a RR that has no output domain. The P~RR then
transfers the phosphoryl group to a histidine containing phosphotransfer protein
(HPT), and this in turn serves as a phosphate donor to a terminal RR which has
an output domain that mediates a cellular response. In other cases the sensor
kinase and the RR lacking an output domain are fused into one protein (hybrid
sensor kinase) (Gao & Stock, 2010). Other variations include the TCS connectors,
a group of proteins that modulate the phosphorylation state and activity of sensor
HK and RR and establish regulatory links between otherwise independent signal
transduction pathways (Mitrophanov & Groisman, 2008).
In general, the mechanism of signal perception mediated by the archetypic
bacterial two-component system in order to elicit an adaptive response can be
summarized in four steps:
1) Signal detection by HK
2) ATP-dependent auto phosphorylation of the HK sensor at its C-terminal
histidine residue (HK activation)
3) Transfer of phosphoryl group to the aspartate residue of the response regulator
in the receiver domain (phosphortransfer and RR activation)
4) Regulation of target genes by the activated RR (response generation)
TCSs enable bacterial to effectively control their physiological and cellular
functions by responding appropriately to a wide range of stimuli such as osmolarity,
nutrient availability, temperature, pH and oxidative stress (Albright et al., 1989).
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Figure 1.1: Schematic representation of a prototypic two-component
system mediated signal transduction. TCS activation is arbitrated through a
series of phosphotransfer reactions which typically involves phosphorylation
and de-phosphorylation of the sensor histidine kinase (HK) and response
regulator (RR). A specific environmental stimulus is detected by the HK through
its sensor domain which brings about a conformational change resulting in two
HK monomers to dimerize and auto cross-phosphorylate (ATP-dependent) at
the conserved histidine residue located at its C-terminal domain. The
phosphorylated HK then serves as a phosphate donor for the RR receiver
domain, resulting in phosphorylation of a conserved Aspartate residue. The
phosphorylation of the aspartate residue subsequently results in the activation
of the RR effector domain that mediates the cellular response, usually by
differential expression of specific target genes.
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P. aeruginosa and two-component systems
Pseudomonas aeruginosa is a ubiquitous, Gram negative bacteria that
exhibits extraordinary ability to colonize diverse ecological niches. Its metabolic
versatility and adaptability has significantly contributed to its ubiquity (Ramos,
2004). Furthermore, P. aeruginosa causes opportunistic infection in humans, and
is the primary pathogen responsible for pulmonary exacerbations and mortality in
patients with cystic fibrosis (Lyczak et al., 2002). Importantly, it is one of the most
recalcitrant nosocomial pathogen, responsible for 10% of all the hospital acquired
infections (Sievert et al., 2013). Beyond high infection rate, P. aeruginosa has one
of the highest case fatality rate amongst all Gram-negative infections (Aliaga et al.,
2002). P. aeruginosa expresses an arsenal of multi-determinant virulence factors,
both cell surface associated (flagella, pili, LPS) and secretory (proteases,
exotoxins, phenazines, haemolysins), that play a crucial role in regulating its
pathogenicity (Balasubramanian et al., 2013). In addition, a major impediment in
treating P. aeruginosa infections is its extraordinary intrinsic and acquired
resistance to several clinically critical antibiotics (Fraimow & Nahra, 2013). These
characteristics together ensures the success of P. aeruginosa as an intractable
pathogen.
Furthermore, successful infection and disease progression depends
significantly on the ability of bacterial pathogens, including P. aeruginosa, to adapt
efficiently to the host environment. P. aeruginosa has evolved complex signal
transduction mechanisms that aid in its effective adaptation by regulating and
coordinating the temporal expression of various genes, in response to both inter6

and intracellular signaling molecules and environmental cues (Hancock & Speert,
2000, Rodrigue et al., 2000, Ventre et al., 2006, Gooderham & Hancock, 2009,
Williams & Camara, 2009, Haussler, 2010, Jimenez et al., 2012). Amongst the
gamut of signaling mechanisms identified in P. aeruginosa, TCS mediated signal
perception play a predominant role in sensing diverse environmental stimuli and
eliciting a pertinent and rapid adaptive response (Rodrigue et al., 2000, Stock et
al., 2000).
P. aeruginosa, genome encodes one of the largest group of TCS proteins

identified in any in any microorganism thus far analyzed (Barakat et al., 2009,
Winsor et al., 2011). To date, 62 HK and 73 RR TCS proteins have been identified
in P. aeruginosa prototypic strain PAO1 (Winsor et al., 2011). This provides the
bacterium with a sophisticated capability to regulate diverse metabolic
adaptations, virulence and antibiotic resistance processes that are hallmark of P.
aeruginosa infections. What follows is a brief description of some prominent ones.
PhoQ-PhoP
PhoQ-PhoP is one of the most extensively studied TCS in the gproteobacterial species (Miller et al., 1989, Gooderham & Hancock, 2009). ). It is
composed of the inner membrane histidine sensor kinase (HK) PhoQ and the
cytoplasmic response regulator (RR) PhoP (McPhee et al., 2006). This TCS was
first identified in Salmonella enterica where it was reported to be involved in
controlling the expression of non-specific acid phosphatase (Kier et al., 1979).
Subsequently, a more profound role of the PhoPQ TCS was identified where it was
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involve in regulating several cellular activities including virulence mechanisms, cell
cytotoxicity, motility, transport of small molecules, acid tolerance, antibacterial
peptide resistance and bacterial surface remodeling (Groisman, 2001, Prost et al.,
2008). The PhoQ-PhoP system has been identified as a major component of
virulence in other Gram-negative bacteria including P. aeruginosa, Escherichia coli
and S. enterica (Gooderham & Hancock, 2009). The PhoPQ TCS is one of the first
reported sensory-response mechanism to use extracellular cations as a primary
signal (Gooderham & Hancock, 2009).
In P.aeruginosa, PhoQ-PhoP TCS has been reported to modulate cellular
adaptations to Mg2+-limiting environments (McPhee et al., 2006). It is now well
established that sub-micromolar concentrations of Mg2+ induce P.aeruginosa
PhoP-mediated transcription, and millimolar concentrations of Mg2+ are known to
repress their expression (Gooderham et al., 2009). Furthermore, it is well
established that the PhoPQ TCS respond to limiting concentrations of cations and
regulate resistance to polymyxin B and cationic antimicrobial peptides through the
regulation of the arnBCDTEF-pmrE LPS modification operon (Macfarlane et al.,
2000, McPhee et al., 2006) Activation of the genes in the arnBCADTEF operon
results in the addition of 4-aminoarabinose to the Lipid A moiety of the
lipopolysaccharide (LPS). The amalgamation of 4-aminoarabinose and Lipid A is
responsible for inducing cytotoxicity in Gram-negative bacteria, because of a
reduction of the net negative charge of the LPS. This limits LPS interaction with
cationic peptides and cationic antibacterial agents such as polymixin B (McPhee
et al., 2003, Moskowitz et al., 2004). PhoQ is also involved in swarming and
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twitching motility as well as in biofilm formation and it is required for virulence
without affecting the T3SS or QS systems (Gooderham et al., 2009). It differs from
the Salmonella PhoQ in that it is also involved in the regulation of transcription of
genes outside the PhoP regulon, including pmrA, algU-mucABCD alginate
production operon, Type II secretion proteins HxcQ and XqhA, the quinolone signal
biosynthetic genes (pqsBCD), iron–scavenging-related genes and siderophore
genes as well as energy-metabolism-related genes including nirO, nosR and
cytochrome o ubiquinol oxidase operon (Gooderham et al., 2009). Interestingly, P.
aeruginosa isolates from cystic fibrosis patients have been shown to contain a lipid
A structure equivalent to that of those formed by the activation of PhoPQ, and to
generate an inflammatory response, suggesting a role of this TCS in eliciting an
immune response. Furthermore, HK-PhoQ has been reported to crosstalk with
other TCS regulatory proteins (PmrA/PmrB) to modulate several cellular
responses (McPhee et al., 2003). McPhee and coworkers have shown that HKPhoQ is able to activate the RR-PmrA independently of HK-PmrB suggesting an
interaction between these TCSs (McPhee et al., 2003). In addition, increased
resistance to antibiotics including polymyxin B, aminoglycosides and quinolones in
phoQ mutants suggest crosstalk between PhoPQ and other TCS (Kwon & Lu,
2006)
GacS-GacA
The sensor HK-GacS (PA0928) and the RR-GacA (PA2586) are members
of a TCS that is present in a wide variety of Gram-negative bacteria (Heeb & Haas,
2001). In P. aeruginosa, the GacSA TCS is central to the regulation of the
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expression of virulence factors, secondary metabolites, biofilm formation and QS
(Kitten et al., 1998, Pessi et al., 2001) and to the switch between acute and chronic
infections, as seen in mouse models of cystic fibrosis infection (Rahme et al., 2000,
Coleman et al., 2003). GacS is a hybrid sensor HK that contains a HK domain, a
RR domain and a histidine phosphotransfer (Hpt) domain (Goodman et al., 2004,
Gooderham & Hancock, 2009). The signal transduction pathway from GacA to
individual virulence genes is complex. Phosphorylated GacA positively regulates
the transcription of two small RNAs, rsmZ and rsmY, which block the negative
regulator RNA-binding protein RsmA, allowing the expression of QS signals,
swarming motility, rhamnolipid and lipid biosynthesis (Heeb & Haas, 2001,
Wolfgang et al., 2003, Brencic & Lory, 2009). The GacSA TCS is also involved in
antibiotic resistance to three different antibiotics: tobramycin, ciprofloxacin and
tetracycline (Linares et al., 2006) apparently mediated also by RsmA/RsmZ. The
mechanisms of resistance are poorly understood, and susceptibility to other
antibiotics or antimicrobial peptides remains unaffected.
RetS and LadS
P. aeruginosa utilizes two orphan sensor kinases, RetS (regulator of
exopolysaccharide and T3SS; PA4856) and LadS (lost adherence sensor,
PA3974), to switch between acute and chronic infections and to regulate virulence
mainly through the interaction with GacA-GacS (Goodman et al., 2004, Yahr &
Greenberg, 2004). RetS contains one HK domain and two tandem RR receiver
domain (Goodman et al., 2004). LadS domain organization is similar to that of
RetS, but it does not contain the second C-terminal RR domain (Ventre et al.,
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2006). LadS regulates both early and late maturation stages of biofilm formation
LadS and RetS are hybrid sensor kinases with a signaling domain consisting of a
7-transmembrane region and a periplasmic sensor domain that mediates homoand hetero-dimer formation (Goodman et al., 2004). RetS is required for T3SS
activation, repression of biofilm formation, and colonization/dissemination in
murine acute infection models (Goodman et al., 2004, Laskowski et al., 2004,
Zolfaghar et al., 2005). Genes under RetS control are inversely regulated by two
other sensor kinases: GacS and LadS, probably through the regulation of the small
RNAs RsmZ and RsmA, as suggested by the demonstration that RetS can directly
interact with GacS modulating the levels of RsmZ and RsmA (Ventre et al., 2006,
Gooderham & Hancock, 2009). LadS regulates biofilm formation probably through
the regulation of the pel exopolysaccharide operon (Ventre et al., 2006). In a rat
model with chronic pulmonary infection, LadS and RetS have been reported to

regulate the expression of HcpI secretion island I (required for chronic
infection), thus are also thought to have an important role in chronic infection in
CF by actively regulating HcpI secretion island I (Potvin et al., 2003). LadS
together with RetS and GacA/GacS/RsmZ forms a intricate and dynamic
network that directs the expression of P. aeruginosa key virulence mechanisms
resulting in acute infection (expression of Type III secretion) and chronic
infections (biofilm formation) (Goodman et al., 2004, Yahr & Wolfgang, 2006,
Gooderham & Hancock, 2009). However, the exact regulatory mechanism as
to how LadS and RetS sensors bring about the cascade of signal transduction
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by modulating the expression of rsmZ and rsmY transcription is not known, but
it is possible that other response regulators may be involved (Laskowski &
Kazmierczak, 2006).
NarL-NarX
P. aeruginosa is often known to assume a biofilm mode of growth that is
marked by a substantial metabolic alterations as a consequence of its genetic and
phenotypic variations (Waite et al., 2006, Schreiber et al., 2007). The ability of P.
aeruginosa to grow as biofilms can be largely attributed to its metabolic flexibility
and adaptability that enables it to grow in a low nutrient and oxygen-limited
environment, a characteristic of biofilms. In particular, anaerobic respiration by P.
aeruginosa is considered to be a vital metabolic process during its growth as a
biolfim in chronic pulmonary infections (Barraud et al., 2006, Palmer et al., 2007).
Under anaerobic conditions, P. aeruginosa survives and supports its growth either
by arginine fermentation or by denitrification (Palmer et al., 2005, Palmer et al.,
2007). NarX and NarL TCS pair in P. aeruginosa is known to be involved in
regulating P. aeruginosa denitrification pathways (Schreiber et al., 2007).
Denitrification pathways play an important role in anaerobic respiration, where, in
the absence of oxygen organism respire nitrate (No3-) or nitrite (No2-). In
P.aeruginosa, the Anr (PA1544), Dnr (PA0527) regulatory proteins in concert with
NarL-NarX TCS control the expression of genes encoding proteins required for
denitrification (Benkert et al., 2008). The NarX is a HK which contains a highly
conserved nitrate recognition region. This region is termed as a P-box which
recognizes environmental presence of nitrate to which NarX responds by
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autophosphorylating a conserved histidine residue (Stewart & Bledsoe, 2008).
Further, the transfer of high energy phosphate to the conserved aspartate residue
of the response regulator NarL results in activation or repression of target operon
(Stewart & Bledsoe, 2008). Nitrate metabolism has been linked to motility, biofilm
formation and virulence. NarX-HK is reported to be required for swarming motility,
although the swarming phenotype has been displayed in a narL mutant as a result
of overproduction of rhamnolipids (Van Alst et al., 2007). Also, narLX double
mutants displayed reduced swimming motility in comparison to individual narL and
narX mutants which exhibited normal motility, suggesting that the flagella
dependent movement requires both the sensor kinase and the response regulator
(Van Alst et al., 2007). Thus, the NarX–NarL TCS is involved in regulation several
P. aeruginosa virulence related phenotypes including motility and biofilm
formation.
Conclusion:
The versatility of two-component regulatory systems in sensing different signals,
both extracellular and intracellular, make them an appropriate system for
regulating expression of virulence and metabolism. P. aeruginosa genome
encodes one of the largest groups of TCSs proteins (135), in sequenced bacteria
(Winsor et al., 2011). Amongst these only few have been extensively studied and
characterized in detail, including PhoP-PhoQ, GacA-GacS, RetS, LadS, and
NarL-NarX, that are reported to be responsible for regulating P. aeruginosa key
virulence determinants. Furthermore, in most of the cases, the environmental
signals that influence TCS pathways remains obscure. However, there are a

13

plethora of uncharacterized putative TCSs in P.aeruginosa. Taking into
consideration the metabolic adaptability and the plethora of uncharacterized
putative TCSs in P.aeruginosa, it is most likely that some of these putative systems
may have important roles in virulence, antibiotic resistance and metabolism.
Further research is required to characterize these role of these putative TCS by
elucidate there activating signals, identifying their targets and also various
regulatory networks into which TCS are integrated, since these systems can be
appropriate drug targets for effective antimicrobial therapeutics.
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CHAPTER 2

Pseudomonas aeruginosa MifS-MifR two-component system is specific for
α-ketoglutarate utilization

This Chapter has been published:
Gorakh Tatke, Hansi Kumari, Eugenia Silva-Herzog, Lourdes Ramirez, and
Kalai Mathee 2015. PLoS ONE. 10(6):e0129629
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Abstract
Pseudomonas

aeruginosa

is

a

Gram-negative,

metabolically

versatile

opportunistic pathogen that elaborates multitude of virulence factors, and is
extraordinarily resistance to a gamut of clinically significant antibiotics. This ability,
in part, is mediated by two-component regulatory systems (TCS) that play a crucial
role in modulating virulence mechanisms and metabolism. MifS (PA5512) and
MifR (PA5511) form one such TCS implicated in biofilm formation. MifS is a sensor
kinase whereas MifR belongs to the NtrC superfamily of transcriptional regulators
that interact with RpoN (σ54). In this study we demonstrate that the mifS and mifR
genes form a two-gene operon. The close proximity of mifSR operon to poxB
(PA5514) encoding a ß-lactamase hinted at the role of MifSR TCS in regulating
antibiotic resistance. To better understand this TCS, clean in-frame deletions were
made in P. aeruginosa PAO1 creating PAO∆mifS, PAO∆mifR and PAO∆mifSR.
The loss of mifSR had no effect on the antibiotic resistance profile. Phenotypic
microarray (BioLOG) analyses of PAO∆mifS and PAO∆mifR revealed that these
mutants were unable to utilize C5-dicarboxylate α-ketoglutarate (α-KG), a key
tricarboxylic acid cycle intermediate. This finding was confirmed using growth
analyses, and the defect can be rescued by mifR or mifSR expressed in trans.
These mifSR mutants were able to utilize all the other TCA cycle intermediates
(citrate, succinate, fumarate, oxaloacetate or malate) and sugars (glucose or
sucrose) except α-KG as the sole carbon source. We confirmed that the mifSR
mutants have functional dehydrogenase complex suggesting a possible defect in
α-KG transport. The inability of the mutants to utilize α-KG was rescued by

16

expressing PA5530, encoding C5-dicarboxylate transporter, under a regulatable
promoter. In addition, we demonstrate that besides MifSR and PA5530, α-KG
utilization requires functional RpoN. These data clearly suggests that P.
aeruginosa MifSR TCS is involved in sensing α-KG and regulating its transport and
subsequent metabolism.
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Introduction
Pseudomonas aeruginosa is a metabolically versatile, Gram-negative
opportunistic pathogen that is well known for its extensive spatio-temporal
distribution (Ramos, 2004). It is a dominant nosocomial pathogen capable of
causing

acute

and

chronic

infections

in

immunocompromised

and

immunosuppressed patients (Ledizet et al., 2012, Turner et al., 2014). In particular,
patients with AIDS, severe burn wounds, cystic fibrosis (Brencic et al.), chronic
obstructive pulmonary disease (COPD), non-CF bronchiectasis and neutropenia
are predisposed to P. aeruginosa infections (Lyczak et al., 2000, Manfredi et al.,
2000, Ramos, 2004, Furukawa et al., 2006, Valderrey et al., 2010). P. aeruginosa
chronic pulmonary infections are characterized by intensive bronchial neutrophilic
inflammation resulting in respiratory failure (Emerson et al., 2002, CohenCymberknoh et al., 2013), a major cause of fatality in CF patients (Lyczak et al.,
2002). Moreover, P. aeruginosa is associated with keratitis (Dart & Seal, 1988) and
chronic suppurative otitis media (Yeo et al., 2007) leading to visual impairment and
deafness (Prevatt et al., 2004, Sun et al., 2010). P. aeruginosa possess numerous
virulence factors, both cell-surface associated and secretory, which significantly
contribute to its pathogenesis (Balasubramanian et al., 2013). Effective treatment
of P. aeruginosa infections is impeded by its extraordinary intrinsic and acquired
resistance to numerous clinically important antibiotics (Fraimow & Nahra, 2013).
Thus, antibiotic resistance and expression of multi-determinant virulence factors
are two critical hallmarks in P. aeruginosa infections that make it an intimidating
pathogen.
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Successful infection and disease progression depends significantly on the
ability of any pathogen to effectively utilize available nutrients that are essential for
its growth and survival. P. aeruginosa is renowned for its extraordinary ability to
utilize wide range of organic compounds such as carbohydrates, amino acids, fatty
acids, mono- and polyalcohols, di- and tri-carboxylic acids as sources of carbon,
nitrogen and energy (Ramos, 2004). However, unlike other bacteria where glucose
is the preferred carbon source (Loomis & Magasanik, 1967, Stulke & Hillen, 2000),
P. aeruginosa preferentially utilizes tricarboxylic acid (TCA) cycle intermediates
(Wolff et al., 1991, Collier et al., 1996), specifically, C4-dicarboxylates of the TCA
cycle such as malate, fumarate and succinate (Liu, 1952, Wolff et al., 1991, Collier
et al., 1996).
The TCA cycle is an amphibolic pathway that serves two main purposes:
energy-generation in aerobic organisms (catabolism), and the generation of
intermediates to serve as biosynthetic precursors for fatty acid, amino acid and
carbohydrate synthesis (anabolism) (Owen et al., 2002). The metabolic
intermediates of the TCA cycle consist of a group of organic anions that include
C4-dicarboxylates

(succinate,

fumarate,

malate

and

oxaloacetate),

C5-

dicarboxylates (alpha-ketoglutarate (α-KG)) and C6-tricarboxylates (citrate,
isocitrate) (Krebs, 1940, Frohman et al., 1951). However, the role of TCA cycle
intermediates is not restricted to energy metabolism or to serve as biosynthetic
precursors. In the recent years, TCA cycle intermediates, in-particular, succinate
and/or α-KG have gained significant importance as biological signaling molecules
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in variety of organisms including, bacteria (Ninfa & Jiang, 2005), animals (He et
al., 2004) and plants (Feria Bourrellier et al., 2010).
Sensing the available nutrients is a prerequisite for mobilizing the uptake
systems. Bacterial two-component systems (TCSs), involving a membrane-bound
histidine sensor kinase (HK) and a cytoplasmic response regulator (RR) play an
integral part in bacteria’s ability to sense physiological cues. In response to stimuli,
the sensor autophosporylates at a conserved histidine residue at the C-terminus,
and subsequently the phosphate is transferred to an aspartate residue at the Nterminus of the RR (Stock et al., 1989, Hoch & Silhavy, 1995, Asai et al., 2000).
TCSs in Bacillus subtilis, Corynebacterium glutamicum, Escherichia coli, Klebsiella
pneumoniae, Rhizobium meliloti and Rhizobium leguminosarum have been shown
to regulate extracellular C4-dicarboxylates and tricarboxylates transport (Jiang et
al., 1989, Bott et al., 1995, Reid & Poole, 1998, Golby et al., 1999, Asai et al.,
2000, Yamamoto et al., 2000, Brocker et al., 2009). Of these, DctB-DctD in R.
meliloti is an extensively studied TCS, which in coordination with sigma factor
RpoN(σ54) regulates the extracellular transport of C4-dicarboxylates succinate,
fumarate and malate (Ronson et al., 1987, Watson, 1990).
Three TCS protein pairs in P. aeruginosa namely, PA5165/PA5166
(DctB/DctD), PA5512/PA5511 (MifS/MifR) and PA1336/PA1335 have been
identified to be homologous to the Rhizobium C4-dicarboxylate transport regulatory
DctB/DctD (Valentini et al., 2011). Amongst the three, very little is known of
PA1336/PA1335. The PA5165/PA5166 (DctB/DctD) TCS has been demonstrated
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to regulate the transport of C4-dicarboxylates, succinate, fumarate and malate in
coordination with the sigma factor RpoN (σ54) (Valentini et al., 2011). The SK MifS
(65.3 kDa) and RR MifR (49.6 kDa) share 51% and 69% sequence identity to the
R. meliloti DctB and DctD, respectively (Stover et al., 2000). The RR MifR is
involved in regulating the maturation stage of P. aeruginosa biofilm formation as
mifR deficient mutants fail to form microcolonies (Petrova & Sauer, 2009). Later
studies reported the interdependence of pyruvate fermentation and functional MifR
in supporting microcolony formation (Petrova et al., 2012). However, the
mechanism by which MifR is activated in this process remains obscure and no
relation with HK MifS has been established. Using clean in-frame deletion mutants
of the mifS, mifR and mifSR genes we show that MifSR TCS regulates P.
aeruginosa α-KG transport and requires functional RpoN.
Materials & Methods
Strains, media and growth conditions
P. aeruginosa wild-type PAO1 (Stover et al., 2000) and its derivatives
PAO∆mifS, PAO∆mifR, PAO∆mifSR and PAO∆rpoN or Escherichia coli strain
DH5α were used in this study (Table 2.1). Saccharomyces cerevisiae strain
InvSC1 (Invitrogen, Life Technologies, Carlsbard, CA, USA) was used for in vivo
homologous recombination (Bascom-Slack & Dawson, 1998). Briefly, all bacterial
cultures were grown in Luria Bertani (LB) broth (5 g tryptone, 10 g sodium chloride,
and 5 g yeast extract per liter) or agar (LB broth with 1.5% agar) (Difco, NJ, USA)
or M9 minimal Media (64 g Na2HPO4-7H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl,
20 mM MgSO4, 1 mM CaCl2 per liter) (Sambrook & Russell, 2001) at 37οC, unless
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specified otherwise. Yeast extract-peptone-dextrose media (YEPD: 20 g Bacto
Peptone, 10 g yeast extract, 20 g dextrose per liter) was routinely used to culture
S. cerevisiae and synthetic define agar-uracil media was used as selection media
for pMQ30 yeast transformants (Shanks et al., 2006). P. aeruginosa competent
cells were prepared as previously described (Choi et al., 2006). For growth curve
and complementation studies M9 minimal media supplemented with glucose,
sucrose or TCA cycle intermediates including citrate, α-KG, succinate, fumarate,
malate or oxaloacetate were used as a sole carbon source at 30 mM each unless
specified otherwise. Motility assays were performed in LB media (Difco, NJ, USA).
For pyocyanin and proverdine production strains were cultivated in King’s A
medium (Difco, NJ, USA) and King’s B medium (King et al., 1954). Cation-adjusted
Mueller Hinton broth and agar (Difco, NJ, USA) was used in MIC assays. For
plasmid maintenance, antibiotics were added to growth media when appropriate,
at the specified concentrations: E. coli: ampicillin (Ap) 100 μg/ml, gentamycin
(Siegmund & Wagner) 15 μg/ml, kanamycin (Km) 20 μg/ml, P. aeruginosa: Gm 75
μg/ml.
Genetic manipulations
Genetic manipulations were carried out using standard techniques
(Sambrook & Russell, 2001). Primers were synthesized by Integrated DNA
Technologies, Inc. (Coralville, IA, USA) and are listed in Table 2.2. Plasmid DNA
isolation was carried out using PureLink Hipure Plasmid Miniprep Kit (Invitrogen,
Life Technologies, Carlsbard, CA, USA) and agarose gel fragments were purified
using Wizard SV Gel and PCR Clean-Up System (Promega, Madison, WI, USA).
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RNA and cDNA was made using RNeasy Mini Kit (Qiagen Inc. Venio, Limburg,
Netherlands) and SuperScript III First-Strand Synthesis System (Invitrogen, Life
Technologies, Carlsbard, CA, USA). Restriction endonucleases were from New
England Biolabs (Ipswich, MA, USA) and DNA sequencing was carried out at
Florida International University (FIU) DNA core and at GENEWIZ Inc (South
Plainfield, NJ, USA). All other chemicals were purchased from SIGMA-ALDRICH
(St. Louis, MO, USA), AMRESCO (Solon, OH, USA) and Fisher Scientific
(Waltham, MA, USA).

Table 2.1: Strains and plasmids used in this study.
Strain/Plasmid
Background
Escherichia coli
Strain ID

DH5α

E. coli

Relevant characteristics
F- Φ80lacZΔM15Δ
(lacZYA-argF)U169 deoR
recA1 endA1 hsdR17 (rkmk+) phoA supE44 λ- thi-1
gyrA96 relA1

Source

New England
Biolabs

Saccharomyces cerevisiae
INVSc1

S. cerevisiae

MATa his3D1 leu2 trp1289 ura3-52

Invitrogen

Pseudomonas aeruginosa
PAO1

Prototypic wild type

PKM900

PAO1

∆mifS (PA5512)

PKM901

PAO1

∆mifR (PA5511)

PKM902

PAO1

∆mifSR (PA5511-PA5512)

PAOΔrpoN

PAO1

∆rpoN (PA4462)

PAO1ΔrpoN
::rpoN

PAO1

∆rpoN att Tn7::rpoN_
aacC1
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(Stover et al.,
2000)
PAO∆mifS; This
study
PAO∆mifR; This
study
PAO∆mifSR;Thi
s study
(Heurlier et al.,
2003)
(Heurlier et al.,
2003)

Plasmids
pCR2.1
TOPO

ApR, KmR; colE1 f1 ori
lacZα

pRK600

CmR; colE1 tra+RK2 mob+

pRK2013

KmR; colE1 tra+ RK2 mob+

pEXG2

GmR; colE1, oriT mob+
sacB+

pMQ30

GmR; colE1, oriT

pPSV37

pGDT001

pCR2.1 TOPO

pGDT002

pCR2.1 TOPO

pGDT003

pPSV37

pGDT004

pPSV37

pGDT005

pPSV37

pGDT006

pPSV37

GmR; colE1
oriT lacIq
PlacUV5
ApR; A ~1.7-kb NheI-XbaI
fragment containing mifS
ORF (PA5512) amplified
from PAO1 genome using
HK_mifSF1
and
HK_mifSR1 primers and
cloned into pCR 2.1 TOPO
ApR; A ~1.3-kb NheI-SacI
fragment containing mifR
(PA5511) ORF amplified
from PAO1 genome using
GDT_mifRF1
and
GDT_mifRR1 primers and
cloned into pCR 2.1 TOPO
GmR; The mifS ORF
subcloned from pGDT001
as an NheI-XbaI fragment
into pPSV37
GmR; The mifR ORF
subcloned from pGDT002
as an NheI-SacI fragment
into pPSV37
GmR; A ~3.0-kb NheI-SacI
fragment containing mifSR
(PA5511-PA5512) ORFs
amplified
from
PAO1
genome using HK_mifSF1
and GDT_mifRR1 primers
and cloned directly into
NheI-SacI-cut in pPSV37
GmR; A ~1.3-kb NheI-SacI
fragmentcontaining
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Invitrogen
(Kessler et al.,
1992)
(Figurski &
Helinski, 1979)
(Rietsch et al.,
2005)
(Shanks et al.,
2006)
(Lee et al.,
2010)

This study

This study

pMifS
This study
pMifR
This study

pMifSR
This study

pPA5530 This
study

PA5530 ORF amplified
from PAO1 genome using
GDT_PA5530F1
and
GDT_PA5530R1 primers
and cloned directly into
NheI-SacI-cut in pPSV37
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Table 2.2. Primers used in this study.
Primer Name
HKmifSUF
HKmifSUR
HKmifSDF
HKmifSDR
mifRUF1
mifRUR1
mifRDF1
mifRDR1
mifSRUF1
mifSRUR1
mifSRDF1
mifSRDR1
HK_mifSF1
HK_mifSR1
GDT_mifRF1
GDT_mifRR1
GDT_PA5530F1

Sequence
5’GGAATTGTGAGCGGATAACAATTTCACACAGGAA
ACAGCTTCAGCTCGACTCCGCCGTCG-3’
5’GACGAAGATCACCTGGTCGCCTAGTTAGCTAGCA
TCGGCGGATCGAAACGGC-3’
5’GCCGTTTCGATCCGCCGATGCTAGCTAACTAGGC
GACCAGGTGATCTTCGTC-3’
5’CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCG
TTCTGATACCGCTCTCATGACCGAA-3’
5’-TTTGAATTCGCCTGGTCGAGCAGCGCA-3’
5’-TTTGCTAGCTCGCTCATGTCG-3’
5’-TTTAAGCTTCTCGGCTTCGACGCCCAT
5’-TTTGCTAGCTCGCGAGGCGTC-3’
5’GGAATTGTGAGCGGATAACAATTTCACACAGGAA
ACAGCTGCGAGCACCAGCGCGCCACT-3’
5’TCTCTGACGCCTCGCGAGGGCTGCTCTAGTTAGC
TAGCATCGGCGGATCGAAACGGCGGC-3’
5’GCCGTTTCGATCCGCCGATGCTAGCTAACTAGAG
CAGCCCTCGCGAGGCGTCAGAGA-3’
5’CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCG
TTCTGATTACGTGTTCAGCGCGCTG-3’
5’GCTAGCAGAAGGAGATATACCATGTCCTTGTCCC
GTCCGCTG-3’
5’-TTTTCTAGATCATGTCGTTACGCTCGTGTC-3’
5’GCTAGCAGAAGGAGATATACCATGAGCGACCAG
GTGATCTTCGTCGAC-3’
5’-TTTGAGCTCTGCTTCAGGCCGGCTCTTCGC-3’
5’GCTAGCAGAAGGAGATATACCATGGAAAGCGCCA
AC-3’
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GDT_PA5530R1
GDT_cotransF1
GDT_cotransR1
GDT_cotransF2
GDT_cotransR2
GDT_p37_SeqF
GDT_p37_SeqR
mifR_seqF
mifR_seqR
mifS_SeqF
mifS_SeqF2
PA5530_seqF
PA5530_seqR
DBS_qRT_clpXF
DBS_qRT_clpXR
GDT_qRT_PA5530F
GDT_qRT_PA5530R
qRT_rpoNF
qRT_rpoNR
qRT_icdF
qRT_icdR
qRT_idhF
qRT_idhR
qRT_sucAF
qRT_sucAR
qRT_lpd3F
qRT_lpd3R

5’TTTGAGCTCTCAATCGGTCGTGATCTTCGAGTGC3’
5’-GGTGTTCAGCCTGATCCTGCCGG-3’
5’-CCGCTTCGCGGATCGTCGCTTC-3’
5’-GGATCGTCCACGAACTCGGCGGC-3’
5’-CAGGCGCACCTCGAAGCCGGAC-3’
5’-GACCCGTTTAGAGGCCCCAA-3’
5’-CGTGCTTTACACTTTATGCTTCCGG-3’
5’-TGGTGCTGGAGAACCGGC-3’
5’-GCAGTTCAGCGCCACGAAC-3’
5’-ATCTGGAACGGCAGTGGAACC-3’
5’-ATCGACGGCGAGTTGCAGCA-3’
5’-TCGCGGCATGGAAGAGAC-3’
5’-CATGCCGCGACGCAG -3’
5'- TGCGATTACGATGTGGAGA -3'
5'- CCCTCGATGAGCTTCAGCA -3'
5'-CGCAACGCATCAAGTCGAT-3'
5'-AGTCGTACCACTCGACCAGGTT-3'
5'-AAATGCGAAAAAGCCATTGAG-3'
5'-CCCTGTGCCTCCAGTAAACC-3'
5'-GCGACCGGTGACAAAATCAC-3'
5'-GGGTTCTTCGGTACGCTCAA-3'
5'-GGCGATGATCCGCAACTC-3'
5'-GCATTACCGCCTTGGTGTCT-3'
5'-CTGCAGCCAGCATCACATG-3'
5'-CGAGATTGAGGCCCTTCTTG-3'
5'-CATGCGGCGGAGATGAAC-3'
5'-ACTTCCGGCTGGGTGTAGATG-3'

qRT in the primer name indicates that the primer was designed for qPCR. Broken
and continuous lines below the primer sequence indicate ribosome binding and
restriction sites respectively.
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Construction of P. aeruginosa ∆mifR mutant
An unmarked mifR clean in-frame deletion mutant of P. aeruginosa was
generated by gene splicing (Horton et al., 1990). Upstream and downstream
flanking regions of mifR were amplified by PCR (GC Rich PCR System, Roche,
Indianapolis, IN, USA), using primers listed in Table 2.2. A 754-bp P1 and a 720bp P2 were amplified using upstream primers mifRUF1-EcoRI and mifRUR1-NheI
and the downstream primers mifRDF1-NheI and mifRDR1-HindIII (Table 2.2),
respectively from PAO1 genomic DNA. After sequencing to ensure fidelity, P1 and
P2 were spliced together to obtain a 1474-bp deletion fragment with a deletion of
mifR containing stop codons at its junction (inserted as part of NheI site in the
primer). This was then sequenced and subcloned into a P. aeruginosa nonreplicative plasmid pEXG2 (Rietsch et al., 2005) as a EcoRI-HindIII fragment and
moved into the wild-type PAO1 strain by allelic replacement (Schweizer & Hoang,
1995) using pRK600 and pRK2013 as the helper plasmids (Figurski & Helinski,
1979, Kessler et al., 1992) . Clones were screened for Gm sensitivity (75 µg ml−1)
and sucrose resistance (8 % sucrose) corresponding to a double cross-over
recombination event and replacement of the target gene with the deletion product.
The presence of the deletion in PAOΔmifR (PKM901) was confirmed by PCR
amplification and sequencing of the deletion product (data not shown).
Construction of P. aeruginosa ΔmifS and ΔmifSR mutants
The unmarked mifS and mifSR deletion in PAO1 was generated by using
the yeast system of double-stranded gap repair and homologous recombination
(Shanks et al., 2009). Briefly, the mifS and mifSR upstream and downstream
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flanking regions were amplified by PCR using primers listed in Table 2.2. To create
a mifSR deletion, an upstream 933-bp P1 and a downstream 1115-bp P2 were
amplified using primer pairs mifSRUF1-mifSRDF1 and mifSRUR1-mifSRDR1,
respectively. Similarly, to create mifS deletion, an upstream 703-bp P1 and a
downstream 653-bp were amplified using primer pairs HKmifSUF-HKmifSDF and
HKmifSUR-HKmifSDR, respectively.
stretches

of

HKmifSUF and mifSRUF1 primers had

homologous

DNA,

GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCT-3’

5’and

5’-

CCAGGCAAATTCTGTTTTATCAGACCGCTTCTGCGTTCTGAT-3’, respectively,
to target recombination of the amplicons with pMQ30 vector. These primer pairs
also had complementing sequences at the 3’ end to facilitate joining to create the
P3 fragment, as well as stop codons (CTAGTTAGCTAG) to prevent any run off
translation. The pMQ30 vector has double selection markers URA3 for yeast and
gentamycin for E. coli (Shanks et al., 2006). Yeast cells were transformed with the
P1, P2 and linearized pMQ30 (BamHI digested) using standard protocols and
(Shanks et al., 2009) colonies were selected on sucrose-uracil plates.
The yeast colonies were checked for the presence of P3 constructs for mifS
and mifSR deletions by amplification using upstream forward (mifSRUF1 and
HKmifSUF, respectively) and downstream reverse (mifSRDR1 and HKmifSDR,
respectively) primers. Yeast DNA was isolated from the positive colonies as
described earlier (Shanks et al., 2009). E. coli was transformed with the
recombinant pMQ30 plasmids containing P3s and screened for gentamycin
resistance. The amplified P3s from the recombinant plasmids were sequenced to
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ensure fidelity. The constructs were then moved into PAO1 strain using tri-parental
mating and screened for single and double crossovers using counter selection with
sucrose and gentamycin as described earlier (Balasubramanian et al., 2012,
Kumari et al., 2014). The presence of the gene deletions in all the mutants were
confirmed using standard molecular methods (PCR and DNA sequencing of the
locus). These strains are henceforth referred to as PAOΔmifS (PKM900) and
PAOΔmifSR (PKM902).
Construction of complementing plasmids
DNA fragments from P. aeruginosa PAO1 with mifS (~1.77 kb) and mifR
(~1.35 kb) were PCR amplified using primer pairs HK_mifSF1-HK_mifSF1R1,
GDT_mifRF1-GDT_mifRR1, respectively. In order to ensure expression of the
genes, the primers are designed such that the ORF will juxtapose against a strong
ribosome binding site (Lehninger et al., 2013). The PCR amplified products were
cloned into pCR2.1 TOPO (Invitrogen, Life Technologies, Carlsbard, CA, USA)
using manufacturers protocol to generate plasmids pGDT001 and pGDT002,
respectively. The fidelity of the PCR amplified product was confirmed by
sequencing. The fragments carrying mifS and mifR were moved into a broad host
range pPSV37-Gm plasmid (Lee et al., 2010) as a NheI-SacI fragments,
downstream of an inducible PlacUV5 promoter to generate plasmids pGDT003 and
pGDT004, respectively. Henceforth, these plasmids are referred to as pMifS and
pMifR.
DNA fragments from PAO1 with mifSR (~3.12 kb) and PA5530 (~1.3 kb)
were

PCR

amplified

using

primer
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pairs

HK_mifSF1-GDT_mifRR1

and

GDT_PA5530F1-GDT_PA5530R1 (Table 2.2), respectively. The PCR amplified
products were cloned directly into pPSV37-Gm plasmid as NheI-SacI fragments,
downstream of an inducible PlacUV5 promoter to generate plasmids pGDT005 and
pGDT006, respectively. Sequence fidelity was confirmed by sequencing using the
primers GDT_p37_SeqF-R, mifR_seqF-R, mifS_seqF-F2 and PA5530_seqF-R
(Table 2.2). Henceforth, these plasmids are referred to as pMifSR and pPA5530.
These expression plasmids were then introduced into wild-type PAO1,
PAO∆mifS, PAO∆mifR, PAO∆mifSR and PAO∆rpoN deletion mutants by
electroporation (Choi et al., 2006) and gentamycin resistant colonies were
selected.
Phenotypic microarray
Comparative phenotypic microarray profiles of wild-type PAO1 with
PAO∆mifR and PAO∆mifS mutant were performed at BioLOG Inc. (Hayward, CA,
USA). Phenotypic profiling was carried out in triplicate and data analyses was done
using OmniLog PM Software.
Growth curves
P. aeruginosa PAO1 and its derivatives were grown overnight at 37˚C in LB
broth with or without antibiotics. Overnight cultures were washed with sterile 0.85%
NaCl (wt/vol) solution to remove spent and residual media. Cultures were diluted
in fresh M9 minimal media to obtain equal optical densities (OD600) of 0.025.
Growth of the cultures was assessed in LB broth and in M9 minimal media
supplemented with glucose (30 mM), sucrose (30 mM) or TCA cycle intermediates
including citrate, α-KG, succinate, fumarate, malate or oxaloacetate (at 30 mM,
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unless specified otherwise) as a sole carbon source in 48 and 96 well plates
(Falcon). Growth was monitored by determining absorbance at 600 nm using
BioTek Synergy HT (Winooski, VT, USA) plate reader for 18-24 h at 37οC. All
experiments were performed multiple times in triplicate.
Pyocyanin and pyoverdine production
Extracellular pyocyanin was quantified by extracting the pigment from
culture supernatants using the chloroform-HCL method as described previously
(Essar et al., 1990). Briefly, 5 ml culture supernatants from stationary-phase
cultures (∼18 h) grown in King’s A medium was extracted with 3 ml chloroform.
Pyocyanin was then re-extracted into 1 ml of 0.2 N HCl, resulting in a pink color,
indicating the presence of pyocyanin that was read at 520 nm. The concentration
is expressed as µg of pyocyanin produced per ml of culture (µg/ml), by multiplying
the optical density OD520 by 17.072 (Essar et al., 1990).
To measure pyoverdine production, cells were grown overnight at 37ᵒC in
King’s B medium (King et al., 1954). Pyoverdine in the supernatant was read at
405 nm and normalized to the initial cell density (OD600). Pyoverdine levels were
expressed as a ratio of OD405/OD600 (Shen et al., 2002).
Minimum Inhibitory Concentration
MICs were determined using the E-test as per the manufacturers protocol
(BioMerieux, USA) and/or by standard broth microdilution method . The assays
were performed in triplicate, each with technical triplicate, for each antibiotic in
cation-adjusted Mueller Hinton broth.
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RNA isolation, cDNA synthesis and qRT-PCR
RNA was isolated from P. aeruginosa wild-type PAO1, PAO∆mifR,
PAO∆mifS and PAO∆mifSR strains grown in LB broth followed by 1 h treatment
with 30 mM α-KG. Briefly, overnight cultures grown in LB broth at 37˚C were
washed with sterile 0.85% saline solution to remove spent media and were
subcultured at 37˚C, 200 rpm in LB media. LB broth was used as a carbon source
for initial growth of cultures since PAO∆mifR, PAO∆mifS, PAO∆mifSR and
PAO∆rpoN strains exhibit growth defects in the presence of α-KG alone. When the
cells reached an optical density at 600 nm (OD600) of 0.6-0.7 all the cultures were
treated with 30 mM α-KG for 1 h. Post treatment, RNA was stabilized by addition
of phenol-ethanol mixture (Brencic et al., 2009). Stabilized RNA was then isolated
using RNeasy Mini Kit (Qiagen, Inc Venio, Limburg, Netherlands) as per
manufacturer’s protocol. Residual genomic DNA contamination was removed
using RQ1 Rnase-free DNase (Promega, Madison, WI, USA) and RNA was
repurified using Rneasy Mini Kit (Qiagen, Inc Venio, Limburg, Netherlands).
Quality of purified RNA was assessed on a denaturing agarose gel (NorthernMax
Gly, Ambion, Life Technologies, Carlsbard, CA, USA) and quantified at 260 nm
(BioTEK, Synergy HT, Winooski, VT, USA). cDNA was then synthesized by
annealing NS5 random primers to total purified RNA and subsequent extension
was carried out using SuperScript III reverse transcriptase (Invitrogen, Life
Technologies, Carlsbard, CA, USA).
qRT-PCR to study expression levels of PA5530 under α-KG induction was
performed using Applied Biosystems Step One cycler and detection system with
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PowerSYBR Green PCR MasterMix with ROX (Applied Biosystems, Life
Technologies, Carlsbard, CA, USA). In addition RNA was isolated from PAO1,
PAO∆mifR, PAO∆mifS and PAO∆mifSR strains grown in M9 Minimal media
supplemented with citrate (30 mM) without α-KG treatment, as described
previously. qRT-PCR to study expression levels of genes encoding sigma-54 rpoN
(PA4462), iso-citrate dehydrogenase (idh (PA2623) and icd (PA2624)), α-KG
dehydrogenase complex (sucA (PA1585) and lpd3 (PA4829)) were done
essentially as described above. The cycling conditions used were 95˚C/2 minutes
(holding); 40 cycles of 95˚C/15 sec, 60˚C/1 min (cycling); 95˚C/15 sec, 60˚C/1 min,
95˚C/15 sec (0.6˚C ramp) (melt curve). Expression was normalized to clpX
(PA1802), whose expression was determined to remain constant between the
samples and conditions tested (Balasubramanian et al., 2012).
Bioinformatic Analyses
Sequence analyses and domain organization studies were performed using the
Simple Modular Architecture Research Tool (SMART) (Schultz et al., 1998) and
InterPro domain prediction database (Hunter et al., 2012). mifS (PmifS) and PA5530
(PPA5530) promoter analyses and motif search was done using the ensemble
learning method SCOPE and GLAM2 (Gapped Local Alignment of Motifs)
(Chakravarty et al., 2007, Frith et al., 2008). Multiple sequence alignment was
generated using ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) and
www.pseudomonas.com (Winsor et al., 2011).
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Statistical Analyses
All data were analyzed for statistical significance using the Student’s t-test
on GraphPad or Analysis of Variance (ANOVA) with post-hoc testing when
appropriate, on IBM SPSS Statistics 22.0 statistical analysis software. Differences
were considered to be significant at p- values < 0.05.
Results
mifS and mifR are a part of a two-gene operon
In eubacteria, the genes that encode a HK and its cognate RR are often
linked and are co-transcribed (Stock et al., 1989). Our sequence analysis of P.
aeruginosa PAO1 genome revealed that mifS (PA5512) and mifR (PA5511) are
adjacent to each other, in the same orientation. The predicted translation start site
of mifR ORF overlaps with mifS translation termination codon indicating that they
are cotranscribed (Figure 2.1A and 2.1B). To determine if these two genes form
an operon, cDNA across the intergenic regions spanning mifS and mifR was
amplified using GDT_cotransF1-R1 and GDT_cotransF2-R2 primers (see
Materials and Methods)x. As expected, 200 bp and 100 bp products were detected
when using primers that span the overlapping region (Figure 2.1C, Lane 3 and
Lane 4). These results confirm that mifS and mifR are a part of a two-gene operon.
As controls, the mifSR genes were also amplified (Figure 2.1C, Lane 2).
Loss of mifS and mifR did not affect antibiotic resistance
To identify the role of MifSR TCS, clean in-frame deletion mutants of mifS,
mifR and mifSR were constructed in the prototypic P. aeruginosa PAO1.
Henceforth they will be referred to as PAO∆mifS, PAO∆mifR and PAO∆mifSR,
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respectively. For complementation studies, recombinant plasmids containing the
entire mifR, mifS and mifSR genes were constructed. The complementing
plasmids with the genes are called pMifS, pMifR and pMifSR. These plasmids were
introduced into the respective mutant strains.
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Figure 2.1: Genome organization of the mifSR gene locus. In P. aeruginosa
PAO1 the mifR (PA5511) ORF has a translation start codon (Briard et al.)
overlapping the mifS (PA5512) termination codon (TGA), denoted in red (B),
suggesting that the mifS and mifR genes are physically linked. The cDNA
amplification of the intergenic region spanning the mifS and mifR genes using
GDT_cotrans F1-R1 and GDT_cotrans F2-R2 primers (Table 1) confirm that the
two genes mifS and mifR are co-transcribed and form an operon (C).
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Previous studies in our lab postulated that the MifSR TCS system, found
81-bp upstream of the pox operon, may contribute to P. aeruginosa ß-lactam
resistance (Kong et al., 2005) as the genes regulated by TCS tend to be co-located
on the chromosome (Stock et al., 1989). However, MIC analyses using E-test and
micro-dilution methods showed that the loss of these genes did not affect the
antibiotic resistance profile when compared to the parent strain, P. aeruginosa
PAO1(Data not shown). Further, qRT-PCR studies showed that deletion of mifS,
mifR and mifSR had no effect on the expression of poxB compared to the parent
PAO1 (Figure 2.2).

Figure 2:2 Expression of poxB (PA5514) in mifSR mutants. Expression of
poxB (PA5514) was tested in mifSR mutants relative to PAO1. Data was
normalized to expression in PAO1. Bars above or below the line represents upand down-regulation, respectively and the bars indicate standard errors. The
clpX gene (PA1802) was used as the housekeeping control. There was no
statistically significant difference (p-value > 0.05) between the wild type PAO1
and mifSR mutant strains as determined by one-way ANOVA and student’s
unpaired t test.
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mifS, mifR and mifSR mutants failed to grow in the presence of α-KG
The PAO∆mifS, PAO∆mifR and PAO∆mifSR mutants exhibited no
discernible phenotype compared to the parent PAO1 when tested for growth,
swimming, swarming, twitching motility (LB media), pyocyanin production (LB &
King’s A media), pyoverdine production (LB & King’s B Media), congo red binding
assay (CR media) and antibiotic resistance (MH media) (Data not shown). Hence,
a comparative phenotypic microarray analysis was performed with the wild-type
PAO1, PAO∆mifR and PAO∆mifS mutants (BioLOG Inc.). Out of approximately
2000 metabolic and chemical sensitivity assays tested, PAO∆mifR exhibited four
gain-of-function and 29 loss-of-function phenotypes whereas PAO∆mifS exhibited
two gain-of-function and 23 loss-of-function phenotypes (Figure 2.3A). A single
gain of function phenotype shared between PAO∆mifS and PAO∆mifR, was the
ability to utilize L-methionine. When metabolism and chemical sensitivity were
compared, the mutants appear more sensitive to various antibiotics (Figure 2.3B).
However, none of these were reproducible in the lab in the MH media. The loss of
mifS and mifR resulted in differential phenotype in the presence of six metabolites,
amongst which, two were common to both mifS and mifR mutants (Figure 2.3B).
The shared metabolic phenotypes involved the utilization of L-methionine and αKG (Figure 2.3C). Compared to the parent PAO1, the mutants did not exhibit any
growth increase when provided with L-methionine (Figure 2.4). This could be
simply due to the difference in culture conditions and BioLOG proprietary media.
The inability to utilize α-KG by PAO∆mifS (Figure 2.5A) and PAO∆mifR
(Figure 2.5B) in the BioLOG assay was reproduced in M9 minimal media
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supplemented with 30 mM α-KG (Figure 2.5C). In fact, all three mutant strains,
PAO∆mifR, PAO∆mifS and PAO∆mifSR failed to grow in the presence of α-KG
(Figure 2.5C). To rule out potential toxicity, the wild-type P. aeruginosa PAO1 and
the mutants were cultured in M9 minimal media with varying concentrations of αKG, ranging from 1 to 80 mM (Figure 2.6). The mutants exhibited no growth in the
presence α-KG after 24 h at 37˚C, whereas the wild-type PAO1 exhibited an
increase in growth that was proportional to α-KG concentration (Figure 2.6B). All
subsequent experiments were done with 30 mM α-KG. The growth defect exhibited
by PAO∆mifS, PAO∆mifR and PAO∆mifSR could be restored to the wild-type
levels by introducing mifR and mifSR genes into the respective mutants (Figure
2.5D and Figure 2.7A).
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Figure 2.3: mifS and mifR dependent phenotypes. To identify the role of
P. aeruginosa mifSR TCS, comparative phenotypic microarray of PAO∆mifS,
PAO∆mifR mutants and wild-type PAO1 strain was performed at BioLOG Inc.
(Hayward, CA, USA). Venn diagram of differentially regulated phenotypes of
the mutants compared to their isogenic parent PAO1, showing gain of
function or loss of function phenotypes (A). Phenotypic differences were
further classified based on metabolic and chemical sensitivity properties (B).
The phenotypes common to both mifS and mifR mutants are listed (C).
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Figure 2.4: Growth curve analysis in the presence of methionine. Growth
curves of P. aeruginosa wild-type PAO1 and mifSR mutants in M9 minimal
media supplemented with glucose (30 mM) and methionine (5 mM) as carbon
and nitrogen source.
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Figure 2.5: Phenotypic microarrays of PAOΔmifS and PAOΔmifR mutants.
The loss of mifS and mifR results in a growth deficient phenotype in the
presence of α-KG as a sole carbon source, as depicted by BioLOG plate PM1,
well D6 (A and B). Loss of growth phenotype was confirmed by growing PAO1,
PAO∆mifS, PAO∆mifR and PAO∆mifSR mutants in M9 minimal media with αKG (30 mM) for 18 to 24 h at 37ᵒC (C). The growth defect was rescued by
expressing mifR and mifSR genes (D) and the gene encoding the α-KG specific
transporter PA5530 (E) in trans.
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in trans.

and mutants as determined by one-way ANOVA with Bonferroni’s post-hoc test, ** p-value < 0.001.

mean with standard deviation of three biological replicates. Statistically significant difference between the wild type

over a period of 24 h at 37˚C. OD600 at 0 h (A) and 24 h (B) is plotted against α-KG concentration. Results shown are

KG (1 to 80 mM) as the sole carbon source. Growth was monitored by measuring absorbance at 600 nm (OD600)

mutants, PAOΔmifS, PAOΔmifR and PAOΔmifSR were grown in M9 minimal media with varying concentrations of α-

Figure 2.6: Growth profile in the presence of varying concentrations of α-KG. PAO1 and its isogenic mifSR
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Growth curves of P.

the presence of pPA5530 (B) in M9 minimal media with α-KG (30 mM).

aeruginosa wild-type PAO1, mifSR single and double deletion mutants and its complimenting clones (A) and in

Figure 2.7: Rescue of α-KG-dependent growth phenotype of mifSR mutants.

mifSR mutants exhibit α-KG dependent growth defect
α-KG is a key TCA cycle intermediate (Figure 2.8) and plays an important
role in regulating carbon and nitrogen metabolism (Doucette et al., 2011). It has
been previously shown that P. aeruginosa preferentially utilizes TCA cycle
intermediates as a carbon source over other compounds (Liu, 1952, Wolff et al.,
1991, Suh et al., 2002). To test if the growth defect exhibited by the loss of mifS
and mifR is restricted to α-KG utilization, the mutants and the complementing
strains were grown in the presence of TCA cycle intermediates citrate, succinate,
fumarate, malate and oxaloacetate at 30 mM each. No difference in growth was
observed between wild type PAO1 and its isogenic mutants in the presence of
other TCA cycle intermediates except for α-KG (Table 2.3). This is not surprising
as P. aeruginosa can use the glyoxylate shunt pathway to bypass the need for αKG (Figure 2.8) (Campbell et al., 1953). Furthermore, no difference in the growth
profile of the wild type PAO1 and mifSR mutants was observed when grown in the
presence of sugars, glucose and sucrose (30 mM each) (Data not shown). To
reconfirm that the presence of α-KG is not toxic, the cells were grown in the
presence of citrate and succinate combined in equal concentration with α-KG. The
mutants and the wild type shared similar early exponential growth (Figure 2.9).
However, the mutants reached stationary phase earlier as compared to the parent
strain PAO1. This suggests that the presence of excess carbon source in the form
of α-KG further contributes to the growth of PAO1. These analyses indicate that
mifSR mutants are only defective in α-KG utilization.

46

Figure 2.8: Tricarboxylic acid (TCA) cycle and its related reactions. Enzymes
converting iso-citrate to α-KG (iso-citrate dehydrogenase: Icd, Idh), α-KG to
succinyl-coA (α-KG dehydrogenase complex: SucA, SucB, Lpd3) and those
involved in the glyoxylate shunt (isocitrate lyase (AceA) and malate synthase G
(GlnB)) are shown in bold. Green boxes indicate the amino acid biosynthetic
precursors of α-KG involved in the anaplerotic reaction.
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growth.

suggests that PAO1 can efficiently utilize excess carbon source in the form of α-KG contributing to its increased

exponential phase but reached stationary phase earlier, suggesting that it has depleted usable C-source. This

succinate (A) and citrate (B) at 30 mM each. In comparison to the wild-type PAO1, mifSR mutants shared a similar

KG is toxic to the cells, wild-type PAO1 and mifSR mutants were grown in the presence of α-KG in combination with

Figure 2.9: Growth curves in presence of α-KG in combination with succinate and citrate. To determine if α-
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growth was monitored by measuring the absorbance at 600 nm. No difference was observed in the growth rate of

cycle intermediates at 30 mM each, as the sole carbon source. Cells were cultured for 18 to 24 h at 37˚C and their

Growth of the wild type PAO1 and mifSR mutants was tested in M9 minimal media supplemented with different TCA

+++, growth; ---, no growth
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α-Ketoglutarate

+++

Succinate

+++

+++

Citrate

Malate

+++

Oxaloacetate

+++

+++

Pyruvate

Fumarate

PAO1

Carbon Source

Table 2.3. Growth properties of mifSR mutants in presence of TCA cycle intermediates.

mifSR mutants are defective in α-KG transport
The absence of growth in the presence of exogenous α-KG could be due to
either failure to enter the cells or loss of the mutants’ ability to convert α-KG to
succinate. The latter is likely if the mutants failed to express a functional α-KG
dehydrogenase complex. The ability of mifSR mutants to grow effectively in the
presence of citrate and succinate suggests that these mutants are likely to harbor
a functional α-KG dehydrogenase complex, unless the mutants bypass it using the
glyoxylate shunt (Figure 2.8). The former is likely as qPCR analysis of genes
encoding isocitrate dehydrogenase (idh, icd) and α-KG dehydrogenase complex
(sucA, sucB, lpd3) revealed no difference in the expression levels in the wild-type
PAO1 and mifSR mutants (Figure 2.10).
α-KG is a hub for anaplerotic reactions, a process for replenishing TCA
cycle intermediates. In this process glutamate, glutamine, proline and arginine act
as precursor molecules for α-KG synthesis (Kornberg, 1966). Growth studies in
the presence of these amino acids would serve as another indirect measure to test
the functionality of α-KG dehydrogenase complex in mifSR mutants. To test this
hypothesis, PAO1, PAO∆mifR, PAO∆mifS and PAO∆mifSR mutants were cultured
in the presence of glutamate, glutamine, proline and arginine (Table 2.4). The
parent PAO1 and the isogenic mutants exhibited similar growth phenotype. From
the expression studies and growth analyses we deduce that the mifSR mutants
are impaired in α-KG transport.

50

Figure 2.10: Quantification of rpoN, acnA, idh, icd, sucA, and Ipd3 mRNA
by qRT-PCR. RNA was isolated from cells grown in M9 minimal media
supplemented with citrate (30 mM), reverse transcribed to cDNA and the
presence of specific transcripts was analyzed by qPCR using gene-specific
primers (Table 5). The expression of genes encoding aconitate hydratase 1
(acnA

(PA1562))

isocitrate

dehydrogenase

(idh

(PA2623))

isocitrate

dehydrogenase, α-KG dehydrogenase complex (icd (PA2623)), sucA (PA1585)
and lpd3 (PA4829), and σ54 (rpoN (PA4462)) were analyzed in mifSR mutants
relative to PAO1 (log10 RQ = 1). Bars above or below the line represents upand down-regulation, respectively and the bars are standard errors. The clpX
(PA1802) gene was used as the housekeeping control. Statistically significant
difference between the wild type and mutants as determined by one-way
ANOVA with Bonferroni’s post-hoc test. Difference in the expression levels of
genes is not statistically significant at p-value < 0.05.
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Table 2.4. Growth profile analysis of the mifSR mutants in presence of
amino acids.

Carbon Source

PAO1

Glutamate
+++
Glutamine
+++
Proline
+++
Arginine
+++
+++, growth; ---, no growth

∆mifR

∆mifS

∆mifSR

+++
+++
+++
+++

+++
+++
+++
+++

+++
+++
+++
+++

Cells were grown in the M9 minimal media with the indicated amino acids (30
mM each). Data is represented in terms of growth and no growth phenotype.
mifSR TCS genes regulate extracellular α-KG transport
In a recent study using transposon mutagenesis; PA5530 was identified as
the functional α-KG transporter (Lundgren et al., 2014). To confirm the role of P.
aeruginosa PA5530 in α-KG uptake and identify the role of mifSR genes, the gene
was amplified and subcloned downstream of the inducible PlacUV5 promoter. The
plasmid pPA5530 was introduced into PAO1 and the mifSR mutants. Expression
of PA5530 in trans in PAO∆mifS, PAO∆mifR, PAO∆mifSR mutants restored their
growth to a level similar to the wild-type PAO1 in M9 minimal media with α-KG (30
mM) as the sole carbon source (Figure 2.7B). Expression of an extra copy of
PA5530 gene in the wild-type PAO1 did not affect its growth (Figure 2.5E). This
finding suggests that expression of PA5530 is likely regulated by MifSR and/or αKG. In fact, expression of PA5530 is regulated by α-KG, as seen in qRT-PCR
analysis when PAO1 was grown in M9 media with varying amounts α-KG (Figure
2.11A). The loss of mifS, mifR and mifSR results in a significant decrease in
PA5530 expression as compared to the wild type PAO1 in the presence of α-KG
(Figure 2.11B). Thus, α-KG-dependent PA5530 expression requires MifSR.
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Bonferroni’s post-hoc test, ** p-value < 0.001

Statistically significant difference between the wild type and mutants as determined by one-way ANOVA with

respectively and the bars indicate standard errors. The clpX gene (PA1802) was used as the housekeeping control.

PAO1 under the respective conditions. Bars above or below the line represents up- and down-regulation,

mutants relative to PAO1, with cells exposed to 30 mM α-KG for 1 h (B). Data was normalized to expression in

type PAO1 with varying concentrations of α-KG (1 h) (A). In addition, the expression of PA5530 was tested in mifSR

Figure 2.11: Expression of PA5530 in response to α-KG. PA5530 gene expression was determined in the wild

RpoN (σ54) is required for α-KG utilization
The closest P. aeruginosa MifS and MifR homologs are R. meliloti DctB and
DctD (Stover et al., 2000). In fact, MifR is 69% similar to R. meliloti DctD that
belongs to the Sigma 54 (σ54) dependent NtrC family of transcriptional regulators
(Stover et al., 2000, Valentini et al., 2011). Thus, it is likely that MifR has the
conserved domains found among NtrC family of regulators, an N-terminal
regulatory, a central σ54 activation and a C-terminal DNA binding domains (Morett
& Segovia, 1993, Osuna et al., 1997). MifR analysis using the simple modular
architecture research tool (SMART) (Schultz et al., 1998) and InterPro (Hunter et
al., 2012) revealed the presence of three domains: CheY-homologous
receiver/regulatory, a central AAA+ region required for σ54 activation, and the DNA
binding helix-turn-helix domains (Figure 2.12A). The central AAA+ domain contains
seven conserved regions designated C1 to C7 (Morett & Segovia, 1993) that are
characteristic of σ54-dependent transcriptional regulators. Sequence analysis of
MifR revealed the presence of all the seven conserved regions in the AAA+ domain
between amino acid residues 144 to 373 (Figure 2.12B).
Since MifR exhibits high identity to σ54-dependent transcriptional regulators,
we hypothesized that P. aeruginosa rpoN mutants should exhibit a α-KGdependent phenotype, similar to the mifSR mutants. To verify this hypothesis, we
tested the ability of PAO∆rpoN mutant to grow in the presence of α-KG (30 mM)
(Table 2.5). As expected, PAO∆rpoN failed to grow in the presence of α-KG (Table
2.5). The growth of the rpoN mutant was restored in PAO∆rpoN::rpoN
complementing strain. Further, in trans expression of mifR and mifSR in
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PAO∆rpoN mutant failed to restore their growth in the presence of α-KG (Table
2.5). This data confirms that MifR regulatory function requires functional RpoN
(σ54).
The small 81-bp mifSR promoter has no obvious RpoN sigma factor -12/24 consensus sequence: 5’-TGGCACG-N4-TTGCW-3’ in which W stands for
either A or T (Figure 2.13A) (Barrios et al., 1999). In fact, it appears to have a
potential -10 (consensus: TATAAT) but lacked -35 (consensus: TTGACA) for
sigma-70 promoter (Figure 2.13A) (Paget & Helmann, 2003). On the other hand,
the promoter region of PA5530 is 315-bp long with strong -12 and -24 boxes
upstream of the predicted transcription start site (Figure 2.13B). We hypothesized
that the inability of rpoN mutant to utilize α-KG can be rescued by expressing
PA5530 under a regulatable promoter PlacUV5. As expected, the growth of the rpoN
mutant was restored when the plasmid harboring the transporter PA5530 was
expressed in trans (Table 2.5). This suggests that expression of PA5530 requires
both MifSR TCS and RpoN.
The presence of a common motif, GATCGGCGGATt/gTCC, in the PmifS and
PPA5530 (Figure 2.13A and 2.13B) suggest that these two operons share some
common regulatory mechanism. In addition, both promoters possess multiple
motifs: PmifS has two sets of large overlapping inverted repeats, and PPA5530 has
three sets of direct repeats (Figure 2.13A and 2.13B). However, the role of these
motifs remains to be elucidated.
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Figure 2.12: P. aeruginosa MifR domain organization and sequence
alignment. (A) MifR domain organization determined using the Simple Modular
Architecture Research Tool (SMART) (Schultz et al., 1998). MifR is a sigma-54
dependent transcriptional activator (Winsor et al., 2011). There are three
functional domains, N-terminal receiver with the conserved aspartate residue at
position 53 (Asp-53) (Purple), central AAA+ ATPase, characteristic of sigma-54
dependent activation proteins (Green), and the C-terminal helix-turn-helix
(HTH) DNA binding (Manfredi et al.) domains. (B) Sequence alignment of MifR
with P. aeruginosa DctD (PA5166), NtrC (PA5125) and R. meliloti DctD.
Vertical bars indicate conserved residues, asterisk (*) indicate residues are
identical at that position. Key residues of the central AAA+ domain (C1 to C7)
are well conserved amongst sigma-54 dependent transcriptional activators. The
horizontal arrow bars indicate HTH domain. Asp-53 indicates the conserved
phosphorylation site of P. aeruginosa MifR. The alignment was generated using
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
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Table 2.5. Growth properties of PAO1ΔrpoN and its derivatives in the
presence of α-KG and LB.

Strain

PAO∆rpoN

Plasmid

α-KG

LB

-

---

+++

Vector

---

+++

pRpoN

+++

+++

pMifR

---

+++

pMifSR

---

+++

pPA5530

+++

+++

+++, growth; ---, no growth
Growth of PAO1ΔrpoN mutant and its derivatives was tested in the M9 minimal
media supplemented with α-KG (30 mM) and in the LB media at 37˚C for 24h.
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Figure 2.13: In silico analysis of mifS (PmifS) and PA5530 (PPA5530) promoter
sequences. Motif search was done using the ensemble learning method
SCOPE and GLAM2 (Gapped Local Alignment of Motifs) (Chakravarty et al.,
2007, Frith et al., 2008). (A) Sequence analysis of the 81-bp (PmifS) (black)
indicates a putative σ70-dependent -10 consensus (TATAAT). However, it lacks
the -35 consensus (TTGACA) for σ70 promoter (Potvin et al., 2008). Arrows
represent the long 17-bp direct and inverted repeats in PmifS with a consensus
GGAt/cAGCGACATCGGCG. (B) The 315-bp promoter region of PA5530
showing strong -12 and -24 σ54-dependent promoter like element and the
proposed transcription start site (+1). Dashed line (blue) depicts a common
motif in PmifS and PPA5530 suggesting a common regulatory mechanism (A and
B). The three pairs of direct repeats in PPA5530 are represented by green, blue
and orange arrows. PPA5530 possess the signature sequence (AAc/uAAc/uAA)
for catabolite repression control (Crc) protein (brown box) (Sonnleitner et al.,
2009). The uncharacterized small antisense RNA (asRNA) identified in the
PPA5530 region (Wurtzel et al., 2012) is indicated by marked line.
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Figure 2.14: Proposed model for α-KG utilization in P. aeruginosa. HKMifS senses the extracellular α-KG to undergo phosphorylation. The phosphate
is transferred to the RR-MifR. The phosphorylated MifR in coordination with
RpoN (σ54) activates the expression of α-KG specific transporter gene PA5530.
PA5530 thus enables the influx of α-KG to meet the metabolic and energy
demands of the cells. PA5530 promoter (PPA5530) region has a Crc binding site
(Figure 2.13), suggesting that it is under the catabolite repression control by
Crc/CrcZ. The PPA5530 also shows the presence of another uncharacterized
small non-coding asRNA indicating a multilayered and complex regulation of
the α-KG transport system.
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Discussion
P. aeruginosa pathogenicity relies significantly on its metabolic flexibility.
However, establishment of successful infection and its progression requires more
than just meeting nutritional demands. Precision in sensing environmental signals
concomitant with a quick and appropriate response is the key to efficient bacterial
adaptation and survival. An arsenal of TCSs encoded in its genome has furnished
P. aeruginosa with a sophisticated capability to regulate diverse metabolic and
virulence processes, ensuring its success as a pathogen (Nishijyo et al., 2001,
Gooderham & Hancock, 2009, Winsor et al., 2011). P. aeruginosa genome
encodes one of the largest groups of TCS proteins identified in any sequenced
bacterial species (Barakat et al., 2009, Winsor et al., 2011). Bacterial TCS’s sense
and respond to a variety of external cues such as nutrient availability, osmolarity,
redox state, temperature, and concentrations of other extracellular molecules
(Stock et al., 2000). However, very few TCS signaling molecules have been
identified to date. In this study we suggest that the P. aeruginosa MifSR TCS
exclusively senses α-KG, a C5 dicarboxylate and a key component of TCA cycle.
P. aeruginosa antibiotic resistance is independent of MifSR TCS
A common feature of bacterial genomes is a close association between the
functionally related genes and their location on the chromosome (Dandekar et al.,
1998, Overbeek et al., 1999). Typically, genes encoding functionally related HKs
and RRs are often physically linked and are co-transcribed as an operon (Stock et
al., 1989, Chen et al., 2004). Indeed, our in silico analysis (Figure 2.1A and 2.1B)
and cDNA amplification (Figure 2.1C) reveled that mifS-mifR genes are co-
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transcribed and form an operon. This also suggests that HK-MifS and RR-MifR are
functionally related and work as a TCS pair. In addition, TCS proteins are known
to regulate expression of genes in their immediate vicinity (Stock et al., 1989). The
mifSR genes are 81 bp upstream of the two-gene poxAB (PA5513-5514) operon.
Due to the proximity of mifSR to poxB which encodes for a β-lactamase, we
postulated that mifSR TCS regulates antibiotic resistance. However, our initial
results nullified this hypothesis in which comparative MIC’s (Data not shown) and
qRT-PCR data (Figure 2.2) showed no difference in antibiotic resistance profiles
or poxB expression between the wild-type PAO1 and mifSR single and double
deletion mutants.
MifSR TCS regulates P. aeruginiosa α-KG utilization
A previous transcriptome study of the wild-type PAO1 and a mifR deletion
mutant cultivated under biofilm-specific conditions showed significant alteration in
the expression of genes involved in regulating P. aeruginosa metabolism, small
molecule transport and amino acid biosynthesis (Petrova et al., 2012). The majority
of the changes observed in phenotypic microarrays of the mifS and mifR mutant
strains cultivated under planktonic conditions were associated with chemical
sensitivity and not with metabolism (Figure 2.3B). Only 12-16% of phenotypic
changes were associated with metabolism. This confirms the significant metabolic
differences in the rich planktonic versus anaerobic mode of biofilm growth in P.
aeruginosa (Waite et al., 2006).
Petrova et al. (2012) have also demonstrated that genes involved in energy
metabolism, including anaerobic metabolism and fermentative pathways using
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arginine (arcDABC) and pyruvate, were expressed significantly less in ∆mifR
mutant biofilms as compared to its parent PAO1 (Petrova et al., 2012). Though
pyruvate is needed for biofilm formation, it cannot compensate for the loss of mifR
(Petrova et al., 2012). Interestingly, the biofilm phenotype associated with the loss
of mifR can be complemented by ldhA encoding D-lactate dehydrogenase to wild
type levels of biomass accumulation and microcolony formation (Petrova et al.,
2012). These findings suggest that MifR somehow regulates expression of ldhA, a
second gene in a three-gene operon gacS-ldhA-PA0926 (Winsor et al., 2011).
Importantly, analyses of the promoters reveal the presence of a shared motif in
PmifS (GATCCGCCGATGTCC) and PPA5530 (GATCGGCGGATTTCC) (Figure 2.13)
and PgacS (AATCCGCCGGGCTGC) suggesting a possible coordinate regulation,
and that need to be verified.
Our phenotypic microarray analyses and growth experiments suggested
that P. aeruginosa α-KG utilization requires MifS and MifR (Figure 2.5 and 2.7A).
The ability of PAOΔmifR, PAOΔmifS and PAOΔmifSR to grow in the presence of
α-KG was restored by in trans expression of mifR and mifSR (Figure 2.7A).
Interestingly, the PAO∆mifS was complemented by pMifR and pMifSR (Figure
2.5D) but not by pMifS alone. To rule out that gene expression may have been
compromised, the mifS gene was cloned downstream of the inducible PlacUV5
promoter. Though the expression of stable protein was visible in a protein gel, it
failed to complement PAO∆mifS mutant (data not shown). This suggests that cisexpression of mifS and mifR is critical for MifS-function. Other researchers have
encountered similar problems involving histidine kinases (Yeung et al., 2011).
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Moreover, complementation of the PAO∆mifS with pMifR suggests that either
phosphorylation is not required or there is a potential crosstalk between MifR and
other non-cognate HKs. Alternatively, phosphorylation of MifR can occur through
small molecule phosphor-donors, like acetyl phosphate, carbamoyl phosphate and
phosphoramidate (Deretic et al., 1992). Such phenomenon is observed with other
TCS RRs (Lukat et al., 1992, Wanner & Wilmes-Riesenberg, 1992, Varughese,
2002). However, this has to be verified.
The C5-dicarboxylate α-KG is an important intermediate in the energygenerating TCA cycle (Figure 2.8) and plays a key role in regulating carbon and
nitrogen metabolism (Doucette et al., 2011). Similar to other bacteria (Janausch et
al., 2002), TCS’s in P. aeruginosa have been reported to regulate transport and
utilization of TCA cycle intermediates such as succinate, fumarate, malate and
citrate (Nishijyo et al., 2001, Valentini et al., 2011). The R. meliloti DctB/DctD
system is a well-characterized TCS that controls the transport of TCA cycle C4dicarboxylates succinate, fumarate and malate (Janausch et al., 2002). Though P.
aeruginosa MifS/MifR proteins are homologous to R. meliloti DctB/DctD TCS
proteins, the mifSR mutants efficiently utilized citrate, succinate, fumarate, malate,
oxaloacetate, sucrose and glucose but exclusively failed to grow in the presence
of α-KG (Table 2.3). This was further supported by another parallel study that
shows that α-KG utilization requires MifR (Lundgren et al., 2014). Thus, the P.
aeruginosa MifSR TCS is specifically and uniquely involved in C5-dicarboxylate αKG utilization.
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MifSR TCS modulates P. aeruginosa α-KG transport
The inability to utilize α-KG suggested that the mifSR mutants either have
a defective α-KG dehydrogenase complex (inability to convert α-KG to succinylcoA, Figure 2.8), or they are deficient in the transport of α-KG into the cell. The
former was ruled based upon multiple findings: unchanged expression levels of
genes encoding α-KG dehydrogenase, lpd3 (PA4829) and sucA (PA1585) (Figure
2.10); the ability to use C4 and C6 dicarboxylates (Table 2.3) and C5 family of amino
acids such as arginine, proline, glutamine, and histidine (Table 2.4). The C5 family
of amino acids act as biosynthetic precursors of glutamate that ultimately are
converted to α-KG by a transamination reaction or through the action of glutamate
dehydrogenase (Lehninger et al., 2013). These findings strongly argued that the
mifSR mutants were defective in their ability to transport α-KG into the cell.
To date, among the identified carboxylate transporters, the C4-dicarboxylate
transporters have been reasonably well characterized. Based on protein sequence
similarity analysis, bacterial C4-dicarboxylate transporters are classified into five
families, namely, dicarboxylate transport (DctA); dicarboxylate uptake (DcuAB),
(DcuC) and (CitT) and the tripartite ATP-independent periplasmic (TRAP) families
(Janausch et al., 2002). Amongst these, DctA transporters, a subgroup of the
dicarboxylate/amino acid:cation symporter (DAACS) family (Busch & Saier, 2002,
Busch & Saier, 2004, Saier et al., 2006), are extensively studied and are implicated
in the transport of C4-dicarboxylates in Echerischia coli (Davies et al., 1999),
Bacillus subtilis (Asai et al., 2000), Rhizobium meliloti (Yarosh et al., 1989, Watson,
1990), Rhizobium leguminosarum (Finan et al., 1981, Ronson et al., 1987) and
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Corynebacterium glutamicum (Youn et al., 2009). As we were trying to identify the
MifSR-dependent transporter Lundgren et al., reported that PA5530 is involved in
α-KG transport (Lundgren et al., 2014). As predicted, in trans expression of
PA5530 was able to restore the ability of mifR, mifS and mifSR mutants to grow in
α-KG (Figure 2.5E). This is further confirmed by the increase in PA5530 expression
in PAO1 in the presence of α-KG (Figure 2.11A). PA5530 shares no homology with
the P. aeruginosa C4-dicarboxylate transporter PA1183 (DctA). However, it does
have conserved protein domain family PRK10406 implicated in α-KG transport and
shares ~70% homology to E. coli and Erwinia spp. α-KG permease KgtP (Seol &
Shatkin, 1991, Marchler-Bauer et al., 2015). A common feature in the transport of
C4-dicarboxylates and other carbon sources in different bacteria is the involvement
of TCS mediated regulatory mechanism. Involvement of TCSs, a stimulusresponse coupled mechanism, in the transport of C5-dicarboxylates suggests a
more profound role of α-KG as a signaling molecule.
P. aeruginosa α-KG transport requires functional RpoN (σ54)
P. aeruginosa RpoN (σ54) is involved in a myriad of functions including
expression of virulence factors and nutrient uptake (Potvin et al., 2008). Functional
RpoN is reported to be critical for maintaining a carbon-nitrogen balance in
Pseudomonads (Kohler et al., 1989, Nishijyo et al., 2001, Cases et al., 2003, Li &
Lu, 2007, Zhang & Rainey, 2008). Sequence analysis of MifR indicated a
requirement of functional RpoN in modulating P. aeruginosa α-KG utilization. Our
study confirms that α-KG utilization in P. aeruginosa PAO1 requires functional
RpoN (Table 2.5). This phenotype is not strain-specific as phenotypic microarray
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profiling (BioLOG) of P. aeruginosa PA14 rpoN mutant exhibited a similar
phenotype, a significant difference in the ability to utilize α-KG as a carbon source
as compared to the wild-type PA14 (Behrends et al., 2013). An RpoN-dependent
phenotype was also observed with citrate and 4-hydroxyphenylacetate utilization
(Behrends et al., 2013). Similarly, utilization of C4-dicarboxylates succinate,
fumarate and malate in R. meliloti and P. aeruginosa also requires the sigma factor
RpoN (σ54) (Ronson et al., 1987, Ronson et al., 1987, Valentini et al., 2011).
The need for RpoN (σ54) to utilize α-KG in P. aeruginosa can be bypassed
by expressing PA5530 encoding for the transporter under a regulatable promoter
but not MifS and MifR. Consistent with the need for RpoN (σ54), the promoter for
PA5530 has the requisite signature sequences (Figure 2.13). Like most complex
RpoN-dependent promoters (Merrick, 1993), the region is long with multiple motifs
that include a signature sequence (AAc/uAAc/uAA) for catabolite repression
control (Crc) protein, a post-transcriptional inhibitor that binds the mRNA
preventing translation (Moreno et al., 2007, Sonnleitner et al., 2009, Browne et al.,
2010). Expression of crc is in-turn regulated by RpoN-dependent non-coding RNA
CrcZ (Sonnleitner et al., 2009) whose absence in rpoN mutant can also lead to
reduced expression of PA5530. Also, analysis of P. aeruginosa PA14 transcripts
indicates that the PA5530 promotor is under a small non-coding antisense RNA
(asRNA) regulation (Wurtzel et al., 2012). Though the role of Crc, CrcZ and the
asRNA in α-KG transport has to be verified experimentally, it suggests an
additional layer of regulation superimposed on the need for MifS and MifR on the
expression of the C5-dicarboxylate transporter PA5530.
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Conclusion
In eukaryotic cells, the mitochondria serve as a hub and reservoir of the
TCA cycle and its intermediates, respectively. Bacterial pathogens can be highly
virulent intruders of the host tissue, causing significant damage leading to cellular
aberrations and injury. Mitochondrial dysfunction, a consequence of cell injury,
results in efflux of TCA cycle intermediates leading to an increase in their
extracellular concentrations (Hebert, 2004). It is known that TCA cycle
intermediates (C4, C5, and C6 dicarboxylates) are present at micromolar (μM)
concentrations in blood that increase with tissues damaged (He et al., 2004,
Hebert, 2004). α-KG can also act as a reactive oxygen species scavenger,
especially for hydrogen peroxide, protecting both host and pathogen (Long &
Halliwell, 2011). For pathogenic bacteria such as P. aeruginosa, efficient uptake
of TCA intermediates from the host is crucial for its survival, especially when it is
bombarded with host reactive oxygen species, and requires the activity of bacterial
carboxylate transport proteins. The transport proteins could be specific for C4, C5,
and C6 intermediates and may use a cognate TCS. This study suggests a complex
regulatory cascade in modulating P. aeruginosa C5-dicarboxylate, α-KG uptake
involving the PA5530 transporter, the MifS/MifR TCS and the sigma factor RpoN
(Figure 2.14). It appears that MifS senses the presence of α-KG and signals MifR.
The activated MifR in concert with RpoN initiates the transcription of α-KG-specific
transporter gene PA5530. Analyses of the published data suggests that the
PA5530 promoter is under several layers of regulation including catabolite
repression mediated by Crc/CrcZ (Sonnleitner et al., 2009) and the small non-
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coding asRNA (Wurtzel et al., 2012). Though the asRNA has been identified
(Wurtzel et al., 2012), it has not been characterized. It is not surprising that the
PA5530 expression is potentially regulated by Crc, as it would allow control of
transporter(s) in response to the presence of carbon sources in the environment.
In addition to MifSR (PA5512/PA5511), PA1336/PA1335 have been identified to
be homologous to the Rhizobium C4-dicarboxylate transport regulatory DctB/DctD
TCS (Stover et al., 2000, Valentini et al., 2011). However, the role of
PA1336/PA1335 remains to be elucidated. The P. aeruginosa genome also
encodes 19 other paralogs of PA5530 dicarboyxlate transporters, most of which
have share less than 50% similarity except for PA0229 (PcaT). PA0229 and
PA5530 have 73% similarity. Future studies will determine if the transporters are
preferentially or hierarchically upregulated depending on the carbon source. It is
also important to note that much of bacterial physiology, particularly of pathogens
such as P. aeruginosa remains a mystery. Metabolic versatility, expression of
virulence factors and antibiotic resistance together makes P. aeruginosa an
portentous pathogen. Thus, understanding the physiological cues and regulation
would provide a better stratagem to fight the often indomitable infections.
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Abstract
Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen responsible
for causing incapacitating infections in individuals with impaired immunity.
Successful infection and disease progression relies significantly on the ability of
any pathogen to effectively utilize available nutrients that are essential for its
growth and survival. Unlike other pathogenic bacteria where glucose is the
preferred carbon source, P. aeruginosa preferentially utilizes tricarboxylic acid
(TCA) cycle intermediates as carbon, nitrogen and energy sources. In P.
aeruginosa, two-component system (TCS) signaling proteins have played an
integral part in regulating the uptake of TCA cycle intermediates, specifically, C4dicarboxylates such as succinate, fumarate and malate. We recently identified a
TCS protein pair PA5512/PA5511 (MifS/MifR) that in- tandem with the sigma factor
RpoN (σ54) facilitate the uptake of extracellular C5-dicarboxylate α-ketoglutarate
(α-KG) by activating the expression of P. aeruginosa α-KG-specific permease
PA5530 (KgtP). In the present study, we demonstrate that besides KgtP, P.
aeruginosa genome encodes a second α-KG transporter PA0229 (PcaT) whose
expression is independent of the MifSR TCS, suggesting an additional layer of
regulation involved in P. aeruginosa α-KG uptake. Importantly, in the recent years,
α-KG has become the focal point of research because of its newly identified role
as a signaling molecule in-addition to its conventional role in metabolism. To date,
very little is known of the physiology of P. aeruginosa when provided with α-KG as
the sole carbon source and their role in pathogenesis. Using PAOΔmifS,
PAOΔmifR and PAOΔmifSR mutants expressing the α-KG transport protein PcaT
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in trans, we additionally investigated the role of MifSR TCS and α-KG in regulating
P. aeruginosa virulence. Multiple virulence phenotypes were tested in the
presence of α-KG, citrate and/or succinate, as a sole carbon source. In comparison
to the wild-type PAO1 strain, mifSR deletion strains exhibited differential regulation
of biofilm formation, pyocyanin and pyoverdine production, motility, and cell
cytotoxicity in the presence of α-KG. Subsequently, mifSR mutant derivatives
exhibited no discernible phenotypes compared to the parent PAO1 when α-KG
was replaced with citrate and/or succinate, as the sole carbon source. Thus, MifSR
TCS regulates the expression of P. aeruginosa’s key virulence determinants in αKG-dependent manner. Simultaneous regulation of multiple mechanisms involved
in P. aeruginosa pathogenesis suggests a complex mechanism of MifSR action.
Understanding the physiological cues and regulation would provide a better
stratagem to fight the often indomitable P. aeruginosa infections.
Introduction
Despite continuous efforts in the development of new antimicrobial drugs,
bacterial infections are frequently associated with high morbidity and mortality
rates. In particular, infections caused by the multidrug resistant bacteria, including,
but not restricted to the so called “ESKAPE” pathogens (Enterococcus faecium,
Staphylococcus

aureus,

Klebsiella

species,

Acinetobacter

baumannii,

Pseudomonas aeruginosa, and Enterobacter species) (Rice, 2008), represent a
major public health concern (Tommasi et al., 2015) and economic burden
worldwide (Boucher et al., 2009). Amongst these organisms, P. aeruginosa is
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frequently implicated in causing injurious infections (Rice, 2008), and has gained
significant attention over the years as one of the most portentous pathogen.
P. aeruginosa is a Gram-negative, ϒ-proteobacteria that is widely
distributed in nature (Green et al., 1974). It is well-known for its nutritional and
ecological resilience, which enables it to endure and thrive in diverse
environmental settings, both natural and artificial (Ramos, 2004). Although, P.
aeruginosa is a multi-host pathogen infecting insects (Bulla, 1975), nematodes
(Mahajan-Miklos et al., 1999), plants (Sing & Schroth, 1977, Rahme et al., 1995)
and mammals (Stevens et al., 1994), it is the epitome of opportunistic human
infections (Ramos, 2004). It is one of the most feared nosocomial pathogen,
accounting for 10% of all the hospital acquired infections (Hancock & Speert, 2000,
Sievert et al., 2013). P. aeruginosa can colonize different tissue types leading to
multifactorial clinical and pathological manifestations including pneumonia
(Driscoll et al., 2007), urinary tract infection (Driscoll et al., 2007), gastrointestinal
infection (Markou & Apidianakis, 2014), chronic suppurative otitis media (Yeo et
al., 2007, Mittal et al., 2015), endocarditis (Fish et al., 1937, Sandre & Shafran,
1996), osteomyelitis (Carek et al., 2001), keratitis (Dart & Seal, 1988), bacteremia
(Kerby, 1947) and soft-tissue infection (Moet et al., 2007). The largest cohorts of
P. aeruginosa infected patients are the ones with AIDS, severe burn wounds,
cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), diabetes,
cardiovascular disease, cancer and those with acquired or primitive immunological
abnormalities (Manfredi et al., 2000, Ramos, 2004, Driscoll et al., 2007, Vento et
al., 2008, Valderrey et al., 2010). Also, beyond high infection rate, P. aeruginosa
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has the highest case fatality rate of all Gram-negative infections (Aliaga et al.,
2002). P. aeruginosa is extensively armed with a set of multi-determinant virulence
factors, both cell surface associated (flagella, pili, LPS) and secretory (proteases,
exotoxins, phenazines, haemolysins), which modulates its pathogenic potential. In
addition to its ability to dodge host immunity, a major setback in effectively treating
P. aeruginosa infections is its extraordinary intrinsic and acquired resistance to a
gamut of clinically critical antibiotics (Breidenstein et al., 2011). Expression of
diverse virulence factors and antibiotic resistance together, makes P. aeruginosa
an indomitable pathogen.
Metabolic versatility is the key to bacterial pathogenesis and disease
progression. In order to survive and multiply in the host systems, bacterial
pathogens have developed mechanisms to regulate their metabolism according to
the nutrient composition and availability (Silby et al., 2011). Carbon and nitrogen
are the two major nutrients required by all living organisms to perform fundamental
cellular activities. P. aeruginosa uses an eclectic range of organic compounds
including carbohydrates, amino acids, fatty acids, mono- and polyalcohols, di- and
tri-carboxylic acids as carbon, nitrogen and energy source (Ramos, 2004).
Although efficiently metabolized via the Entner-Doudoroff pathway, sugars are less
preferred carbon source (Entner & Doudoroff, 1952, Lessie & Phibbs, 1984).
Instead, P. aeruginosa has a predilection for tricarboxylic acid (TCA) cycle
intermediates, specifically, C4-dicarboxylates of the TCA cycle such as malate,
fumarate and succinate (Liu, 1952, Collier et al., 1996).
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The TCA cycle, classical (Krebs, 1940) or the modified form (Romano &
Conway, 1996, Hugler et al., 2005, Zhang & Bryant, 2011), is one of the most
important central metabolic pathway used by all organisms to generate energy.
Essentially, the TCA cycle plays a dual role in cell metabolism: 1) it produces
carbon dioxide and reduced electron carriers (NADH and FADH2) by oxidation of
acetyl-CoA to generate energy (catabolism), and 2) provides cells with precursor
metabolites as building blocks for the synthesis of carbohydrates, fatty acids,
nucleic acids and amino acids (anabolism) (Owen et al., 2002). Because of its
amphibolic nature and ubiquity, it is not surprising that different organisms use and
modulate TCA cycle according to their metabolic requirements, thus giving rise to
a considerable diversity in its way of operating. Moreover, it is becoming evident
that the TCA cycle is embedded in a more complex network of metabolic pathways,
and its intermediates, beyond their canonical function play a profound role as intraand extracellular signals (Benit et al., 2014, Huergo & Dixon, 2015, Haas et al.,
2016).
TCA cycle intermediates are organic acids, that based on the number of
carbon atoms are classified into three groups C4-dicarboxylates (succinate,
fumarate, malate and oxaloacetate), C5-dicarboxylate (α-Ketoglutarate (α-KG))
and C6-tricarboxylates (citrate and iso-citrate) (Krebs, 1940). Amongst these, the
C5-dicarboxylate α-KG has gained significant attention because of its newly
established role as a signaling molecule in-addition to its conventional role in
metabolism. There is mounting evidence that corroborates the role of α-KG as a
signaling molecule in all three domains of life, archaea (Dodsworth et al., 2005),
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bacteria (Ninfa & Jiang, 2005) and eukaryota (Lancien et al., 2000, He et al., 2004).
Indeed, it is now known that α-KG plays a key role in many signaling pathways
including, but not limited to, regulation of carbon/nitrogen metabolism (Doucette et
al., 2011), cyclic AMP (cAMP) synthesis (Rabinowitz & Silhavy, 2013), paracrine
mediator in regulating renal acid-base balance (Tokonami et al., 2013) and in
epigenetic regulation mediated through histone modification (Letouze et al., 2013,
Carey et al., 2015) and α-KG-dependent oxygenases (Loenarz & Schofield, 2008).
In bacteria, intracellular levels of α-KG acts as a key indicator of the cellular
C/N status (Doucette et al., 2011). α-KG provides the major carbon skeleton for
nitrogen assimilation pathways (Commichau et al., 2006). High levels of
intracellular α-KG signals nitrogen starvation, thereby activating the transcription
of nitrogen assimilation genes (Leigh & Dodsworth, 2007). It is now well
established that α-KG directly regulates nitrogen metabolism by binding and
modulating the activity of either the nitrogen regulatory PII protein GlnB in E. coli
(Ninfa & Jiang, 2005) and/or the transcription factor NtcA in cyanobacteria
(Tanigawa et al., 2002, Vazquez-Bermudez et al., 2002). Signal perception
mechanisms mediated by α-KG, nitrogen regulatory PII and NtcA proteins has
been studied and reviewed extensively (Forchhammer, 2008, Forchhammer,
2010, Huergo et al., 2013, Huergo & Dixon, 2015). Furthermore, endogenous αKG acts as a reactive oxygen species scavenger, particularly of hydrogen peroxide
thus acting as a protectant against oxidative damage (Mailloux et al., 2009, Lemire
et al., 2010) and cyanide poisoning (Kunz et al., 1998). Recent studies have
reported the use of exogenous α-KG as a preferred carbon source during the
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course of infection by pathogenic bacteria (Guo et al., 2012, Cai et al., 2013). This
together suggests a more intricate and intense role of α-KG in regulating bacterial
physiology and metabolism.
Sensing the available nutrient is a prerequisite for bacterial growth and
virulence. Bacteria have evolved various host-adapted nutrient acquisition
strategies to modulate the uptake systems. One canonical mechanism by which
most bacteria sense and respond to the available nutrient is the two-component
systems (TCSs). TCSs are made of two signal transduction proteins, a membranebound histidine sensor kinase (HK) and a cytoplasmic response regulator (RR),
usually a DNA binding protein (Gross et al., 1989). In response to stimuli, the
sensor autophosporylates at a conserved histidine residue at the C-terminus, and
subsequently the phosphate is transferred to an aspartate residue at the Nterminus of the RR (Stock et al., 1989, Stock et al., 2000). The phosphorylated RR
then modulates the expression of various genes required to bring about the
appropriate response (Bourret et al., 1989). Given the importance of TCA cycle
intermediates as a preferred carbon source in numerous bacteria (Finan et al.,
1983, Collier et al., 1996, Tang et al., 2005), it is not surprising that the TCSs are
involved in regulating their uptake. In both, Gram-negative and Gram-positive
bacteria TCS proteins have been implicated in regulating the transport and
utilization of TCA cycle intermediates, particularly the C4-dicarboxylates
(succinate, fumarate and malate) and the C6-tricarboxylate (citrate) (Asai et al.,
2000, Janausch et al., 2002). However, not much is known about the assimilation
of the C5-dicarboxylate α-KG.

77

The TCS proteins responsive to extracellular α-KG has been identified in
limited number of bacterial species, including Escherichia coli (Cai et al., 2013),
Rhizobium tropici (Batista et al., 2009) and most recently in P. aeruginosa (Tatke
et al., 2015). In P. aeruginosa, a TCS protein pair PA5512/PA5511 (MifS/MifR)
together with the sigma factor RpoN (σ54) regulates the transport of extracellular
α-KG by activating the expression of the α-KG-specific permease PA5530, a Major
Facilitator Superfamily (MFS) of secondary active transporter protein (Lundgren et
al., 2014, Tatke et al., 2015). P. aeruginosa MifS/MifR pair is homologous to the
Rhizobium meliloti C4-dicarboxylate transport regulatory DctB/DctD TCS (Winsor
et al., 2011). No role of P. aeruginosa MifS and MifR in the utilization of TCA cycle
C4-C6 di and tricarboxylates (succinate, fumarate, malate, oxaloacetate and citrate)
has been established (Tatke et al., 2015). Thus, P. aeruginosa MifSR TCS is
specifically and uniquely involved in α-KG utilization.
Previously, the MifR protein has been identified to be essential for regulating
P. aeruginosa biofilm formation (Petrova & Sauer, 2009) and pyruvate
fermentation (Petrova et al., 2012). Additionally, in P. aeruginosa, nutritional cues
such as individual carbon and nitrogen sources have been known to influence
several clinically relevant virulence phenotypes such as motility, biofilm
development, quorum sensing and pigment production (Kohler et al., 2000,
Klausen et al., 2003(a), Palmer et al., 2005, Shrout et al., 2006, Palmer et al.,
2007). To date, very little is known about the physiology of P. aeruginosa when
provided with α-KG as the sole carbon source. Here we show that, MifS/MifR TCS
and the C5-dicarboxylate α-KG plays a perspicacious role in regulating P.

78

aeruginosa pathogenicity by modulating its key virulence traits, including, motility,
pigment production, biofilm formation and cell cytotoxicity. This study is one of the
first to report a novel role of the regulatory mechanism exerted by MifSR TCS and
significantly highlights the potential role of α-KG as a signaling molecule in P.
aeruginosa.
Materials & Methods
Bacterial strains, media and growth conditions
The bacterial strains and plasmids used in this study are listed in Table 3.1.
Briefly, strains of Pseudomonas aeruginosa and Escherichia coli were routinely
cultured in Luria Bertani (LB) broth (5 g tryptone, 10 g sodium chloride, and 5 g
yeast extract per liter) or agar (LB broth with 1.5% agar) (Difco, NJ, USA) or in M9
minimal Media (64 g Na2HPO4-7H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl, 20
mM MgSO4, 1 mM CaCl2 per liter) (Sambrook & Russell, 2001) at 37οC, unless
specified otherwise. P. aeruginosa competent cells were prepared using the
sucrose (300 mM) method as previously described (Choi et al., 2006). Growth
curves, complementation studies and phenotypic assays were performed in M9
minimal media supplemented with TCA cycle intermediates, α-KG, succinate
and/or citrate (at 30 mM each), as described previously (Tatke et al., 2015). For
selection and maintenance of plasmids, antibiotics when used, were at the
following specified concentrations, unless specified otherwise: E. coli: ampicillin
(Ap) 100 μg/ml, gentamycin 15 μg/ml, kanamycin (Km) 20 μg/ml, P. aeruginosa:
Gm 75 μg/ml.
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Cell culture and media
A549, a human lung adenocarcinoma epithelial cell line was provided by
Dr. Rahul Mittal (University of Miami, Miller School of medicine, Miami, FL). The
J774 E-clone, a murine macrophage cell line, also a generous gift from Dr. Philip
Stahl (Washington University Medical school, St Louis, MO) and the human
epithelial adenocarcinoma cell line was obtained from ATCC (ATCC®CCL-2™).
J774 E-clone cell lines were maintained under a 5% CO2 atmosphere in Dubelco’s
Minimum Essential Medium (DMEM), supplemented with 10% heat-inactivated
fetal calf serum (FCS), 2 mM L-glutamine, 100 Units/mL penicillin and 100 μg/mL
of streptomycin. A549 cells were grown in Roswell Park Memorial Institute Medium
(RPMI) 1640 (Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal
calf serum (FCS), 24 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), 2 mM L-glutamine, 100 Units/mL penicillin, 100 μg/mL of streptomycin
and incubated at 37°C in 5% CO2. HeLa cells were cultured in DMEM
supplemented with 10% FCS and 2 mM L-glutamine and 1% non-essential amino
acids in presence of 5% CO2 at 37°C. All chemicals and reagents were purchased
from Sigma-Aldrich (St. Louis, MO), unless otherwise indicated.
Genetic manipulations
Genetic manipulations were carried out as previously described using
standard techniques (Green et al., 2012). Polymerase Chain Reaction (PCR)
amplification was performed using the AccuPrime high-fidelity Taq DNA
Polymerase (Invitrogen, Life Technologies, Carlsbard, CA, USA). Primers for PCR
and sequencing were synthesized by Integrated DNA Technologies, Inc.
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(Coralville, IA, USA) and are listed in Table 3.2. DNA purification and plasmid DNA
isolation was carried out using nucleic acid purification kits (Promega, Madison,
WI, USA) and PureLink Hipure Plasmid Miniprep Kit (Invitrogen, Life Technologies,
Carlsbard, CA, USA). Wizard® SV Gel and PCR Clean-Up System kits (Promega,
Madison, WI, USA) were used for PCR product and agarose gel fragment
purification. RNA extraction and cDNA synthesis was performed using RNeasy
Mini Kit (Qiagen Inc. Venio, Limburg, Netherlands) and SuperScript III First-Strand
Synthesis System (Invitrogen, Life Technologies, Carlsbad, CA, USA). Restriction
enzymes were from New England Biolabs (Ipswich, MA, USA), and DNA
sequencing was carried out at Florida International University (FIU) DNA core and
at GENEWIZ Inc. (South Plainfield, NJ, USA). All other chemicals were purchased
from Sigma-Aldrich (St. Louis, MO, USA), Amresco (Solon, OH, USA) and
TheromoFisher Scientific (Waltham, MA, USA), unless otherwise specified.
PCR amplification and cloning of pcaT
DNA fragments from PAO1 with pcaT (~1.3 kb) and PA0703 (~1.3 kb) were
PCR amplified using primer pairs GDT_pcaTF1-GDT_pcaTR1 (Table 3.2),
respectively. The primers are designed such that the ORF is contiguous to a strong
ribosome binding site (AGGAGA), to ensure expression of the genes (Lehninger
et al., 2013). The PCR amplified pcaT was cloned directly into a broad host range
pPSV37-Gm (Lee et al., 2010) plasmid as a NheI-SacI fragments, downstream of
an inducible PlacUV5 promoter to generate plasmids pGDT007, respectively. The
fidelity of the PCR product was confirmed by sequencing using the primers
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GDT_p37_SeqF-R, pcaT_seqF-R and PA0703_seqF-R (Table 3.2). Henceforth,
this plasmid is referred to as pPcaT, respectively.
The expression plasmid pPcaT was subsequently introduced by
electroporation (Choi et al., 2006) into PAO1 and its isogenic mutants PAO∆mifS,
PAO∆mifR, PAO∆mifSR and PAO∆rpoN.
Growth curves
Growth curves were performed as described previously (Tatke et al., 2015). Briefly,
P. aeruginosa wild type PAO1 and its isogenic mutant derivatives were grown
overnight in LB broth with or without antibiotics at 37°C. After overnight growth,
spent and residual media was removed by centrifugation and the cultures were
washed with sterile 0.85% NaCl (wt/vol) solution. Cultures were then diluted in
fresh M9 minimal media supplemented with TCA cycle intermediates including αKG, succinate and/or citrate (at 30 mM each) as a sole carbon source to obtain
equal optical densities (OD600) of 0.025. Growth was monitored in 48-96 well plates
(Corning-Falcon, NY, USA) by determining absorbance at 600 nm using BioTek
Synergy HT plate reader for 14-18 h at 37°C. The experiments were performed
multiple times in triplicates.
Motility assays
Motility assays were examined on 0.3%, 0.6% and 1% (wt/vol) M9 minimal
media agar plates as a described previously (Deziel et al., 2001). All cultures were
grown overnight in LB media at 37°C. Overnight cultures were washed with sterile
0.85% NaCl (wt/vol) solution and diluted to OD600 of 1. Swimming and swarming
motilities were evaluated by spotting 1-2 μl cultures onto 0.3% and 0.6% (wt/vol)
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M9 minimal media agar plates with α-KG or citrate (at 30 mM each) as a sole
carbon source. Twitching motility was evaluated by stab inoculating OD600
normalized cultures onto 1% (wt/vol) M9 minimal media agar plates with α-KG or
citrate (at 30 mM each) as a sole carbon source. Plates were incubated at 37°C
and motility patterns were assessed 24 to 48 h post-incubation. Diameters of the
swim or twitch zones were measured in millimeter (mm) and swarming was
assessed by determining the surface coverage on agar plates post incubation.
Each form of motility was assessed multiple times with three replicates for each
mutant.
Rhamnolipid assay
P.

aeruginosa

wildtype

PAO1,

PAO1(pPcaT),

PAOΔmifS(pPcaT),

PAOΔmifR(pPcaT) and PAOΔmifSR(pPcaT) strains were assayed for rhamnolipid
production using the cetyltrimethylammonium bromide (CTAB) methylene blue
agar plate assay as described previously (Siegmund & Wagner, 1991). Briefly, all
cultures were grown overnight at 37°C in LB broth. Spent and residual media from
the overnight culture was removed by centrifugation, and the cultures were washed
with sterile 0.85% NaCl (wt/vol) solution. Rhamnolipd production was evaluated by
spot inoculating OD600 normalized cultures on M9 minimal media supplemented
with 30 mM α-KG (unless otherwise specified), 0.0005% (wt/vol) methylene blue
and 0.02% (wt/vol) CTAB. Plates were incubated at 37°C for 24 h followed by
incubation at room temperature for at least 48 h until a blue halo appeared around
the colonies, indicating rhamnolipid production (Siegmund & Wagner, 1991). The
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diameter of the blue halo (in millimeter (mm)) around the colonies was measured
as a mark of rhamnolipid production.
Pyocyanin production
Pyocyanin produced was measured by extracting the pigment from culture
supernatants using the chloroform-hydrochloric acid (HCL) method as described
previously (Essar et al., 1990). Briefly, 5-ml culture supernatant from the
stationary-phase cultures (∼18 h) grown in M9 minimal media supplemented with
TCA cycle intermediates including α-KG, citrate and succinate (30 mM each)
individually as a sole carbon source was mixed with 3 ml chloroform to extract
pyocyanin into the organic phase. Pyocyanin from the organic phase was then reextracted into 1 ml of 0.2 N HCl. The resulting pink color formation, an indication
of the presence of pyocyanin was read at 520 nm. The concentration is expressed
as µg of pyocyanin produced per ml of culture (µg/ml), by multiplying the optical
density OD520 by 17.072 (Essar et al., 1990). Absorption spectra analysis (250 nm
to 800 nm) to detect pyocyanin from the cell free culture supernatants, was
performed using the Beckman Coulter Inc., DU 800 spectrophotometer.
Pyoverdine production
To measure pyoverdine production, cells were grown overnight at 37°C in
M9 minimal media supplemented with α-KG, succinate and/or citrate, individually
(at 30 mM each) as a sole carbon source. Extracellular pyoverdine from the culture
supernatant was read at 405 nm and normalized to the initial culture density
(OD600). Pyoverdine levels were expressed as a ratio of OD405/OD600 (Shen et al.,
2002). Absorption spectra analysis (250 nm to 800 nm) to detect pyoverdine from
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the cell free culture supernatants, was performed using the Beckman Coulter Inc.,
DU 800 spectrophotometer.
Cytotoxicity assay
P. aeruginosa wild-type PAO1 and its isogenic PAO∆mifR, PAO∆mifS,
PAO∆mifSR, mutant strains and its derivatives were used for the cytotoxicity
assay. Their cytotoxicity was assessed using a human lung adenocarcinoma
epithelial cell line (A549), a murine macrophage cell line (J774 E-clone) and HeLa
cells.

Bacterial

cytotoxicity

was

quantified

by

measuring

the

lactate

dehydrogenase (LDH) enzyme activity from the culture supernatant post 24 h
infection with P. aeruginosa strains (Hauser & Engel, 1999). Briefly, monolayers of
J774 E-clone, A594 and HeLa cells (106 cells/mL) were incubated with bacterial
suspension containing 108 CFU/mL of bacteria. Overnight bacterial cells were
subcultured into M9 minimal media with α-KG (30 mM) to a final OD600 nm of 0.1.
The infection was synchronized by centrifugation for 5 minutes at 1000 x g and
incubated for 24 hours at 37°C in 5% CO2. Cell-free culture supernatant were then
collected and the amount of lactate dehydrogenase (LDH) enzyme activity was
assayed in a 96-well plate using the Sigma kit as per manufacturer’s instructions
(Sigma Aldrich, St. Louis, MO). Triplicate wells were used for each test, and all
tests were repeated at least three times.
Biofilm formation
Biofilm formation was assessed on 96-well polystyrene flat-bottomed
(Costar, Corning NY) and/or on non-tissue culture-treated 96-well polyvinyl
chloride (PVC) U-bottom (Falcon) microtiter plates, as described previously
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(Friedman

&

Kolter,

2004,

O'Toole,

2011).

Briefly,

PAOΔmifS(pPcaT),

PAOΔmifR(pPcaT), PAOΔmifSR(pPcaT), PAO1 (pPcaT) as well as the control
strains PAO1(wildtype), PAOΔretS (positive control, hyperbiofilm producer) and
PAOΔpel∆psl∆algD (negative control, no biofilm producer) were grown in LB broth
overnight at 37°C. Cultures were then diluted to an OD600 of 0.0025 in M9 minimal
media supplemented with α-KG, succinate or citrate individually (at 30 mM each).
The plates were incubated under static condition at room temperature for 24, 48
and 72 hours. At each time point, the culture was decanted and the plates were
washed by gently submerging them in a small water tub in order to remove the
unattached cells, and the plates were dried for 10-15 minutes at room temperature.
To stain the biofilm, 0.1% solution of crystal violet (St. Louis, MO, USA) in water
was added to each well (200 µL). After 20-minute incubation at room temperature,
crystal violet was decanted, and the plates were washed 7 to 8 times in a small
water tub. Plates were then inverted and left to dry overnight. Quantification of the
attached and stained cells was done after solubilization of the dye with absolute
ethanol (200 µL). The optical density of the solution reflecting the relative biofilm
formation was measured at 590 nm using BioTek Synergy HT (Winooski, VT, USA)
and expressed as relative biofilm formation (OD590 mutant / OD590 wildtype) (Ueda
& Wood, 2009). The experiments were performed multiple times in triplicates.
RNA isolation and cDNA synthesis
P. aeruginosa wild-type PAO1 and its isogenic PAO∆mifR, PAO∆mifS,
PAO∆mifSR, PAO∆rpoN mutant strains and its derivatives were used for RNA
extraction. Total RNA was extracted from cells grown to mid-exponential phase
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with or without α-KG (at 30 mM) treatment. Briefly, cultures were grown overnight
in LB broth at 37°C. Post incubation overnight cultures were washed with sterile
0.85% saline solution to remove spent media and were subcultured at 37°C, 200
rpm in LB media. LB media was used as a preferred nutrient source for initial
growth of cultures since PAO∆mifR, PAO∆mifS, PAO∆mifSR and PAO∆rpoN
mutants exhibit growth defects in the presence of α-KG alone. When the cells
reached an OD600 of 0.6-0.7, all the cultures were treated with 30 mM α-KG for 2
h. Post treatment, the RNA was stabilized by adding phenol-ethanol mixture
(Brencic et al., 2009). The stabilized RNA was then isolated using RNeasy Mini Kit
(Qiagen Inc. Venio, Limburg, Netherlands) as per manufacturer’s protocol.
Residual genomic DNA contamination was removed using RQ1 RNase-free
DNase (Promega, Madison, WI, USA) and RNA was repurified using RNeasy Mini
Kit (Qiagen Inc. Venio, Limburg, Netherlands). RNA quality was preliminarily
checked on a denaturing agarose gel (NorthernMax Gly, Ambion) followed by
analysis on the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
Samples with RNA Integrity Numbers of 8.0 or above were subsequently used for
cDNA synthesis. cDNA was synthesized by annealing NS5 random primers to total
purified RNA and subsequent extension was carried out using SuperScript III
reverse transcriptase, as per the manufacturers protocol (Invitrogen, Life
Technologies, Carlsbard, CA, USA).
Quantitative real-time PCR
P. aeruginosa genes encoding α-KG transporter proteins (pcaT and
PA5530 (kgtP)) and pyocyanin synthesis (phzA1, phzB1, phzA2, phzM and phzS)
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were amplified (qRT-PCR) under α-KG induced condition at 30 mM, using the ABI
7500 (Applied Biosystems, Life Technologies, Carlsbard, CA, USA) cycler with
Power SYBR Green PCR MasterMix with ROX (Applied Biosystems, Life
Technologies, Carlsbard, CA, USA). The gene-specific primers used to quantitate
the expression levels of the transcript are listed in Table 3.2. Ten nanograms of
cDNA was used per reaction well in the qRT-PCR assays. The cycling conditions
used were 95˚C/2 minutes (holding); 40 cycles of 95˚C/15 sec, 60˚C/1 min
(cycling); 95˚C/15 sec, 60˚C/1 min, 95˚C/15 sec (0.6˚C ramp) (melt curve). The
reading was normalized to P. aeruginosa clpX (PA1802), whose expression was
determined to remain constant between the samples and conditions tested. The
qRT-PCR assays for each gene was repeated twice in triplicate, and the mean
value of the quantification was calculated. Melting curves were determined to
ensure primer specificity.
Bioinformatic and statistical analyses
Sequence analyses and multiple sequence alignments were generated
using

ClustalW2

http://www.ebi.ac.uk/Tools/msa/clustalw2/

and

www.pseudomonas.com (Winsor et al., 2011). Student’s t-test or Analysis of
Variance (ANOVA) with post-hoc testing, when applicable, was used to analyze
statistical differences. The t-test and ANOVA were performed using GraphPad and
IBM SPSS statistics 22.0 statistical analysis software. A p-value of < 0.05 was
considered statistically significant.
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Table 3.1: Strains and plasmids used in this study.
Strain ID

Strain/Plasmid
Relevant characteristics
Background

Source

Escherichia coli

DH5α

E. coli

F- Φ80lacZΔM15Δ (lacZYAargF)U169 deoR recA1
endA1 hsdR17 (rk- mk+)
phoA supE44 λ- thi-1 gyrA96
relA1

New
England
Biolabs

Pseudomonas aeruginosa
PAO1

Prototypic wild type

PKM900

PAO1

∆mifS (PA5512)

PKM901

PAO1

∆mifR (PA5511)

PKM902

PAO1

∆mifSR (PA5511-PA5512)

(Stover et
al., 2000)
PAOΔmifS
(Tatke et al.,
2015)
PAOΔmifR
(Tatke et al.,
2015)
PAOΔmifSR
(Tatke et al.,
2015)

Plasmids
GmR; colE1 oriT lacIq PlacUV5

pPSV37
pGDT004

pPSV37

pGDT005

pPSV37

pGDT006

pPSV37

GmR; The mifR ORF
subcloned from pGDT002 as
an NheI-SacI fragment into
pPSV37
GmR; A ~3.0-kb NheI-SacI
fragment containing mifSR
(PA5511-PA5512) ORFs
amplified from PAO1
genome using HK_mifSF1
and GDT_mifRR1 primers
and cloned directly into NheISacI-cut in pPSV37
GmR; A ~1.3-kb NheI-SacI
fragment containing PA5530
ORF amplified from PAO1
genome using
GDT_PA5530F1 and
GDT_PA5530R1 primers
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(Lee et al.,
2010)
(Tatke et
al., 2015)

(Tatke et
al., 2015)

(Tatke et
al., 2015)

pGDT007

pPSV37

and cloned directly into NheISacI-cut in pPSV37
GmR; A ~1.3-kb NheI-SacI
fragment containing pcaT
(PA0229) ORF amplified
from PAO1 genome using
This study
GDT_pcaTF1 and
GDT_pcaTR1 primers and
cloned directly into NheISacI-cut in pPSV37

Table 3.2: Primers used in this study.
Primer Name
GDT_pcaTF1
GDT_pcaTR1
GDT_p37_SeqF
GDT_p37_SeqR
pcaT_seqF
pcaT_seqR
DBS_qRT_clpXF
DBS_qRT_clpXR
GDT_qRT_pcaTF
GDT_qRT_pcaTR
GDT_qRT_PA5530F
GDT_qRT_PA5530R
qRT_phzA1F
qRT_phzA2R
qRT_phzA2F
qRT_phzA2R
qRT_phzSF
qRT_phzSR
qRT_phzMF
qRT_phzMR

Sequence
5’GCTAGCAGAAGGAGATATACCATGACTGCCCCTG
TTCAC-3’
5’-TTTGAGCTCCCGTCAGGGCTCGTCGTT-3’
5’-GACCCGTTTAGAGGCCCCAA-3’
5’-CGTGCTTTACACTTTATGCTTCCGG-3’
5’-TTCGTGATCGGCGCGATC -3’
5’-CAGCCAGAGGGCGATCAC-3’
5'- TGCGATTACGATGTGGAGA -3'
5'- CCCTCGATGAGCTTCAGCA -3'
5'- TGCGATTACGATGTGGAGA -3'
5'- CCCTCGATGAGCTTCAGCA -3'
5'-CGCAACGCATCAAGTCGAT-3'
5'-AGTCGTACCACTCGACCAGGTT-3'
5'- GGCACAACGTGCGGATCT -3'
5'- CGCACTCGACCCAGAAGTG-3'
5'- GCCCTGCGCGAATACG -3'
5'- CCATTCCTCTTTTTCCCGTTCT -3'
5'- GCCCTGCGCGAATACG -3'
5'- CCATTCCTCTTTTTCCCGTTCT -3'
5'- GAGCGCATCCATCGACTGAT -3'
5'- GGTATCGCCCTGGAAGATCTC -3'
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Results and Discussion
Acquisition of energetically favorable carbon and energy sources from the
extracellular milieu of nutrients is of paramount importance to bacterial survival and
disease progression. The C5-dicarboxylate α-KG is a key intermediate of the
energy-generating TCA cycle and plays an important role in regulating the cellular
carbon and nitrogen metabolism (Doucette et al., 2011). An important aspect of
the nutrient acquisition process is their transport from the environment into the cells
via the transporter proteins. The transport of α-KG has been studied in only a
handful of bacteria including P. aeruginosa (Lundgren et al., 2014, Tatke et al.,
2015), E. coli (Seol & Shatkin, 1991, Cai et al., 2013), R. trpopici (Batista et al.,
2009), X. oryzae (Guo et al., 2012) and Staphylococcus aureus (Tynecka et al.,
2001). In P. aeruginosa, E. coli and R. tropici extracellular α-KG transport is
arbitrated by TCS proteins MifS/MifR (Tatke et al., 2015), KguS/KguR (Cai et al.,
2013) and KgtS/KgtR (Batista et al., 2009), respectively. The present study further
explores the role of P. aeruginosa mifSR encoding the sensor kinase MifS and
response regulator MifR in regulating α-KG transport. Furthermore, using the
PAOΔmifS, PAOΔmifR and PAOΔmifSR mutants and their derivatives, we
additionally investigated the role of MifSR TCS and the C5-dicarboxylate α-KG in
regulating P. aeruginosa virulence.
P. aeruginosa possess multiple α-KG transport proteins
The E. coli transporter KgtP is the most extensively studied α-KG permease
(Seol & Shatkin, 1991, Seol & Shatkin, 1992, Seol & Shatkin, 1993). A homology
search in P. aeruginosa PAO1 genome revealed the presence of two ORFs
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PA0229 (pcaT) and PA5530 encoding the putative dicarboxylic acid transport
proteins that are homologs of E. coli α-KG permease KgtP. After here we name P.
aeruginosa PA5530 as KgtP. In recent studies, KgtP has been characterized and
identified as the functional α-KG transporter, whose expression is regulated by the
MifSR TCS in coordination with the alternate sigma factor RpoN (σ54) (Lundgren
et al., 2014, Tatke et al., 2015). In P. puitda, PcaT has been implicated in the
transport of β-ketoadipate (Ondrako & Ornston, 1980). However, in P. aeruginosa
PcaT function was not previously explored.
Our sequence analyses of P. aeruginosa PcaT and KgtP with E. coli KgtP
using BLASTP revealed that P. aeruginosa PcaT (PA0229) is the closest E. coli
KgtP homolog with 88% similarity and 70% identity, suggesting a similar function.
P. aeruginosa PcaT and KgtP share 72% similarity and 55% identity, and have the
conserved protein domain family PRK10406 implicated in α-KG transport
(Marchler-Bauer et al., 2015). This data strongly suggests that P. aeruginosa PcaT
is capable of transporting α-KG into the cells. To confirm the role of P. aeruginosa
pcaT in α-KG uptake, pcaT was amplified and subcloned downstream of the
inducible PlacUV5 promoter to generate the plasmid pPcaT. The plasmid pPcaT was
then introduced into the wild-type PAO1 and its isogenic mifSR mutant strains. The
PAOΔmifS, PAOΔmifR and PAOΔmifSR mutants exhibit an α-KG-dependent
growth defect due to the deficiency in the transport of extracellular α-KG (Tatke et
al., 2015). Expression of pcaT in trans in the mifSR mutants restored their growth
to a level comparable to the wild-type PAO1 in M9 minimal media with α-KG (30
mM) as the sole carbon source (Figure 3.1).
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Figure 3.1: Growth of mifSR mutants in the presence of α-KG and pPcaT.
Growth curves of P. aeruginosa wildtype PAO1 and mifSR mutants expressing
pcaT, encoding the putative carboxylic acid transporter in trans in M9 minimal
media with α-KG (30 mM). Results shown are mean with standard deviation of
three biological replicates.

Table 3.3: Growth Properties of the mifSR mutants and its
derivatives in the presence of α-KG
PAO1

∆mifR

∆mifS

∆mifSR

EV

+++

---

---

---

pPcaT

+++

+++

+++

+++

pPA5530

+++

+++

+++

+++
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Furthermore, growth of the wild-type PAO1 was not affected by the expression of
an extra copy of the pcaT gene (Figure 3.1). This finding confirms the role and
ability of P. aeruginosa PcaT in transporting extracellular α-KG into the cells.
Biochemical studies have hinted to the presence of inducible α-KG
transporters in Pseudomonas spp (Campbell & Stokes, 1951, Edwards et al.,
1979). This was supported by our recent findings where the expression of P.
aeruginosa kgtP gene encoding the α-KG permease was significantly induced by
α-KG (Tatke et al., 2015). To test if the expression of pcaT gene is induced by the
presence of extracellular α-KG, qRT-PCR analysis was performed. Expression of
pcaT was tested in the wild-type PAO1 grown with varying amounts of α-KG (1 –
80 mM). The presence of α-KG resulted in the activation of pcaT expression in a
concentration independent manner (Figure 3.2). This data suggests that pcaT
expression is induced by α-KG.
The mifSR mutants failure to grow in the presence of α-KG is the result of
a defect in the expression of α-KG transporter proteins (Tatke et al., 2015). This
growth deficient phenotype can be rescued by uncoupling the MifSR regulatory
control over pcaT and kgtP by expressing these genes under a regulatable
promoter (Table 3.3). This suggests that MifSR TCS, similar to kgtP, regulates
pcaT expression. To determine if this is true, we looked at the pcaT and kgtP RNA
levels in the ΔmifS, ΔmifR and ΔmifSR mutant strains. Corroborating our previous
findings (Tatke et al., 2015), expression of kgtP was downregulated in the mifSR
deficient strains (Figure 3.3). However, surprisingly, pcaT expression was
upregulated in the absence of mifSR and the presence of α-KG (Figure 3.3). This
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suggests that MifSR TCS negatively regulates pcaT expression. In the
experimental set up, the regulatory control of pcaT was uncoupled by expressing
it under PlacUV5. In the mifSR mutants, there is an intact pcaT, however it is unable
to rescue the a-KG dependent growth defect (Table 3.3), despite the increased
expression (Figure 3.3). This implies that perhaps pcaT expression is controlled
post-transcriptionally by an un-identified factor which requires intact MifSR. These
findings strongly suggests that MifSR TCS inversely regulates the expression of
P. aeruginosa pcaT and kgtP.
Our sequence analysis of the pcaT upstream promoter (PpcaT) region
revealed the presence of a putative weak RpoN (σ54) sigma factor binding -24/-12
sequence: TGGCAC-N7-TCGCC (Barrios et al., 1999) and an A-rich motif
adjacent to the ribosome binding site with a signature sequence (AAc/uAAc/A) for
the catabolite repression control (Crc) protein (Figure 3.4) (Sonnleitner et al., 2009,
Browne et al., 2010). Crc is a post- transcriptional inhibitor that prevents translation
initiation by binding to the mRNA (Moreno et al., 2007, Sonnleitner et al., 2009). In
addition, we identified four putative GGA trinucleotide motifs in the PpcaT, a
characteristic binding site recognized by the post-transcriptional control RsmA
family of proteins (Brencic & Lory, 2009). Also, in the predicted secondary structure
of the pcaT leader sequence using Mfold we found that the GGA motifs are
exposed in the steam-loop structures which could acts as a substrate for RsmA
binding, as has been observed for several known RsmA targets (Figure 3.4).
Though the role of Crc and RsmA in α-KG transport has to be verified
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experimentally, it suggests an additional layer of regulation controlling pcaT
expression.

Figure 3.2: pcaT gene expression in response to α-KG. qRT-PCR was used
to measure the relative quantities of pcaT mRNA after P. aeruginosa PAO1
cells were induced for an hour with varying concentration of α-KG (1 to 80 mM).
Bars above or below the line represents up- and down-regulation, respectively,
and the error bars indicate standard errors. Data were normalized to expression
in PAO1 uninduced cells. The clpX gene (PA1802) was used as the
housekeeping control. Statistically significant difference as determined by oneway ANOVA with Bonferroni’s post-hoc test, ** p-value < 0.001 compared with
expression in the uninduced condition.
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way ANOVA with Bonferroni’s post-hoc test, ** p-value < 0.001.

housekeeping control. Statistically significant difference between the wild type and mutants as determined by one-

gene encoding the α-KG transporter protein [Our Reference] was tested. The clpX gene (PA1802) was used as the

respectively, and the error bars indicate standard errors. Furthermore, expression of the recently reported PA5530

Data was normalized to expression in PAO1. Bars above or below the line represents up- and down-regulation,

single and double deletion mutants relative to the wildtype PAO1, with cells exposed to α-KG (30 mM) for an hour.

Figure 3.3: Quantification of pcaT mRNA in mifSR mutants. The expression of pcaT was tested in the mifSR
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recognized by the post-transcriptional control RsmA family of proteins.

(brown box). Yellow box depicts the four putative GGA trinucleotide motifs in the PpcaT, a characteristic binding site

(Purple). PpcaT possess the signature sequence (AAc/uAAc/uAA) for catabolite repression control (Crc) protein

(A). Sequence analysis of the 148-bp (PpcaT) showing weak -12 and -24 RpoN (σ54) dependent promoter like element

Figure 3.4 Promoter analysis of α-KG permease encoding pcaT gene. Genome organization of pcaT gene locus

MifS/MifR TCS regulates P. aeruginosa virulence
Success of P. aeruginosa as a recalcitrant pathogen relies significantly on
its metabolic flexibility, which is exhibited by its ability to utilize a myriad of organic
compounds as carbon and energy source for its survival and growth. Furthermore,
P. aeruginosa is conspicuous for its ability to cause both acute and chronic
infections in immunocompromised patients (Bodey et al., 1983). This versatility is
manifested in part by expression of a vast array of virulence determinants, both
cell-associated and secretory, that are capable of overpowering the host cell
defenses and catabolizing macromolecules (Gellatly & Hancock, 2013). It is
therefore not surprising that the synthesis and regulation of multiple virulence
factors is controlled by nutrient availability. Carbon and nitrogen sources have
been shown to influence several virulence related phenotypes in P. aeruginosa
including biofilm development (Klausen et al., 2003(a), Shrout et al., 2006), motility
(Kohler et al., 2000), pigment production (Palmer et al., 2007, Dandekar et al.,
2012) and cell cytotoxicity (Bains et al., 2012). To date, very little is known of the
physiology of P. aeruginosa when provided with α-KG as the sole carbon source
and its role in virulence. Importantly, it is now known that extracellular α-KG is a
primary carbon source for some pathogenic bacteria during infection (Guo et al.,
2012, Cai et al., 2013). Considering these findings, we further explored if a-KG has
a more profound physiological role in regulating P. aeruginosa virulence and if
MifSR TCS play any role. An impediment in performing experiments with mifSR
mutants in the presence of α-KG was there in#ability to grow in media with α-KG
as the sole carbon source (Table 3.3). To circumvent the problem, all the virulence
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related phenotypic assays were performed using ΔmifS, ΔmifR and ΔmifSR
mutants harboring pPcaT plasmid, unless specified otherwise. Thus, in the mifSR
mutants, in trans expression of the α-KG transporter PcaT ensures the influx of
extracellular α-KG into the cells while manifesting the effect of mifSR deletions on
P. aeruginosa virulence phenotypes.
Enhanced biofilm formation in the absence of mifSR
Biofilm mode of growth is one of the hallmark of P. aeruginosa chronic
infections (Tolker-Nielsen, 2014). Subsequently, biofilm infections are difficult to
eradicate as a result of biofilm’s inherited tolerance to clinically significant
antibiotics (Costerton et al., 1999). It has been long known that TCS signaling
proteins play a crucial role in modulating P. aeruginosa biofilm formation
(Mikkelsen et al., 2011). The response regulator MifR, has been implicated in
regulating P. aeruginosa biofilm formation, as mifR-deficient strains failed to form
mature biofilms due to a defect in microcolony formation (Petrova & Sauer, 2009).
Furthermore, previous studies have reported the interdependence of pyruvate
fermentation and requirement of functional MifR in supporting microcolony
formation (Petrova et al., 2012). Considering the above results in the light of
previous findings (Tatke et al., 2015) we investigated the impact of MifSR TCS on
P. aeruginosa biofilm formation in the presence of α-KG (30 mM) as the sole
carbon source. As mentioned before, because of the inability of the PAO∆mifR,
PAO∆mifS and PAO∆mifSR mutants to grow in the presence of α-KG (Table 3.3)
(Tatke et al., 2015), biofilm formation was assessed using mifSR mutant strains
harboring the pPcaT plasmid, unless otherwise specified. Also, to rule out the
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possible role of pPcaT affecting biofilm formation, the wild-type strain PAO1
expressing PcaT in trans was used as a control.
Compared

to

the

wild-type

PAO1

strain,

PAO∆mifR(pPcaT),

PAO∆mifS(pPcaT) and PAO∆mifSR(pPcaT) mutants exhibited an increase in
biofilm formation in the presence of α-KG as carbon source (Figure 3.5A). The
difference was significant at all time points (P-value > 0.005) tested over a period
of 72 hours. Importantly, expression of the wild-type mifR and mifSR genes in trans
in the PAO∆mifR and PAO∆mifSR mutants restored the biofilm formation to the
wild-type PAO1 levels (Figure 3.5A). Furthermore, the presence of pPcaT itself did
not have any adverse effect on biofilm formation, as PAO1(pPcaT) formed
comparable level of biofilm as that of the wild-type PAO1 without pPcaT (Figure
3.5A). Additionally, our positive control PAOΔretS a hyper biofilm forming strain
and the negative control PAOΔpelΔpslΔalgD that forms no biofilms showed the
expected results (Figure 3.5).
We have previously shown that MifSR TCS is specific for regulating P.
aeruginosa α-KG transport, as mifS, mifR and mifSR mutants exhibited no growth
difference compared to the wild-type PAO1 in the presence of TCA cycle C4dicarboxylate (succinate, fumarate, malate) and/or the C6-tricarboxylate (citrate)
intermediates (Tatke et al., 2015). It was of interest to investigate if the enhanced
biofilm formation phenotype of mifSR(pPcaT) mutants is α-KG specific. To test
this, biofilm formation ability of the mifSR(pPcaT) mutants was evaluated in the
presence of citrate and/or succinate (30 mM each) as the sole carbon source. No
difference in biofilm formation between the mifSR(pPcaT) mutant strains and the
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wild-type PAO1 was observed over a period of 72 hours in the presence of
succinate (Figure 3.5B) or citrate (Figure 3.5C) as a carbon source. These findings
suggests that MifSR TCS negatively regulates biofilm formation in an α-KG
dependent manner.
It is now well established that the type and availability of nutrients
significantly impact biofilm development and composition (Bowden & Li, 1997,
Sauer et al., 2004). In P. aeruginosa, biofilm formation and development
progresses distinctly in the presence of different carbon and nitrogen sources
(Klausen et al., 2003(a), Klausen et al., 2003(b), Shrout et al., 2006). Most of the
studies to date have looked at the influence of citrate, succinate, pyruvate,
glutamate, casaminoacids, and sugars on the formation of P. aeruginosa biofilms
(De Kievit et al., 2001, Klausen et al., 2003(a), Klausen et al., 2003(b), Shrout et
al., 2006, Petrova et al., 2012). The present study is one of the first to report α-KG
mediated two-component signaling in regulating P. aeruginosa biofilm formation.
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Figure 3.5: α-KG dependent regulation of biofilm formation by mifSR
mutants. Biofilm formation of the wild-type PAO1 and mifSR mutants
expressing pcaT in trans, hyperbiofilm producing PAOΔretS (positive control),
and less biofilm producing PAOΔpelΔpslΔalgD (negative control) in M9 minimal
media with α-KG (A), succinate (B) and citrate (C) at 30 mM each, as a sole
carbon source. The data shown is the relative biofilm formation of each mutant
and complementing strain as compared to that of the wild type PAO1 as
described in material and methods. Each result represents the mean with
standard deviation of three biological replicates. The inset, taken at 72 hours,
demonstrates the superior biofilm formation capacity of PAOΔmifS(pPcaT),
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants compared to PAO1 in the
presence of α-KG (D). Statistically significant difference between the wild type
and mutants as determined by one-way ANOVA with Bonferroni’s post-hoc test,
** p-value < 0.001.
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mifSR deletion mutants are defective in swarming motility
In pathogenic bacteria including P. aeruginosa, motility facilitates
successful invasion, survival and colonization within a host, increases nutrient
acquisition efficiency and helps challenging or evading the host defenses, thus
playing an indispensable role in its virulence (Kazmierczak et al., 2015).
Depending on the growth conditions and medium, P. aeruginosa exhibits three
types of motility, namely swimming, swarming and twitching (Rashid & Kornberg,
2000). The motility is controlled by two cell-surface appendages, a single polar
flagellum and type-IV pili (Harshey, 2003). The flagellum enables swimming in
liquid environments (Toutain et al., 2005) whereas type-IV pili mediates twitching
across solid surfaces (Burrows, 2012). Swarming is a coordinated rapid movement
over semi-solid or viscous surfaces requiring both flagella and type-IV pili (Kohler
et al., 2000). In P. aeruginosa, motility plays a crucial role in facilitating the
transition from a free-living planktonic growth to the more sessile biofilm mode of
growth (Sauer et al., 2002).
On the basis of our findings that P. aeruginosa mifSR-deficient strains form
hyper-biofilms in the presence of α-KG, we hypothesized that MifSR TCS is
involved in regulating motility. To test this, we compared swimming, swarming and
twitching on 0.3%, 0.6% and 1% agar in the wild-type PAO1 and PAO∆mifR,
PAO∆mifS and PAO∆mifSR mutants harboring the pPcaT plasmid, in the presence
of α-KG (30 mM) as the sole carbon source. The mifSR(pPcaT) mutants
demonstrated no significant defect in the flagellum-mediated swimming and typeIV pili mediated twitching motilities in the presence of α-KG (Figure 3.6).
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Figure 3.6: Swimming and twitching motility of mifSR mutants in the
presence of α-KG. Swimming and twitching motility of the wild-type PAO1,
PAOΔmifS(pPcaT), PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) was assessed on
media supplemented with α-KG (30 mM). The experiment was repeated
multiple times with biological replicates.

Figure 3.7: α-KG specific swarming motility in mifSR mutants. Swarming
motility

of

the

wild-type

PAO1,

PAO1(pPcaT),

PAOΔmifS(pPcaT),

PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants and the pMifR and pMifSR
complementing clones was assessed on media supplemented with α-KG or
citrate (30 mM each). The experiment was repeated multiple times with
biological replicates.
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However, compared to P. aeruginosa wild-type PAO1, the ability of ∆mifS(pPcaT),
∆mifR(pPcaT) and ∆mifSR(pPcaT) mutants to swarm was completely abolished in
the presence of α-KG (Figure 3.7A). The swarming defect exhibited by these
mutants could be restored to that of the wild-type PAO1 by expressing mifR and
mifSR in trans in the ∆mifR and ∆mifSR mutants (Figure 3.7C). Furthermore, no
difference in swarming motility was observed in the PAO1(pPcaT) control strain
suggesting that the swarming motility defect in ∆mifS(pPcaT), ∆mifR(pPcaT) and
∆mifSR(pPcaT) mutants is pPcaT-independent and MifSR-dependent.
In our previous study using rich media, such as LB, no role of MifSR TCS
was established in regulating P. aeruginosa motility (Tatke et al., 2015). The above
data further supports the argument that the swarming defect is α-KG dependent.
To further investigate, if the inability of mifSR mutants to swarm was α-KG-specific,
we tested the ability of these mutants to swarm on other TCA cycle intermediates
including succinate and citrate. Interestingly, P. aeruginosa wild-type PAO1 and
the mifSR mutants with or without pPcaT exhibited identical swarming phenotypes
in the presence of succinate or citrate (Figure 3.7B). Also, no difference in
swimming and twitching motility was observed in presence of citrate or succinate
as a carbon source. Together, these findings clearly argues for the requirement of
a functional MifSR in modulating P. aeruginosa swarming motility exclusively in the
presence of α-KG.
Swarming motility in P. aeruginosa is often regulated in response to
rhamnolipid production (Kohler et al., 2000, Caiazza et al., 2005). Rhamnolipids
are surface-active agents that help in reducing surface tension to drive flagellum-
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mediated translocation over semi-solid surfaces (Kohler et al., 2000). In addition,
rhamnolipids have been recovered from CF patient sputa and are involved in
inactivation of mammalian tracheal cells and erythrocyte destruction, indicating
their importance as virulence factors (Hastie et al., 1986, Kownatzki et al., 1987,
Jensen et al., 2007). Lack of swarming in the ∆mifS(pPcaT), ∆mifR(pPcaT) and
∆mifSR(pPcaT) mutants can be attributed to a difference

in rhamnolipid

production in the presence of α-KG. To test if the swarming defect in the mifSR
mutants is concomitant with rhamnolipid production we performed the rhamnolipid
plate assay with α-KG as a carbon source. No significant difference was observed
in rhamnolipid production in the ∆mifS(pPcaT), ∆mifR(pPcaT) and ∆mifSR(pPcaT)
mutants as compared to the wild-type PAO1 with or without pPcaT in the presence
of α-KG (Figure 3.8). Although interesting, this is not surprising as similar findings
have been reported in P. aeruginosa where swarming phenotype was independent
of rhamnolipid production (Yeung et al., 2011, Guo et al., 2014).
Swarming motility by itself is a complex surface associated behavior
controlled by multiple physical factors (flagella, type IV pili and rhamnolipid) (Kohler
et al., 2000, Deziel et al., 2003) and transcriptional regulatory networks (Yeung et
al., 2009) . Additionally, swarming motility is also dependent on the availability of
specific nutrients (Rashid & Kornberg, 2000, Harshey, 2003, Bains et al., 2012). In
P. aeruginosa, swarming motility is influenced by the presence of specific carbon
and nitrogen sources (Kohler et al., 2000, Bernier et al., 2011). Swarming is
augmented in response to nitrogen limitation, and in the presence of certain amino
acid such as glutamate, histidine, proline and aspartate (Kohler et al., 2000).
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Interestingly α-KG is central to both these processes, it is a well-established signal
for nitrogen starvation (Leigh & Dodsworth, 2007) and is also a precursor for the
synthesis of amino acids glutamate, histidine and proline (Owen et al., 2002).
Together, our finding suggests a more intricate network of metabolic control
exerted by α-KG on P. aeruginosa swarming motility that still needs to be further
explored. Furthermore, in P. aeruginosa swarming motility and biofilm mode of
growth are inversely regulated i.e., strains that are deficient in swarming motility
produce more biofilm while strains that exhibit increased swarming motility produce
less biofilms (Caiazza et al., 2007). This is achieved by a complex interplay
between several regulatory mechanisms including TCSs and the seconder
messenger molecule cyclic-di-GMP (Goodman et al., 2004, Caiazza et al., 2007,
Kuchma et al., 2007, Merritt et al., 2007, Merritt et al., 2010). It has been shown
that the intracellular levels of cyclic-di-GMP influence a wide array of bacterial
behaviors, with the common trend being that an increase in the levels of cyclic-diGMP encourages sessile behaviors, such as biofilm formation, while the
degradation of cyclic-di-GMP favors motile behaviors, such as swarming. As the
mifSR mutant exhibits a swarming defect and a hyperbiofilm phenotype, it will be
of interest to examine if MifSR TCS plays a role in regulating the levels of cellular
cyclic-di-GMP in the presence of α-KG. Regardless, our data is reminiscent of
these findings that shows an inverse relationship between biofilm formation and
swarming motility modulated through the MifSR signaling cascade. However, at
this point, the precise transcriptional regulatory control exerted by MifS/MifR TCS
proteins on biofilm formation and swarming motility in the presence of α-KG

108

remains to be elucidated. Our study shows that MifSR TCS positively regulates
swarming motility and negatively regulates biofilm formation in an α-KG dependent
manner.

Figure 3.8: Rhamnolipid production in the presence of α-KG. Rhamnolipid
production of the wild-type PAO1 (Vector), PAO1 (pPcaT), PAOΔmifS(pPcaT),
PAOΔmifR(pPcaT),

PAOΔmifSR

(pPcaT)

was

assessed

using

the

cetyltrimethylammonium bromide (CTAB) methylene blue agar plate (A) and
the diameter of the blue halo around the colonies was measured as a mark of
rhamnolipid production (B)
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Pyocyanin production is negatively regulated by mifSR
One of the hallmarks of P. aeruginosa infections is the production of
extracellular, redox-active phenazine compounds. Pyocyanin, a nitrogencontaining heterocyclic blue-green pigment is the major phenazine-derived
compound produced by P. aeruginosa (Pierson & Pierson, 2010). Pyocyanin
functions both as a crucial virulence factor (Lau et al., 2004) and as a signaling
molecule (Dietrich et al., 2006). Furthermore, pyocyanin exhibits antibiotic
properties that allow P. aeruginosa to gain dominance over other competing
microorganisms, including bacteria and fungi, during infection (Baron & Rowe,
1981, Kerr et al., 1999, Price-Whelan et al., 2006). Importantly, both in vitro and
in vivo studies have revealed that pyocyanin plays an pivotal role in establishing
P. aeruginosa infections and is essential for its full virulence (Mahajan-Miklos et
al., 1999, Ran et al., 2003, Lau et al., 2004, Allen et al., 2005, Cezairliyan et al.,
2013). In our earlier experiments when pPcaT was introduced in the ΔmifS, ΔmifR
and ΔmifSR mutants, a visual difference in the pigment production was observed
in the presence of α-KG (Figure 3.9). In particular, there was a difference in the
production of the blue-green color, a characteristic of pyocyanin (Frank & Demoss,
1959). This prompted us to ask if pyocyanin production is α-KG dependent and if
it is regulated by the MifSR TCS. To test this, we compared the amount of
pyocyanin made by ΔmifS(pPcaT), ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants to
that of wild-type PAO1 strain in the presence of TCA cycle intermediates including
α-KG, citrate and succinate (30 mM each), as a carbon source. There was no
significant difference in the amount of pyocyanin (ug/ml) produced in the presence
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of citrate and/or succinate between the wild-type PAO1 and the mifSR mutant
derivatives (Figure 3.9). However, as compared to the parent PAO1, the
mifSR(pPcaT) mutants produced significantly (p-value < 0.0005) higher amount (a
five-fold increase) of pyocyanin in the presence of α-KG (Figure 3.9). This
phenotype was rescued by complementing the mifR and mifSR mutant strains with
the wild-type mifR and mifSR genes (Figure 3.9). Also, the comparable amount of
pyocyanin produced by the wild-type PAO1 and PAO1(pPcaT) suggests, that the
presence of an extra copy of pcaT does not influence this phenotype. Furthermore,
absorbance spectra analysis of the overnight cell free culture supernatants showed
a characteristic peak of pyocyanin at 310-325 nm (Mavrodi et al., 2001, Reszka et
al., 2004). The absorbance peak intensity of the ΔmifS(pPcaT), ΔmifR(pPcaT) and
ΔmifSR(pPcaT) mutants was significantly higher as compared to the wild-type
PAO1 strain indicative of more pyocyanin production in the mifSR mutant
derivatives (Figure 3.12).These findings strongly suggests an α-KG dependent
regulation of P. aeruginosa pyocyanin production by the MifSR TCS proteins.
Pyocyanin production in P. aeruginosa involves a complex pathway
consisting of two homologous operons phzA1B1C1D1E1F1G1 (phzA1) and
phzA2B2C2D2E2F2G2 (phzA2) and two additional genes phzM and phzS
encoding phenazine modifying enzymes (Mavrodi et al., 2001). To determine if the
difference in pyocyanin production in the presence of α-KG is a function of change
in gene expression, qRT-PCR was performed to assess the transcript levels of
phzA1, phzA2, phzM and phzS genes in the PAO1(pPcaT) and the mifSR(pPcaT)
mutants. For the qRT-PCR analysis PAO1(pPcaT) was used as the reference
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strain since it exhibited the same pyocyanin phenotype as that of the wild-type
PAO1 strain without pPcaT. In the PAO1(pPcaT) strain, presence of α-KG appears
to inhibit the expression of the phz genes namely, phzA1, phzA2, phzM and phzS
(Figure 3.10). The above data suggests that α-KG is a repressor of pyocyanin
synthesis in P. aeruginosa. In the mifSR(pPcaT) mutant derivatives the expression
of phzA1 was significantly induced in the presence of α-KG as compared to the
wild-type PAO1(pPcaT). However, the second phzA2 operon and, phzS and phzM
genes did not show a significant increase in expression. Pyocyanin production is
a characteristic of P. aeruginosa stationary growth phase. Here the cells were
induced with α-KG for an hour, we suspect that prolong induction of the cells with
α-KG might result in a differential expression of the other genes involved in
pyocyanin synthesis in the mifSR(pPcaT) mutants. In P. aeruginosa PAO1, the
expression of phzA1 accounts for majority of phenazine production (Liang et al.,
2008), and our qRT-PCR findings suggests that the hyper-production of pyocyanin
could be accounted for by an increased expression of phzA1 in the mifSR(pPcaT)
mutant strains. Together these findings indicate that MifSR TCS is negatively
regulating P. aeruginosa pyocyanin production in the presence of α-KG.
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Figure 3.9: Pyocyanin production in mifSR mutants in the presence of
α-KG. Pyocyanin production was measured quantitatively from the overnight
culture supernatants of the wild-type PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT),
PAOΔmifR(pPcaT), PAOΔmifSR(pPcaT) mutants and the pMifR and pMifSR
complementing clones in M9 minimal media supplemented with α-KG, and/or
succinate (30 mM each) , using the chloroform and HCL method, as described
in materials and methods. Results shown are mean with standard deviation of
three biological replicates. Statistically significant difference between the wild
type and mutants as determined by one-way ANOVA with Bonferroni’s posthoc test, ** p-value < 0.001.
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Bonferroni’s post-hoc test, ** p-value < 0.001 compared with expression in PAO1 (B).

strain (A). Statistically significant difference between the wild type and mutants as determined by one-way ANOVA with

as determined by Student’s unpaired t test, ** p-value < 0.001 compared with expression in the wildtype PAO1 uninduced

as the housekeeping control. Statistically significant difference between the wildtype PAO1 uninduced and induced cells

line represents up- and down-regulation, respectively and the bars are standard errors. The clpX (PA1802) gene was used

expression of phz genes were analyzed in the mifSR mutant derivatives relative to PAO1 (B). Bars above or below the

(PA4217), were analyzed in the wildtype PAO1 with and without α-KG treatment (A). Additionally, effect of α-KG on the

genes involved in phenazine biosynthesis, particularly, phzA1 (PA4210), phzA2 (PA1899), phzM (PA4209) and phzS

Figure 3.10: Quantification of phenazine specific genes by qRT-PCR in the presence of pPcaT. Expression of the

mifSR positively regulates pyoverdine production
P. aeruginosa produces several siderophores that play a pivotal role in
scavenging iron from the host, a vital process required for bacterial growth and
infection (Bullen, 1981, Poole & McKay, 2003, Skaar, 2010). Amongst these,
pyoverdine, a yellow-green fluorescent pigment is the primary siderophore
produced by P. aeruginosa (Meyer, 2000, Lamont et al., 2009). Pyoverdine is not
only an efficient iron scavenger and transporter during P. aeruginosa infection and
biofilm formation (Banin et al., 2005, Visca et al., 2007) but also, a signaling
molecule established in regulating multiple virulence-associated traits (Beare et
al., 2003, Visca et al., 2007). Indeed, several in vivo studies in animal and
nematode models demonstrated the requirement of pyoverdine as an important
virulence factor essential for successful P. aeruginosa infections (Meyer et al.,
1996, Takase et al., 2000, Kirienko et al., 2013). Considering the fact that P.
aeruginosa MifSR TCS is involved in modulating P. aeruginosa virulence
associated pigment production in the presence of α-KG, we investigated its role in
pyoverdine production. To test this, we compared the amount of pyoverdine made
by ΔmifS(pPcaT), ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants to that of wild-type
PAO1 strain in the presence of TCA cycle intermediates including α-KG and
succinate (30 mM each), as a carbon source. As compared to the parent PAO1,
the mifSR(pPcaT) mutants produced significantly (p-value < 0.005) less
pyoverdine in the presence of α-KG (Figure 3.11). This phenotype was rescued by
complementing the mifR and mifSR mutant strains with the wild-type mifR and
mifSR genes (Figure 3.11). No difference in pyoverdine production was observed
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when succinate was provided as the sole carbon source (Figure 3.11) suggesting
an α-KG dependent regulation. Also, the comparable amount of pyoverdine
produced by the wild-type PAO1 and PAO1(pPcaT) suggests, that the presence
of an extra copy of pcaT does not influence this phenotype. These findings strongly
suggests an α-KG dependent regulation of P. aeruginosa pyoverdine production
by the MifSR TCS proteins.
Furthermore, absorbance spectra analysis of the overnight cell free culture
supernatants showed a characteristic peak of pyoverdine at 400-405 nm
(Vandenende et al., 2004). The absorbance peak intensity of the ΔmifS(pPcaT),
ΔmifR(pPcaT) and ΔmifSR(pPcaT) mutants was lower as compared to the wildtype PAO1 strain indicative of less pyoverdine production in the mifSR mutant
derivatives (Figure 3.12). Together the data suggest that MifSR TCS positively
regulates pyoverdine production in the presence of α-KG, as the sole carbon
source.
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Figure 3.11: Pyoverdin production in mifSR mutants in the presence of
α-KG. Pyoverdin levels of wild-type PAO1, PAO1(pPcaT), PAOΔmifS(pPcaT),
PAOΔmifR(pPcaT), PAOΔmifSR (pPcaT) mutants and the pMifR and pMifSR
complementing clones in M9 minimal media supplemented with α-KG and/or
succinate (30 mM each) was quantitated by measuring the absorbance A405.
Values are normalized with respect to culture density and A405/A600 ratio
expressed the pyoverdin levels. Each result represents the mean with standard
deviation of three biological replicates. Statistically significant difference
between the wild type and mutants as determined by one-way ANOVA with
Bonferroni’s post-hoc test, ** p-value < 0.001.
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analysis of the overnight cell free culture supernatant show a characteristic peak of

Figure 3.12: Pyocyanin and Pyoverdine absorbance spectra.

Loss of mifR increases cell cytotoxicity
P. aeruginosa expresses and utilizes an arsenal of virulence mechanisms
to gain competitive advantage over its host in-order to establish acute and chronic
infections. Most of these mechanisms rely on numerous virulence factors and/or
exoproteins, which are intentionally released by this pathogen via diverse and
complex secretion machinery. Most of the secreted virulence factors are toxins
and hydrolytic enzymes that induce cell cytotoxicity thus causing damage and
annihilation of the host cells. Moreover, in a previous microarray gene expression
study significant alteration in expression of genes encoding secreted virulence
factors was observed in mifR mutant compared to its wild-type PAO1 (Petrova et
al., 2012). Since our data indicated that MifSR TCS proteins regulated the
transport of extracellular α-KG, and modulate different virulence determinants, we
examined the ability of mifSR mutant derivatives to infect and destroy A549 lung
fibroblast cell cultures in the presence of α-KG.
Since all the virulence related phenotypes exhibited by the ∆mifS(pPcaT),
∆mifR(pPcaT), ∆mifSR(pPcaT) mutants were α-KG dependent, bacterial cells
were grown overnight and sub-cultured in M9 minimal media with α-KG (30 mM)
before infecting the respective cell cultures. Release of lactate dehydrogenase
(LDH) was measured as a function of cell damage using colorimetric LDH activity
assay (Hauser & Engel, 1999). The ∆mifR(pPcaT) and ∆mifSR(pPcaT) mutants
exhibited two-fold increase (P-value < 0.005) in cytotoxicity compared to the wildtype PAO1 in the presence or absence pcaT (Figure 3.13A). Interestingly no
difference in cytotoxicity was observed in case of ∆mifS(pPcaT) compared to the
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parent strain PAO1. This could be the result of a potential crosstalk between MifR
and other noncognate HKs that needs to be verified. Furthermore, introduction of
the wild type mifR and mifSR genes into ∆mifR and ∆mifSR mutants restored
cytotoxicity to the wild-type PAO1 levels. In-order to rule out the cytotoxicity seen
is not specific to A549 lung fibroblast, HeLA and J774-Eclone cells were assessed.
All three cell-lines exhibited the same phenotype (Figure 3.14) suggesting
increased virulence of mifR and mifSR mutants leading to higher cytotoxicity.
Subsequently, when α-KG was replaced with succinate as the carbon source, no
discernable difference in cell cytotoxicity was observed between the mifSR(pPcaT)
mutants and the parent PAO1 strains (Figure 3.13B). The data suggests that MifR
independent of MifS, negatively regulates P. aeruginosa cell cytotoxicity.
Bacterial pathogens are one of the most portentous infiltrators of the host
system, causing significant damage leading to cellular aberrations and injury. In
the mammalian cells TCA cycle intermediates including α-KG are mainly found in
cytoplasm and mitochondria. Cell injury, results in the efflux of intracellular
metabolites leading to an increase in their extracellular concentrations. It is known
that TCA cycle intermediates (C4, C5, and C6 dicarboxylates) are present at
micromolar (μM) concentrations in blood that increase with tissues damaged (He
et al., 2004, Hebert, 2004).Therefore it is possible that α-KG might act as a marker
of the intensity and level of cellular damage that signals P. aeruginosa to
downregulate its cytotoxic determinants via mifR regulatory circuit. This is one of
the first report of α-KG mediated two-component signaling in regulating P.
aeruginosa cell cytotoxicity.
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type and mutants as determined by one-way ANOVA with Bonferroni’s post-hoc test, ** p-value < 0.001.

shown are the mean of three replicates with standard deviation. Statistically significant difference between the wild

and the LDH release was monitored after 24 h of infection. The experiment was repeated three times and the data

in M9 media with α-KG (30 mM) were cocultured with A549 lung fibroblast cells with α-KG (A) and without α-KG (B),

cytotoxicity was determined by the lactate dehydrogenase (LDH) release assay post 24 h of infection. Bacteria grown

Figure 3.13: Cytotoxicity effect of P. aeruginosa PAO1 and mifSR mutants on A549 lung fibroblast. Cell
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Figure 3.14: Cytotoxicity effect of P. aeruginosa PAO1 and mifSR mutants on HeLA and J774-Eclone cells.
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MifSR TCS and α-KG dependent regulation of P. aeruginosa virulence.
To confirm that the expression of α-KG transporter PcaT itself in the mifSR
mutants had no effect on P. aeruginosa α-KG-dependent virulence phenotypes,
we performed pigment (pyocyanin and pyoverdine) production, absorbance
spectra analysis and cell cytotoxicity assays with the wild type PAO1 and mifSR
mutants in the presence of PA5530 (KgtP) (the previously reported α-KG
transporter) (Tatke et al., 2015). Similar to the mifSR(pPcaT) mutants,
mifSR(pKgtP) mutants produced significantly (p-value < 0.0005) higher and lower
amounts of pyocyanin and pyoverdine in the presence of α-KG, as compared to
the parent PAO1 strain with and/or without pKgtP (Figure 3.15A and 3.15B).
Furthermore, absorbance spectra analysis of the cell free culture supernatants
showed the characteristic peak of pyocyanin at 310-325 nm and pyoverdine at
400-405 nm. The absorbance peak intensity of the ∆mifS(pKgtP), ∆mifR(pKgtP)
and ∆mifSR(pKgtP) mutants was higher for pyocyanin and lower for pyoverdine as
compared to the wild-type PAO1 strain (Figure 3.15C). In addition, in the presence
of α-KG, similar to the mifSR(pPcaT) mutants, ∆mifR(pKgtP) and ∆mifSR(pKgtP)
exhibited increased cell cytotoxicity, and no difference in cell-cytotoxicity was
observed in the case of mifS(pKgtP) compared to the parent PAO1 strain (Figure
3.15D). The mifSR(pKgtP) results corroborates with our mifSR(pPcaT) data,
suggesting that mifSR mutant exhibited phenotypes are transporter independent
and α-KG-dependent.
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Figure 3.15: mifSR(pKgtP) virulence assays in the presence of α-KG.
Pyocyanin production (A), pyoverdine production (B), absorbance spectra (C)
and cell cytotoxicity (D) of PAO1, PAO1(pKgtP), mifS(pKgtP), mifR(pKgtP),
mifSR(pKgtP) mutants in the presence of α-KG (30 mM).
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Conclusion
P. aeruginosa is one of the most formidable, opportunistic human pathogen
infamous for its ability to cause several localized and systemic infections (Tummler
et al., 2014). Its ability to colonize different host niches is largely dependent on its
metabolic flexibility and environmental adaptability dictated by genetic versatility
(Mathee et al., 2008). P. aeruginosa preferentially utilizes TCA cycle intermediates
as carbon and energy source over other compounds (Collier et al., 1996), and αKG is a key intermediate of the TCA cycle (Krebs, 1940). α-KG plays a crucial role
in regulating carbon-nitrogen metabolism (Doucette et al., 2011) and importantly,
α-KG is considered to be a signaling molecule in both prokaryotes (Ninfa & Jiang,
2005) and eukaryotes (Lancien et al., 2000, He et al., 2004). Furthermore, recent
studies have reported preferential utilization of extracellular a-KG as a principle
carbon source during infection by pathogenic bacteria (Guo et al., 2012, Cai et al.,
2013). The data together suggests a profound role of α-KG in regulating bacterial
physiology and metabolism. However, limited analysis of the physiological roles of
α-KG in bacteria, including P. aeruginosa, has left its role in pathogenesis unclear.
The present study provides a novel insight into the role of α-KG and MifSR TCS in
regulating P. aeruginosa pathogenesis.
Our findings, suggests a complex regulatory cascade in modulating P.
aeruginosa C5-dicarboxylate, α-KG uptake involving a combined action of multiple
α-KG transporters namely PcaT (PA0229) and KgtP (PA5530), the MifS/MifR TCS
and the sigma factor RpoN (Figure 3.16). It appears that MifS senses the presence
of α-KG and signals MifR. The activated-MifR along with the sigma factor RpoN

125

initiate the transcription of α-KG transporter genes pcaT and kgtP. Interestingly,
our findings suggests that the MifSR TCS inversely regulates the expression of
pcaT and KgtP genes (Figure 3). Furthermore, sequence analysis of pcaT
promoter (PpcaT) and our previous published PkgtP findings (Tatke et al., 2015)
together indicates that the expression of both pcaT and kgtP genes is under
several layers of transcriptional and post-transcriptional controls, suggesting a
complex regulatory mechanism involved in modulating P. aeruginosa α-KG
uptake. The presence of two α-KG transporters regulated in an opposite fashion
in P. aeruginosa is of interest due to their possible function in responding to
nutritional cues. Furthermore, it is also possible that the presence of two α-KG
transporters is due to a difference in their substrate affinities and may indicate a
role for each in changing gene expression based upon environmental α-KG
concentrations. Future studies will determine if P. aeruginosa α-KG transporters
are preferentially or hierarchically regulated depending on the carbon source.
In addition to the role of MifSR TCS in modulating extracellular α-KG
transport, in this study we illustrate the interdependence of MifSR TCS and the C5dicarboxylate α-KG in regulating the expression of P. aeruginosa’s key virulence
determinants. The results presented here show that MifSR TCS in an α-KG specific
manner positively regulates swarming motility and pyoverdine production while
negatively regulates biofilm formation and pyocyanin production. Interestingly, αKG dependent cell cytotoxicity was found to be MifS-independent and MifRdependent, suggesting a potential crosstalk between MifR and other noncognate
HKs. Together, these findings strongly suggest a complex mechanism of MifSR
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action involving multiple regulatory controls that are achieved by modulating
expression of numerous genes in α-KG-dependent manner. Identifying the α-KG
dependent members of MifSR regulon will significantly help in delineating the role
of MifSR signaling pathway in P. aeruginosa pathogenesis.
Successful adaptation of P. aeruginosa to different niches depends
extensively on its ability to regulate gene expression as specified by the
environmental cues. Although a plethora of TCSs have been identified in P.
aeruginosa (Winsor et al., 2011) that warrants its adaptability, only a handful of
TCS signaling molecules are known to date. Recent research progresses show
that, TCA cycle metabolites in-addition to their canonical role in metabolism are
increasingly been recognized as a bacterial TCS activating signals (Janausch et
al., 2002, Sevvana et al., 2008, Zhou et al., 2008, Brocker et al., 2009, Cai et al.,
2013, Valentini & Lapouge, 2013, Tatke et al., 2015). Our data indicates that the
TCA cycle C5-dicarboxylate α-KG is the signaling molecule activating P.
aeruginosa MifSR TCS. This is one of the first reports to answer fundamental
questions pertaining to α-KG utilization in P. aeruginosa and its role as a
messenger in MifSR regulatory mechanism. Metabolic processes and virulence
mechanisms are closely interconnected and are hallmarks of P. aeruginosa
infections. Hopefully, this and future studies on this regulatory system and
metabolism pathway will add significantly to the understanding of an intricate link
between virulence and metabolism in pathogens that would provide a better
stratagem to fight the often indomitable infections.
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Figure 3.16: Proposed model for α-KG-dependent MifS and MifR TCS
signal perception mechanism. HK-MifS senses the extracellular α-KG to
undergo phosphorylation. The phosphate is transferred to the RR-MifR. The
phosphorylated MifR in coordination with RpoN (σ54) activates the expression
of α-KG specific transporter gene PA5530. PA5530 thus enables the influx of
α-KG to meet the metabolic and energy demands of the cells. Also, activated
MifR, directly or indirectly represses the expression of pcaT gene. pcaT
promoter (PpcaT) region has a Crc binding site, suggesting that it is under the
catabolite repression control by Crc/CrcZ. The (PpcaT) also shows the presence
RsmA binding site indicating a multilayered and complex regulation of the α-KG
transport system. Further, in the presence of α-KG as a carbon source MifR
positively regulates swarming motility and pyoverdine production while
negatively regulates biofilm formation, pyocyanin and cell cytotoxicity.
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CHAPTER 4

General Discussion

130

Overview
Pseudomonas aeruginosa is a metabolically versatile, Gram-negative ϒproteobacteria that is well known for its widespread spatiotemporal distribution
(Ramos, 2004). Although, a primary inhabitant of soil and water, it has an
extraordinary ability to survive and thrive in a myriad of natural and artificial
environments (Walker et al., 2004, Gellatly & Hancock, 2013). Importantly, P.
aeruginosa is a dominant nosocomial pathogen and an epitome of opportunistic
infections in humans (Bodey et al., 1983, Lyczak et al., 2000, de Bentzmann &
Plesiat, 2011). It is the fourth most commonly-isolated nosocomial pathogen and
accounts for 10 percent of all hospital-acquired infections (Gaynes et al., 2005). P.
aeruginosa is infamous for its ability to cause wide range of human infections that
can vary from acute to chronic, local to systemic and self-limiting to life-threatening
(Campa et al., 1993, Sousa & Pereira, 2014, Tummler et al., 2014). In particular,
P. aeruginosa pose a high risk to individuals with impaired immunity and those
suffering from the recessive genetic disorder, cystic fibrosis (Ratjen & Doring,
2003). In patients with CF, chronic and recurrent pulmonary infections by P.
aeruginosa are a leading cause of morbidity and mortality (Sorde et al., 2011,
Winstanley et al., 2016). P. aeruginosa produces multi-determinant virulence
factors, both cell associated and secretory, which modulate its pathogenicity and
ensures its success as a pathogen (Balasubramanian et al., 2013). Despite
extensive efforts in the development of new anti-pseudomonal drugs, therapeutic
intervention in the treatment of P. aeruginosa infections has not been very
effective, particularly due its extraordinary intrinsic and acquired resistance to a
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repertoire of clinically significant antibiotics (Hancock & Speert, 2000, Falagas &
Bliziotis, 2007, Lister et al., 2009) . Thus, the pathogenesis of P. aeruginosa
infections is multifactorial, and is manifested by its diverse metabolic capabilities,
expression of virulence factors and antibiotic resistance.
Another key factor accounting for the success of P. aeruginosa as an
invincible pathogen is its environmental and metabolic adaptability. This flexibility
allows survival, growth and rapid colonization of different host milieus, leading to
successful infection and disease progression (Silby et al., 2011). In human host,
since the environmental conditions are highly variable and erratic, pathogenic
bacteria need a dedicated regulatory system that supports their adaptation to
perpetual changes. To perform these adaptations, P. aeruginosa has evolved an
intricate and dynamic array of signaling networks that in addition to modulating the
basic housekeeping functions, coordinate the temporal expression of various
genes in response to both inter- and intracellular signaling molecules and
environmental cues (Rodrigue et al., 2000, Ventre et al., 2006, Gooderham &
Hancock, 2009, Williams & Camara, 2009, Haussler, 2010, Jimenez et al., 2012).
Of the many signaling mechanisms elucidated in P. aeruginosa, two-component
system (TCS) mediated signal perception play a pivotal role in sensing diverse
environmental stimuli and elicit a pertinent and rapid adaptive response (Rodrigue
et al., 2000, Stock et al., 2000, Alm et al., 2006).
TCSs in P. aeruginosa have been shown to regulate many physiological
aspects of its lifestyle, including global responses to stress (Wood et al., 2006,
Leech et al., 2008), chemotaxis (Gooderham & Hancock, 2009), antibiotic
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resistance (Gooderham & Hancock, 2009), carbon/nitrogen metabolism (Nishijyo
et al., 2001, Li & Lu, 2007), nutrient uptake (McPhee et al., 2006, Valentini et al.,
2011, Tatke et al., 2015), expression of virulence factors (Gooderham & Hancock,
2009, Mikkelsen et al., 2011, Okkotsu et al., 2014) and transition from free living
planktonic to sessile biofilm mode of growth (Mikkelsen et al., 2011). While a
plethora of TCS signaling proteins (135) have been identified in P. aeruginosa only
a few have been extensively characterized and the regulatory targets for many
TCS systems are still unknown (Rodrigue et al., 2000, Barakat et al., 2009, Winsor
et al., 2011). Furthermore, in most of the cases, the environmental signals that
influence TCS pathways remains obscure (Mascher et al., 2006, Mitrophanov &
Groisman, 2008). Though the environmental cues sensed by TCSs are poorly
understood, they are largely accountable for determining the outcome of P.
aeruginosa infections and pathogenesis. Also, in many instances TCSs are known
to work in tandem with other signal transduction pathways, thus forming a complex
network allowing P. aeruginosa to assimilate numerous external cues into a
cohesive regulatory circuit that modulates a lifestyle continuum (Coggan &
Wolfgang, 2012). Understanding the complexities of TCS signaling is the key to
understanding P. aeruginosa pathogenesis.
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Summary
MifSR TCS regulates P. aeruginosa α-KG transport and virulence
P. aeruginosa genome encodes one of the largest groups of TCS proteins
identified in any sequenced bacterial species (Barakat et al., 2009, Winsor et al.,
2011). Amongst these, only few TCSs have been completely characterized. This
dissertation investigated the role of a previously uncharacterized TCS protein pair
MifS and MifR in regulating P. aeruginosa pathogenesis. MifS is a sensor histidine
kinase (HK) and MifR is the response regulator (RR). During the course of the
dissertation, the RR MifR was reported to have a dual function, in regulating the
maturation stage of biofilm formation (virulence) and in pyruvate fermentation
(metabolism) (Petrova & Sauer, 2009, Petrova et al., 2012).

However, the

mechanism by which MifR is activated in this process remains obscure and no
relation with the histidine kinase MifS has been established. Our work identified a
novel role of the MifS-MifR TCS proteins in regulating P. aeruginosa metabolism
by exclusively modulating the utilization of a key tricarboxylic acid (TCA) cycle
intermediate, α-Ketoglutarate (Chapter 2) (Tatke et al., 2015). Specifically, we
show that MifSR TCS regulates the uptake of extracellular α-KG by positively
regulating the expression P. aeruginosa PA5530 (kgtP) gene encoding a putative
α-KG permease (Chapter 2, Figure 2.11). Additionally, we show that the transport
of extracellular α-KG in P. aeruginosa is a consequence of an orchestrated
interplay between the MifSR TCS and the alternate sigma factor RpoN (σ54)
(Chapter 2, Figure 2.14). To date, this work is one of the first to establish the role
of P. aeruginosa MifS/MifR TCS in regulates α-KG transport in association with the
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sigma factor RpoN (Tatke et al., 2015). In addition, we identified that besides KgtP,
P. aeruginosa genome encodes a second α-KG permease PcaT (PA0229) whose
expression is independent of MifSR TCS, suggesting an additional layer of
regulation involved in P. aeruginosa α-KG uptake (Chapter 3).

Lastly, our

phenotypic assay revealed the α-KG specific exclusivity of MifSR TCS in
modulating P. aeruginosa virulence mechanism (Chapter 3). We show that MifSR
TCS in the presence of α-KG as a sole carbon source regulates the expression of
P. aeruginosa biofilm formation, swarming motility, pigment production (pyocyanin
and pyoverdine) and cell cytotoxicity (Chapter 3 and Figure 4.1). Simultaneous
regulation of multiple mechanisms involved in P. aeruginosa pathogenesis
suggests a complex mechanism of MifSR action. To date, to our knowledge, this
is one of the first report of α-KG mediated two-component signaling in regulating
P. aeruginosa metabolism and virulence. Together, this work established the role
of α-KG as a signaling molecule and that MifSR TCS system is a master regulator
of α-KG transport in P. aeruginosa. Here we propose a model for α-KG dependent
MifSR TCS signaling in P. aeruginosa (Figure 4.2).
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MifSR TCS in the presence of α-KG.

Figure 4.1: Overview of P. aeruginosa virulence phenotypes differentially regulated by

Figure 4.2: Proposed model for α-KG dependent MifSR TCS
signaling in P. aeruginosa. Sensor MifS senses the extracellular αKG as an environmental cue to undergo phosphorylation. The
phosphate is then transferred to the response regulator MifR. The
phosphorylated MifR together with the alternate sigma factor RpoN
activates the expression of α-KG specific transporter gene kgtP. KgtP
then enables the influx of extracellular α-KG to meet the metabolic
demands of the cells. In addition, MifSR TCS in the presence of α-KG
as a carbon source differentially regulates P. aeruginosa key virulence
determinants including biofilm formation, swarming motility, cell
cytotoxicity and the production of pyocyanin and pyoverdine.
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phosphotransfer from histidine kinase (HK) to the response regulator (RR) is one
of the predominant strategy used by bacteria for coupling environmental signal to
adaptive responses. Bacterial TCS signal transduction mechanisms have always
been a subject of extensive research because of the versatility of its components
(HK and RR) to probe the environmental conditions and decide how best to
respond by orchestrating the expression of several desired genes. In the recent
years, with the advent of new biochemical and molecular biology techniques,
substantial advances have been made in understanding the molecular
mechanisms regulated by TCS signaling pathways. While the work in this
dissertation using high-throughput phenotypic microarray studies and molecular
and biochemical techniques have helped significantly to get an insight into a novel
role of α-KG mediated signaling via the MifS and MifR TCS proteins in P.
aeruginosa, there remains many unanswered questions.
Outlined below are some ideas and avenues for further research that are
based on the results published in this dissertation and/or are based on my
preliminary data mentioned in this section.
•

Determine the α-KG dependent MifR regulon

•

Elucidate the role of RpoN (σ54) and TCS signaling in regulating P. aeruginosa
TCA cycle intermediate transport and pathogenesis

(Each future research direction is strengthen with a brief discussion)
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Determine the α-KG dependent MifR regulon
P. aeruginosa response regulator MifR is a part of the signal transduction
MifS/MifR TCS. MifR on average is 60-65% similar to the known P. aeruginosa
NtrC superfamily of TCS response regulators including DctD, CbrB, AauR, NtrC,
AlgB, FleR and PilR, suggesting similar functions (Winsor et al., 2011). These
transcriptional regulators are known to regulate a myriad of functions in P.
aeruginosa including carbon assimilation, nitrogen metabolism, nutrient uptake,
motility, antibiotic resistance (Ritchings et al., 1995, Arora et al., 1997, Gooderham
& Hancock, 2009) and alginate synthesis (Wozniak & Ohman, 1991, Ma et al.,
1998, Leech et al., 2008). Our phenotypic assays under nutrient rich conditions
indicated no role of MifR in regulating P. aeruginosa antibiotic resistance (Figure
4.3) or other virulence related characteristics (Figure 4.4) (Tatke et al., 2015).
Therefore, we performed a high throughput phenotypic microarray (BioLOG) with
mifR deletion mutant and the wild-type PAO1 strains where numerous metabolic
and chemical sensitivity phenotypes were tested simultaneously (Chapter 2,
Figure 2.5). Our phenotypic microarray data indicated the role of RR MifR in
regulating P. aeruginosa metabolism by modulating the utilization of C5dicarboxylate α-KG, a key TCA cycle intermediate as a carbon and energy source.
Subsequently, our growth profile, genetic complementation and qRT-PCR
expression studies showed that MifR in concert with the sigma factor RpoN (σ54)
regulate extracellular α-KG transport by modulating the expression of P.
aeruginosa α-KG-specific permease PA5530 (KgtP) (Chapter 2) (Tatke et al.,
2015).
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biological replicate trials are shown.

parent PAO1 and mifSR deletion mutants to four major classes of antibiotics. Representative data from three different

Figure 4.3: Effect of mifSR deletion on P. aeruginosa antibiotic resistance. Antibiotic resistance profile of the
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Figure 4.4: Effect of mifSR deletion on P. aeruginosa virulence. Overview
of P. aeruginosa virulence phenotypes under nutrient rich conditions.
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In P. aeruginosa, TCA cycle intermediates, including α-KG is known to
trigger carbon catabolite repression (CCR), a mechanism by which cells facilitate
hierarchical uptake and utilization of carbon substrates for efficient growth (Wolff
et al., 1991, collier 1996). Subsequent studies have showed that, CCR in
Pseudomonas Spp. is mediated by the catabolite repression control (Crc) protein,
a translational repressor (Rojo 2010). Our in silico analysis of the kgtP promoter
region revealed the presence of a CA-rich motif with a signature sequence
(AAc/uAAc/uAA) for the Crc protein (Chapter 2, Figure 2.13) (Tatke el al 2015). It
is now well established that the expression of crc gene encoding the Crc protein is
modulated by RpoN (σ54) dependent small non-coding RNA CrcZ and the
CbrA/CbrB TCS (sonnleitner 2009). Also, our analyses indicates that the kgtP
promoter is under a small non-coding antisense RNA (asRNA) regulation (Chapter
2, Figure 2.13) (Tatke et al., 2015). This suggests additional layers of regulation
superimposed on the need for MifR in regulating P. aeruginosa α-KG transport.
Subsequently, we also identified a second chromosomally encoded α-KG
permease in P. aeruginosa namely, PA0229 (PcaT) (Chapter 3). Interestingly, our
qRT-PCR expression data and complementation studies suggests that the
expression of pcaT gene is independent of the MifS-MifR TCS signaling cascade.
(Chapter 3, Figure 3.3). Furthermore, in silico analysis of the pcaT promoter region
revealed the presence of a weak RpoN (σ54) binding site, the signature sequence
(AAc/uAAc/uAA) for the translational repressor Crc protein and four putative GGA
trinucleotide motifs, that are the characteristic binding sites for the posttranscriptional control RsmA family of proteins (Chapter 3, Figure 3.3). Presence,
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of shared common motifs (RpoN (σ54) and Crc binding sites) in the kgtP and pcaT
promoter regions indicates an overlapping regulatory control. Though the role of
asRNA, CrcZ, Crc and RsmA in P. aeruginosa α-KG transport and utilization is
currently unknown, it suggest a more profound and complex mechanism of MifR
controlled α-KG transport. This is one of the first study to report the role of a TCS
response regulator in regulating bacterial α-KG assimilation.
Furthermore, efficient utilization and catabolism of extracellular nutrients is
a primary requirement for all pathogenic bacteria to manifest their full virulence
potential during the course of infection. Metabolic processes and virulence
mechanisms are closely interconnected and are hallmarks of P. aeruginosa
infections. Therefore, it is not surprising that the regulation of many virulence
determinates is controlled by nutrient availability. In P. aeruginosa, specific carbon
and nitrogen sources have been known to influence several clinically relevant
virulence phenotypes such as motility (Kohler et al., 2000), pigment production
(Palmer et al., 2007), biofilm development (Klausen et al., 2003(a), Shrout et al.,
2006) and quorum sensing (Dandekar et al., 2012). In this study we illustrated the
interdependence of RR MifR and the C5-dicarboxylate α-KG in regulating the
expression of P. aeruginosa’s key virulence determinants (Chapter 3). We show
that MifR in the presence of α-KG as the sole carbon source positively regulates
swarming motility and pyoverdine production while negatively regulates biofilm
formation, pyocyanin production and cell cytotoxicity (Chapter 3 and Figure 4.1).
Furthermore, a previous microarray transcriptome study of the parent PAO1 and
mifR deficient mutant cultivated under biofilm-specific condition exhibited
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significant alteration in the expression of genes encoding transporter proteins,
secretion factors, type II and type III secretion systems (Petrova et al., 2012).
Hyper pyocyanin production and increased cell cytotoxicity of the mifSR mutants
suggested an overall increase in the concentration of extracellular proteins. Using
the Bradford assay (Bradford, 1976) we quantitated the amount of total proteins
present in the culture supernatant of the mifSR mutants grown overnight in the
presence of α-KG and/or succinate (30 mM each), as a sole carbon source. The
results obtained were intriguing as the concentrations of extracellular proteins in
the culture supernatant were significant lower in the miSR mutants as compared
to the wild-type PAO1 strains in the presence of α-KG (Figure 4.5). In addition,
when cells were grown in the presence of succinate no difference was observed
in the extracellular protein concentration in mifSR mutants compared to the wildtype PAO1 (Figure 4.5). Together, this data indicates that MifR in the presence of
α-KG affects numerous transport and virulence associated mechanisms in P.
aeruginosa. However, at this point, the transcription regulatory network and the
gene expression pattern regulated by MifR that manifest these phenotypic effects
are unclear.
There are numerous previously described signaling pathways in P.
aeruginosa that independently or in association are capable of positively regulating
swarming motility and negatively regulating biofilm formation and pyocyanin
production. These pathways include the cell density dependent quorum sensing
(Las, Rhl and PQS) signaling system, GacS/GacA two-component system and
cyclic-di-GMP signaling (Goodman et al., 2004, Caiazza et al., 2007, Kuchma et
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al., 2007, Merritt et al., 2007, Merritt et al., 2010). In a recent study, Pertova and
co-workers reported that, mifR overexpression in the P. aeruginosa parent PAO1
strain positively affects cyclic-di-GMP levels in a biofilm-specific manner (Petrova
et al., 2012). At this point it is not clear if any of these pathways are regulated by
MifR in the presence of α-KG, either directly or indirectly. Future work focused on
elucidating the α-KG dependent members of MifR regulon using the high
throughput RNA-seq approach will provide a new perspective to decode and better
understand the correlations between P. aeruginosa metabolism and virulence.
These studies will also substantially impact our understanding of the profound role
played by the metabolite α-KG as a messenger in regulating molecular
pathogenesis of the intractable pathogen P. aeruginosa. I have finished the
required RNA-Seq experiments using the wild-type PAO1 and PAOΔmifR mutant
derivatives expressing pcaT in trans in the presence and absence of α-KG. The
RNA-seq was performed using the Next-generation sequencing Illumina Platform
and the RAW FASTQ data has been generated. Currently, I am analyzing and
validating the RNA-seq data using CLC Genomic Workbench, Python
programming and qRT-PCR expression studies. Future work focused on validation
of RNA-seq data using phenotypic assays will help to better understand the role of
RR MifR and the metabolite α-KG in regulating P. aeruginosa physiology.
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Figure 4.5: Effect of mifSR deletion on extracellular protein concentration.
The extracellular proteins were quantitated using the Bradford assay from the
culture supernatant of mifSR mutants grown over night in the presence of α-KG
and succinate (30 mM each), as the sole carbon source.
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Elucidate the role of RpoN (σ54) and TCS signaling in regulating
P. aeruginosa TCA cycle intermediate transport and pathogenesis
Success of P. aeruginosa as a recalcitrant pathogen can be largely
attributed to the repertoire of transcriptional regulators encoded by its genome.
These regulators form an intricate and dynamic networks to exquisitely tune the
expression of genes responsible for phenotypic adaptation and virulence during
infection. P. aeruginosa has one of the largest genome amongst sequenced
bacteria and transcriptional regulators encompass about 10% of the genome
(Galan-Vasquez et al., 2011).

Amongst transcriptional regulators, sigma (σ)

factors are the indispensable global regulators of gene expression. They confer
promoter recognition specificity to the RNA polymerase core enzyme (Borukhov &
Severinov, 2002, Campbell et al., 2002, Murakami & Darst, 2003) in order to
orchestrate the process of transcription initiation (Burgess et al., 1969), a key step
in gene regulation (Browning & Busby, 2004) . To date, the regulatory machinery
predicted in P. aeruginosa prototypic strain PAO1 comprises of approximately 550
transcriptional regulators and 26 putative sigma factors (one RpoN (σ54), eight
RpoD (σ70), and 17 of extra cytoplasmic function (ECF) family (Potvin et al., 2008,
Perez-Rueda et al., 2009, Galan-Vasquez et al., 2011). Amongst these of special
interest is the alternate sigma factor RpoN (σ54) which is a global regulator involved
in P. aeruginosa nitrogen metabolism, motility, carbon assimilation, nutrient
transport, quorum sensing and virulence (Potvin et al., 2008).
Our comparative growth curve analyses of P. aeruginosa wild-type PAO1
and the PAOΔrpoN mutant strains in the presence of TCA cycle C4, C5 and C6 di-
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and tricarboxylic acid intermediates exhibited intriguing results (Figure 4.6). The
PAOΔrpoN mutant failed to grow in the presence of all the TCA cycle intermediates
including succinate (C4), α-KG (C5) and citrate (C6) as the sole carbon source
(Figure 4.6). Furthermore, the growth defect exhibited by PAOΔrpoN could be
restored to the parent strain PAO1 levels by introducing the wild-type rpoN in the
PAOΔrpoN mutant (Figure 4.6). This data strongly hints at the role of RpoN (σ54)
as the master regulator of TCA cycle C4, C5 and C6 di- and tricarboxylic acid
intermediate transport in P. aeruginosa. A unique feature of the RpoN (σ54)
dependent transcription activation of genes is the requirement of an additional
transcriptional regulatory protein called the RpoN (σ54) binding protein that aids in
transcription initiation (Thony & Hennecke, 1989, Potvin et al., 2008). In P.
aeruginosa, to date, 22 RpoN (σ54) binding proteins have been predicted of which
nine (close to 41%) belong to the signal transduction TCS. In the extensively
studied Rhizobium meliloti and Rhizobium leguminosarum, RpoN (σ54) together
with the RR DctD, a part of the DctB/DctD TCS pair, is reported to regulate the
transport of C4-dicarboxylates succinate, fumarate and malate (Ronson et al.,
1987, Watson, 1990, Janausch et al., 2002).
In P. aeruginosa, three TCS protein pairs namely, DctB/DctD, MifS/MifR
and PA1336/PA1335 have been identified to be homologous to the Rhizobium
RpoN dependent C4-dicarboxylate transport regulatory DctB/DctD TCS (Tatke et
al., 2015). The response regulator proteins of these TCS pairs namely, DctD, MifR
and PA1335 share 67%, 69% and 68% identity to the R. meliloti RR DctD (Winsor
et al., 2011), suggesting a similar function. During the course of the dissertation,
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Valentini et al. showed that, P. aeruginosa DctD in concert with RpoN (σ54)
regulates the transport of C4-dicarboxylate succinate, fumarate and malate by
initiating the transcription of dctA and dctPQM genes encoding the C4dicarboxylate transporters (Valentini et al., 2011). Also, we recently reported a key
finding that the assimilation of extracellular C5-dicarboxylate α-KG requires a
functional RpoN (σ54) to work in tandem with the RR MifR in order to activate the
expression of P. aeruginosa α-KG permease encoding kgtP (PA5530) gene
(Chapter 2) (Tatke et al., 2015). Interestingly, P. aeruginosa RRs DctD and MifR
are functionally exclusive with the only shared feature being the requirement of
RpoN (Valentini et al., 2011, Tatke et al., 2015). This suggests that P. aeruginosa
has a dedicated sensory-response mechanism to facilitate the assimilation of
specific class of TCA cycle intermediates (C4, C5 and C6), respectively. While the
role of P. aeruginosa RpoN in the transport of C4 (succinate, fumarate, malate)
(Valentini et al., 2011) and C5 di-carboxylates (α-KG) (Tatke et al., 2015) is
reported, its role in the transport of C6-tricarboxylate (citrate) is unclear. Also, the
role of PA1336/PA1335 TCS in P. aeruginosa is unknown.
Our sequence analysis of P. aeruginosa PAO1 genome revealed the
presence of two ORFs PA5476 (citA) and PA5468 encoding the putative C6tricarboxylate citrate transport proteins (Winsor et al., 2011). The promoter for citA
and PA5468 genes have the putative -12/-24 RpoN (σ54) binding signature
sequences (Thony & Hennecke, 1989, Winsor et al., 2011). Furthermore, the RR
PA1335 has the conserved domains found among NtrC family of regulators, an Nterminal regulatory, a central RpoN (σ54) activation and a C-terminal DNA binding
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domains (Winsor et al., 2011). Since PA1335 exhibits high identity to RpoN (σ54)
dependent transcriptional regulators, it is possible that the RR PA1335, part of the
PA1336/1335 TCS in concert with RpoN facilitate extracellular citrate transport by
regulating the expression of citA and PA5468 genes. Future studies aimed at
characterizing the role of RpoN and PA1336/PA1335 TCS in citrate transport will
provide a vital missing link in our understanding of the fundamental aspects of P.
aeruginosa di- and tri carboxylate transport (Figure 4.7).
It is worth mentioning that P. aeruginosa utilizes TCA cycle intermediates
as the preferred carbon, nitrogen and energy source (Wolff et al., 1991, Collier et
al., 1996). The involvement of RpoN (σ54) in regulating the uptake of TCA cycle
intermediates strongly suggests its role as a protagonist that decides the fate of
carbon and energy utilization patterns in P. aeruginosa. Recently, amongst all
sigma factors, RpoN has been recognized as a central player having the largest
impact on P. aeruginosa global gene expression that ensures its pathogenic
success (Schulz et al., 2015). Future studies using comparative transcriptome
profiling approaches should elucidate the function-specific molecular mechanisms
manifested by RpoN in concert with DctB/DctD, MifS/MifR and PA1336/PA1335
TCS regulatory proteins. Furthermore, it would be interesting to determine if RpoN
and the DctB/DctD, MifS/MifR and PA1336/PA1335 function together in any
capacity to regulate P. aeruginosa virulence in a nutrient source specific manner.
These studies will significantly contribute to a greater understanding of P.
aeruginosa’s complex metabolic networks and will provide a reliable scaffold for
elucidating the transcriptional network of this portentous pathogen.
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source. Cells were cultured for 18 h at 37°C and their growth was monitored by measuring the absorbance at 600 nm.

supplemented with TCA cycle intermediates α-KG (A), succinate (B) and citrate (C) at 30 mM each, as the sole carbon

wild-type PAO1, PAOΔrpoN mutant and PAOΔrpoN::rpoN complimenting strain was tested in M9 minimal media

Figure 4.6: Growth curve analysis in the presence of TCA cycle intermediates. Growth curves of P. aeruginosa

Figure 4.7: P. aeruginosa RpoN and TCS mediated TCA cycle
intermediate transport. Model representing P. aeruginosa RpoN and TCS
response regulator mediated transport mechanism of TCA cycle C4 (yellow),
C5 (blue) and C6 (purple) di- and tri-carboxylates. The response regulators are
represented in orange. Green and red arrows represent positive regulation
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Concluding Remarks
Due to the rapid emergence of antibiotic resistance in bacterial pathogens,
researchers are relentless search for new targets for drug discovery. Although,
TCSs have been identified in lower eukaryotes such as yeast and plants, no
reports on the presence of TCS in mammalian cells have been reported (Gotoh et
al., 2010). This has made TCS proteins an attractive drug target (Schreiber et al.,
2009, Gotoh et al., 2010, Bem et al., 2015). Furthermore, the metabolite α-KG itself
has been considered to have significant therapeutic potential in mammals
(Grzesiak et al., 2016, Zdzisinska et al., 2016). Our results indicates that α-KG is
a repressor of P. aeruginosa acute (pyocyanin and cell cytotoxicity) and chronic
infection (biofilm formation) phenotypes. Understanding the physiological effects
of α-KG on P. aeruginosa and its effect manifested through MifR transcriptional
control will help significantly in development of new therapeutic options.
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Abstract

In the last 70 years, we have seen a radical change in our perception and
understanding of the microbial world. During this period, we learned from Woese
and Fox there exists a third kingdom called “Archea” based on the phylogenetic
studies of the 16S ribosomal RNA that revolutionized microbiology (Woese & Fox,
1977, Woese et al., 1978). Further, we were forced to reckon with the fact that
Koch and Pasteur’s way of growing cells in test-tubes or flasks planktonically does
not necessarily translate to the real-life scenario of bacterial life style, where they
prefer to live and function as a closely knit microbial community called biofilm.
Thanks are due to Costerton, who led the crusade on the concept of biofilms and
expanded its scope of inquiry, which forced scientists and clinicians worldwide to
rethink how we evaluate and apply the data. Then progressively, disbelief turned
into belief, and now it is universally accepted that the micro-organisms hobnob with
the members of their community to communicate and coordinate their behavior,
especially in regards to growth patterns and virulence traits via signaling
molecules. Just when we thought that we were losing the battle against bacteria,
antimicrobials were discovered. We then witnessed the rise and fall of antibiotics
and development of antibiotic resistance. Due to space and choice limitation, we
will focus on the three areas that caused this major paradigm shift (i) antimicrobial
resistance (AMR), (ii) biofilm and (iii) quorum sensing (QS), and how the Journal
of Medical Microbiology played a major role in advancing the shift.
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Antimicrobial resistance (AMR)
It is notable that this 70th anniversary collection for the journal coincides
with the 70th anniversary of the Nobel Prize to Florey and Chain for their work on
penicillin, a β-lactam antibiotic. It was first used to treat a patient in 1942, which
revolutionized medicine and ushered in the age of antibiotics. Yet, resistance
mechanisms that could inactivate penicillin, the β-lactamases, were already
present among bacteria (Abraham & Chain, 1988). As has been uncovered over
the years, the origins of most drug-specific antibiotic resistance mechanisms are
genetically encoded functions that predate the introduction of the antibiotics. These
mechanisms have been derived from the antibiotic-producing organisms, from the
pathogens themselves or from commensals or environmental bacteria. Selective
pressure by antibiotics has led to horizontal transmission of these resistance genes
and further optimization (evolution) of the mechanisms (Davies, 1994, Davies &
Davies, 2010).
The Journal of Medical Microbiology has published many insightful reviews
on AMR, and important laboratory and epidemiological studies of the prevalence
and spread of specific resistance mechanisms. A 1973 paper (Anderson et al.,
1973) presented a study of antibiotic-resistance transfer in the intestines of human
volunteers, finding that Resistance-factors (R-factors) were successfully
transferred when treated with antibiotics, and not in the absence of treatment. A
later review of plasmid-mediated, horizontally-transmitted, enzymatic resistance to
ampicillin and trimethoprim was the subject of an Oakley Lecture (Amyes, 1989).
This lecture acknowledged the growing numbers of resistance determinants to
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each antibiotic, but emphasized evolutionary patterns showing that the enzymes
fell into a small number of groups. The metallo-β-lactamases, which can hydrolyze
the carbapenems, were flagged more than 20 years ago as an emerging medical
challenge (Payne, 1993). That challenge was realized recently with the advent of
the NDM-1 metallo-β-lactamase. A recent review uses the rapid global spread of
the NDM-1 β-lactamase as an example – and a warning – of the looming public
health problem of antibiotic resistance that may only be controlled through
international cooperation (Johnson & Woodford, 2013).
It is not only transmissible factors that are responsible for AMR. Especially
in Gram-negative pathogens, intrinsic impermeability of the cell envelope and
efflux mechanisms also plays a role. Mutational changes in these factors can lead
to decreased susceptibility. Pseudomonas aeruginosa is a particularly problematic
pathogen because it utilizes a variety of these mechanisms to put up a formidable
barrier, limiting greatly the number of classes of chemotherapeutics that can
overcome those mechanisms, to β-lactams, aminoglycosides, fluoroquinolones
and colistin. A recent review in the Journal of Medical Microbiology describes this
phenomenon (Strateva & Yordanov, 2009). In addition to permeability barriers and
efflux, certain antibiotics, such as fluoroquinolones, can select mutations in the
genes encoding their molecular targets.

For the commonly used systemic

monotherapeutic agents, resistance does not occur via single mutations in the
target as they are generally not single proteins but are, rather, the products of
multiple genes or a pathway (Silver, 2007). It is clear that new antimicrobial
therapies are needed to bolster the diminishing antibacterial armamentarium, but
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this is a difficult undertaking (Silver, 2011). AMR has become a real and proximate
threat that requires constant monitoring - and the Journal of Medical Microbiology
remains at the forefront of the undertaking.
Biofilm
The notion that microorganisms, in nature, exist as a sessile, systematized,
multicellular communities was first described in the late 17th century by Van
Leeuwenhoek. He examined plaque samples from his own teeth and found them
to be a complex aggregation of micro-organisms, which he then referred to as
“animalcules”. Even though the biofilm mode of bacterial existence was known for
several centuries, the concept was not promulgated until the late 20th century. The
late 1980s and 1990s saw an increased recognition of the fact that bacteria in their
natural habitat survive and function as organized communities, encapsulated
within a polymeric matrix - a crusade led by Costerton, the pioneer and father of
biofilm research (Costerton et al., 1987, Lappin-Scott et al., 2014).
In the years that followed, P. aeruginosa emerged as the model organism
to glean information on the various aspects of biofilm mode of bacterial lifestyle.
Our appreciation for this lifestyle was facilitated by the advent of non-destructive
investigation techniques, especially the use of live-monitor systems with confocal
laser scanning microscopy. This provided an unprecedented ability to see (and
almost feel) the beautiful architectural formations held together by an extracellular
matrix. This also led us to question many aspects of biofilm that were accepted as
a fact, especially where repetition has led to persuasion – the illusory truth effect.
At that point, it was well established that P. aeruginosa secretes alginate, a
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complex exopolysaccharide made of guluronic and mannuronic acid that provides
selective advantage for its survival in lungs of patients with cystic fibrosis (Song et
al., 2003). The scientific community was persuaded that alginate was the matrix in
P. aeruginosa biofilms. The Journal of Medical Microbiology was bold enough to
publish the paper by Stapper et al that questioned the “illusion of truth” (Stapper et
al., 2004). Notwithstanding the importance of alginate in infection, this paper
alluded to the potential contribution of other polysaccharides, which turned out to
be Psl and Pel polysaccharides (Ma et al., 2012, Jennings et al., 2015).
Micro-organisms coexist in a complex society that includes bacteria, fungi,
archaea and viruses, forming the multifaceted polymicrobial or mixed species
biofilm communities. This provides the communities a competitive advantage such
as AMR, metabolic cooperation, quorum sensing (QS), and many other synergies.
It is only in the last few years that we have begun to fathom the complex nature of
the mixed-species biofilm phenotype and its physiological role during infection.
Adam et al presented a study on mixed fungal-bacterial biofilms using Candida
albicans and Staphylococcus epidermidis, organisms that are frequently
implicated in catheter-associated infections (Adam et al., 2002). Their findings
highlighted

the

coexistence

of

different

microbial

species,

and

their

interdependence in the biofilm formation and AMR. In a follow-up study, the same
group focused on the composition of Candida’s polymeric matrix, which contains
carbohydrates, proteins, hexosamine, phosphorous and uronic acid, and its
importance in promoting AMR (Al-Fattani & Douglas, 2006). Their work provided a
critical insight into the complex biofilm phenotype. Following a series of articles in
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the journal, Wilson published an insightful review that highlighted the antimicrobial
sensitivity in oral biofilms (Wilson, 1996). This review summarized studies
pertaining to the susceptibility of oral bacteria to antimicrobials, based on the type
of biofilm models used. The author also emphasized the need for research in
studying the resistance profile of oral biofilm communities, which can be crucial in
developing an efficient therapeutic regimen. The Journal of Medical Microbiology
has been instrumental in advancing biofilm research by publishing these studies,
first of their kind to focus on the mixed-species biofilm and its contribution to AMR.
More importantly, the recognition of mixed biofilms in nature was the
precursor to the microbiome studies that were facilitated by metagenomic
analyses. Now, one could look at the potential relationship between groups of
organisms within a single niche that makes a bacterial social network (Fernandez
et al., 2015). This was clearly facilitated by metagenomic analysis heralded by
polymerase chain reaction (PCR) that has become a breastwork in all laboratories,
replacing traditional techniques. This has revolutionized how we view ourselves,
realizing that the number of bacteria exceeds the number of human cells by 10:1.
The ease with which DNA is being sequenced and the rapid growth of DNA
databases, and the development of eubacterial-specific, fungal-specific and
species-specific primers, will enable rapid detection of micro-organisms that will
become a mainstay in clinical laboratories. Although we borrowed the knowledge
of soil microbiologists who developed bacterial-specific primers over 20 years ago,
we have to thank the human microbiome project (HMP) launched in 1990, which
truly contributed to the refinement of many bacterial-specific DNA primers (Jaric et
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al., 2013). The Journal of Medical Microbiology contributed to this revolution by
publishing two articles, one that focuses on fungal-specific (Makimura et al., 1994)
and the other on bacterial-specific (Harris & Hartley, 2003) analyses. The latter
compared molecular diagnostics with standard culture techniques and offers a
broad-range 16S rDNA PCR optimized to obtain the highest level of sensitivity for
the detection of bacteria in clinical specimens. The future of rapid detection and
diagnosis of infection truly rests on adopting molecular tools as part of routine
clinical work.
The HMP studies have contributed significantly to our knowledge of the
human microbiome (Turnbaugh et al., 2007). It is now known that the human
gastrointestinal tract alone harbors a diverse array of microbes that are critical to
host nutrition, regulation of intestinal angiogenesis, and development of the
immune response. Alterations in the composition of the intestinal microbiota have
been associated with various disease states (Larson & Welch, 1993, Masseret et
al., 2001). A leading example of this is Clostridium difficile-associated diarrhea
(CDAD), an infection caused by the Gram-positive C. difficile. CDAD occurs
primarily in patients whose colonic microbiotas have been functionally altered by
antibiotic therapy (Kelly & LaMont, 2008). C. difficile was identified in 1935 in a
stool sample from a healthy neonate (Hall & O'Toole, 1935). However, it was not
until 1976, just over four decades after its identification, that it was successfully
cultured using the reinforced clostridial medium (Hafiz & Oakley, 1976). The
Journal of Medical Microbiology took the lead in publishing the findings at a time
when C. difficile was still considered a human commensal and was not associated
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with any disease. It was later in 1978 that C. difficile was first reported to be a
human pathogen (Larson et al., 1978). In the recent years CDAD has become
rampant, with morbidity and mortality increased over the decades past (Kelly &
LaMont, 2008, Britton & Young, 2014). Colonic dysbiosis due to the use of
antibiotics favors C. difficile germination and growth, as it is resistant to most of the
antibiotics (Knecht et al., 2014, Theriot et al., 2014). Following the HMP, many
studies have targeted alternative therapeutic regimens against C. difficile,
including fecal transplantation. The Journal of Medical Microbiology has always
been in the vanguard even before the HMP published data pertaining to the fecal
microbial load (Stephen & Cummings, 1980) and the effect of C. difficile infection
on fecal microbiome (Hopkins & Macfarlane, 2002).
Quorum sensing (QS)
In the 1960s and 70s, scientists decried the notion that bacteria have the
ability to communicate. In the 1990s this notion was christened as QS, by which
bacteria can sense bacterial numbers (cell density), integrate and process the
environmental cues, and coordinately modify their behavior by expressing target
genes (Nealson & Hastings, 1979, Greenberg, 2003). Now, ample evidence exists
for inter-species, inter-genera and inter-kingdom communications using largely
diffusible small molecules called quoromones or autoinducers (Williams, 2007). In
Gram negative, these molecules are largely made of small chemicals, whereas
Gram positive tend to use oligopeptides. These signaling molecules interact with
cognate receptors. It became clear that bacteria employ QS to coordinate the
expression of virulence factors critical for initiation and establishment of infection.
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It was also shown that the QS molecules themselves acted as virulence factors by
being potent stimulators of multiple eukaryotic cells (Smith & Iglewski, 2003).
Subsequently, a flurry of activities began in this area with everyone looking to link
their pet system to QS. A significant publication in Science using the P. aeruginosa
PAO1, which had seen many passages and its isogenic QS mutants, argued the
complete dependence on QS for biofilm formation (Davies et al., 1998). Once
again, the Journal of Medical Microbiology led the way in debunking this story. In
2007, Schaber and colleagues were able to isolate QS-deficient clinical isolates
and demonstrate their ability to form biofilms, although the quality of the biofilm
varies (Schaber et al., 2007). This seriously questioned whether QS was critical
for biofilm formation and infection. In fact, recent work by Greenberg’s team
showed that within a colonizing community, one could have social cheaters who
can coexist and that QS plays a role in policing this cooperation (Wang et al.,
2015).
With the emergence of AMR it seems natural that research turn towards
finding anti-QS molecules as an alternative therapy. With the first report of
furanones as anti-QS molecules (Manefield et al., 1999), there was a slew of
articles that focused on everything from natural products to synthetic compounds.
Once again, the opportunistic pathogen P. aeruginosa became the protagonist in
the search for anti-QS molecules, but investigations also included Gram-positives
such as Staphylococcus spp. (Nostro et al., 2007). Some researchers randomly
looked at herbs, including ancient remedies such as ginseng (Schneper et al.,
2011), and others took an ethnobotanic approach by looking at natural products
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that are used by local communities for medicinal value (Adonizio et al., 2006). The
latter identified various medicinal plants that had anti-QS activities which
attenuated bacterial pathogenic virulence factor production, and could rescue
Caenorhabditis elegans from P. aeruginosa-induced death (Adonizio et al., 2008).
However, with over 15 years of searching, an anti-QS panacea has not emerged.
This is, in part, due to the ability of the QS and the anti-QS molecules to elicit an
immune response that can lead to inflammation.
Though the focus has largely been on looking at the infecting organism for
drug targets, we tend to forget that the host contributes to the bacterial
shenanigans. It was well known that in the lungs of cystic fibrosis patients, P.
aeruginosa lives in a novel biofilm lifestyle as aggregates (Sriramulu et al., 2005)
surrounded by “frustrated” phagocytes (Høiby et al., 1993), and accumulate
mutations (Oliver et al., 2000). However, it was in the late 1990s that the role of
neutrophils in the critical phenotypic conversion contributing to poor prognosis for
the patient was demonstrated (Mathee et al., 1999). This study suggested antioxidants and anti-inflammatory agents as potential therapeutic measures. In 2009,
a paper by Parks and colleagues not only explored the role of neutrophil in the
quality and quantity of biofilm, but also proposed neutrophil necrosis as a potential
drug target (Parks et al., 2009).
In this 70 year journey, the Journal of Medical Microbiology has been one
of the torch bearers in advancing scientific research by critically reviewing and
publishing articles related to the diverse medical microbiology field. The journal
has never shied away from thinking outside the box, allowing it to embrace new
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viewpoints. This will substantially benefit basic research and will help in solving the
mysteries of the microbial world, whether they be antibiotic resistance, biofilm
formation, QS or the more advanced microbiome studies.
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Abstract
Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium with
remarkable abilities to adapt to environmental challenges. A primary pathogen
responsible for all Gram negative infections in clinical settings, it is associated with
lung decline and the untimely demise of people with cystic fibrosis (CF). One of
the hallmarks of P. aeruginosa chronic infection in CF patients is the presence of
mucoid isolates that spells poor prognosis. Here we report a rapid detection
technique for P. aeruginosa based on capillary microextraction of volatiles (CMV)
using the newly invented dynamic headspace sampling device. The method is
composed of a one min dynamic sampling followed by 17 min GC-MS analysis
time. The simple, sensitive and rapid method identified 2-aminoacetophenoe and
1-undecene as biomarkers for the presence of P. aeruginosa. The comparison
results between the mucoid and non-mucoid strains show potential use of 1undecene for differentiation of acute and chronic infection of P. aeruginosa using
the non-invasive CMV-based breath analyzer.
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Introduction
Pseudomonas aeruginosa is a Gram negative opportunistic pathogen
implicated

in

causing

systemic

infections

in

immunocompromised

and

immunosuppressed individuals (Bodey et al., 1983, Ramos, 2004). Its metabolic
versatility and adaptability has significantly contributed to its ubiquity (Ramos,
2004). It has increasingly been recognized as a major cause of morbidity and
mortality in many clinical settings accounting for 1 in every 10 hospital-acquired
infections (Abraham & Chain) (Giamarellou, 2000). From 1975 to 2003, the percent
of HAI pneumonias caused by P. aeruginosa nearly doubled in the US, from 9.6 to
18.1% (Gaynes & Edwards, 2005, Talbot et al., 2006). Unfortunately, the prognosis
for these patients is often poor. Beyond high infection rate, P. aeruginosa also
contributes to the highest case fatality rate of all Gram-negative infections (Aliaga
et al., 2002). It is the primary pathogen responsible for lung decline and mortality
in patients with cystic fibrosis (CF) (Doggett, 1969, Lyczak et al., 2002). In the CF
lungs, transition from acute to chronic infections is marked by the development of
resistance to antibiotics (Workentine et al., 2013), and conversion to a mucoid
phenotype (Penketh et al., 1983, Govan & Nelson, 1992). The mucoid phenotype
is due to constitutive production of alginate (Alg), a component of extracellular
polymeric (EPS) matrix (Flemming et al., 2007). Mucoidy protects the bacteria from
opsonization, phagocytosis, reactive oxygen species and antibiotics (Mathee et al.,
1999, Pritt et al., 2007). Thus, early detection of P. aeruginosa infections plays a
major role in the treatment stratagem and clinical outcome.
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For early and precise detection of P. aeruginosa, numerous culture,
biochemical, Polymerase Chain Reaction (PCR) and serology based approaches
have been developed (Qin et al., 2003, Xu et al., 2004, Tramper-Stranders et al.,
2005, Tramper-Stranders et al., 2006, Daines et al., 2014). In particular, during the
last decade, there has been a substantial upsurge in PCR-based approaches for
early detection of P. aeruginosa in the respiratory samples of CF patients
(Deschaght et al., 2011). However, in spite of the fact that PCR amplifications
have been successfully used as a routine technique for identification of viruses in
clinical samples (Niesters, 2002), their use in bacterial diagnostics including P.
aeruginosa, is still limited. This is mostly due to the questionable specificity and
sensitivity of these techniques. To date, P. aeruginosa detection and identification
greatly relies on culture-based approaches which are time consuming, influenced
by testing conditions and subject to physician interpretation which may lead to
misinterpretation and misidentification (Deschaght et al., 2011). This together
strongly suggests the need for development of new diagnostic tools that will help
pave the way for a more efficient and specific P. aeruginosa detection techniques.
Breath analysis is a potential revolution in disease diagnostics since the
collection of exhaled breath is a safe, non-invasive, easy and simple procedure,
and each individual contains information regarding their own internal state
(Cepelak & Dodig, 2007, Hunter & Dweik, 2008). Urea breath test (UBT) has been
effectively used to detect Helicobacter pylori infections with a success rate of 90%
(Gisbert & Pajares, 2004). Breath analyses have also been widely tested in
experimental studies to identify biomarkers that can be correlated to various
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diseases (Dent et al., 2013, Koutsokera et al., 2013, Sarbach et al., 2013). Bulk
matrix of breath is largely composed of nitrogen, oxygen, carbon dioxide, water,
and inert gases. However, the breath condensate contains trace amounts (parts
per billion (ppb) to parts per trillion (ppt)) of inorganic gases, volatile organic
compounds (VOCs), and other normally nonvolatile substances that can serve as
biomarkers (Miekisch et al., 2004). For example, nitric oxide (NO) gas was
reported with an increased concentration in patients with airway inflammation such
as asthma and bronchiectasis (Kharitonov et al., 1997); and the odor of acetone in
the breath was a characteristic feature of diabetic coma (Crofford et al., 1977).
P. aeruginosa has been reported to produce a “grape-like” odor. The
compound responsible for this peculiar odor has been identified as 2aminoacetophenone (2-AA) by Mann in 1966 (Mann, 1966). Importantly, 2-AA was
not detected in any other respiratory pathogens and thus was used as a biomarker
for P. aeruginosa infection and/or colonization in the lung (Groenewold et al.,
2011). Although specific for P. aeruginosa infections, 2-AA has also been identified
in certain foods including corn, dairy, honey products and wine (Karagul-Yuceer et
al., 2002, Fan et al., 2007, Schmarr et al., 2007, Scott-Thomas et al., 2010). Breath
sample analysis of uninfected individuals shortly after eating these foods may give
a false positive which could limit the diagnostic procedures (Scott-Thomas et al.,
2010). In addition to 2-AA, spontaneously expectorated sputum containing P.
aeruginosa show the presence of 2-nonanone, 2,4-dimethyl-1-heptene, 1heptene, isopentanol, and limonene (Savelev et al., 2011); and P. aeruginosa
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stationary growth culture releases dimethyl sulfide, 1-undecene, and 2-nonanone
(Zscheppank et al., 2014, Briard et al., 2016).
In this study, a novel, fast, dynamic headspace sampling device, capillary
microextraction of volatiles (CMV), was used to capture volatile compounds
released by P. aeruginosa on standard culture plates. The analytical method
consists of sampling the headspace above the culture plates for 1 min using the
CMV device followed by inserting it into a thermal probe that is connected to a GC
split/splitless (S/SL) injection port, followed by ~17 min chromatographic program
of GC-MS analysis after thermal desorption of the absorbed analytes from CMV.
The CMV tube (Figure A2.1) performs similarly to commercial sorbent tubes in
terms of extraction efficiency, sensitivity, breakthrough and recovery. However, it
does not require the complicated thermal desorption accessory normally
associated with sorbent tubes. Due to its extremely high surface area and phase
volume, small volume sampling (~ 1 L) results in sub-ng absolute detection limits
for the analytes of interest, making the CMV technique capable of detecting ppb
concentrations of VOCs in air. In this study, we report the presence of the
biomarkers 1-undecene and 2-AA among others from the P. aeruginosa.
Moreover, we report that the presence of 1-undecene can be used for the
differentiation between mucoid and nonmucoid strains of P. aeruginosa. Compare
to previously described method, this is one of the first reporting of an inexpensive,
fast and ultra-sensitive technique for the detection of P. aeruginosa that is
accessible to a moderately equipped analytical laboratory requiring only GC-MS
instrumentation (Table A2.1).
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Table A2.1. Comparison of extraction and analytical parameters between this
work and previous reports of biomarker detection from pathogens.

Extraction
Method
Setup

(Savelev et (Zscheppank
al., 2011)
et al., 2014)
SPME (DVBCarboxenNT, closed
PDMS),
system
closed
system
Easy Moderate
Moderate

Extraction
50 min
Time
Extraction
37 °C
Temperature
Injection
Split/Splitless
Port
Pulsed
Mode
Splitless
Mode
EI, 70 eV,
Detector
full-scan
ZB-Wax, 30
Column
m x 0.25 mm
x 0.25 um
Initial temp
40 °C, 5 min
Ramp
Ramp
Ramp

5 °C/min to
100 °C
5 °C/min to
150 °C, 2
min
5 °C/min to
230 °C

Ramp
Ramp
Run Time
He

44 min
1 mL/min

12 min

This Report

(Scott-Thomas
et al., 2010)

CMV, semiclosed
system

SPME
(Carbowax/PEG),
closed system

Easy
1 min

5 min

RT

Optima 1, 30
m x 0.32 um
x 1 um
35 °C
1 °C/min to
53 °C, 3 min
15 °C/min to
120 °C
5 °C/min to
160 °C
2.5 °C/min to
180°C
2 °C/min to
200 °C
51 min
1.5 mL/min
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TDU

PTV-1079

Split/splitless

Split (50:1)

DB-5ms, 8
m x 0.25 mm
x 0.25 um
40 °C, 1 min
15 °C/min to
115 °C, 1
min
25 °C/min to
280 °C, 3
min

ZB-Wax, 30 m x
0.25 mm x 0.25
um
60 °C, 2 min

16.6 min
1 mL/min

10 °C/min to 250
°C, 2 min

21 min
1.2 mL/min
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terminated sol-gel PDMS glass fiber filters were packed in glass capillary tubing.

device was shown in scale. (b) Detailed schematic of a CMV device where vinyl-

Figure A2.1. Capillary Microextraction of Volatiles (CMV) device. (a) A 2 cm CMV

Materials and Methods
Bacteria strains, media and growth conditions
Bacterial strains used in this study are listed in Table A2.2. Luria-Bertani
(LB) (Fisher Scientific) broth was used for routine cultivation of bacterial cultures
and was supplemented with 1.5% agar when needed, unless specified otherwise.
All cultures were grown overnight in LB broth with shaking at 200 rpm, at 37˚C for
Pseudomonas

aeruginosa

(Mucoid/Non-mucoid),

Staphylococcus

aureus,

Escherichia coli, 26˚C for Serratia marcescens, Chromobacterium violaceum and
30˚C for Bacillus strains. Briefly, overnight cultures were diluted to obtain equal
optical densities. Culture densities were normalized to a final A600 of 0.05-0.08
before inoculating on LB agar plates by swabbing the surface with adjusted culture
suspensions. Plates were allowed to dry before incubating overnight for 12 to 16
h at 37˚C, 30˚C and/or 26˚C depending on the culture. In addition, mixed culture
suspension of P. aeruginosa prototypic PAO1, E. coli (DH5α), S. marcescens, B.
cereus and S. aureus in different combination were used. For mixed bacterial
cultures, the plates were incubated overnight at 30˚C. In total, 280 culture plates
were sampled, and each strain was analyzed at least three times. All the sampling
and analyses were accomplished using blind study method. The culture plates
containing all the bacteria, including the negative controls, were labeled with
reference IDs to minimize any bias during the headspace sampling. The LB agar
plate with no culture was used as a negative control.
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Dynamic headspace sampling using CMV devices
The CMV devices were recently developed and reported as an efficient way
to detect trace amounts of explosives (Fan & Almirall, 2014). Fabrication of the
CMV devices has been described elsewhere (Fan & Almirall, 2014). These 2-cm
length open-ended sampling devices allow for fast dynamic headspace sampling.
The CMV devices were conditioned in an oven at 250 °C for an hour prior to use,
cooled to room temperature and connected to a hand-held air monitoring vacuum
pump (Escort Elf Air Sampling Pump, Zefon International Inc., Ocala, FL) that
provides a flow through the CMV device at the rate of 1.5 liters per min (LPM). For
the culture plates sampling, the LB agar culture plates were popped open with a
small opening where the CMV devices were simply inserted into the plates for 1
min dynamic sampling at a flow rate of 1.5 L/min (Figure A2.2). The CMV sampling
device capable of sub-nanogram detection of VOCs, when coupled to GC-MS (Fan
& Almirall, 2014, Tarifa & Almirall, 2015) (Air Chemistry, Inc, Miami, FL).
Sample analysis using GC-MS
After 1 min sampling, the CMV device was disconnected from the tubing
and inserted into a probe for thermal desorption into an Agilent Technologies
7890A GC S/SL injector that was connected to thermal separation probe adaptor
from Agilent Technologies Inc., Santa Clara, CA. The injector was set to 180 °C.
The Agilent Technologies 7890A GC system was equipped with a 5975C inert XL
mass spectrometer detector (MSD). The GC column used in this research was a
DB-5ms Ultra Inert, 8 m × 0.25 mm × 0.25 µm column. For the initial study, the GC
oven temperature ramp started at 40 °C, was held for 1 min and ramped at 15
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°C/min to 200 °C and held for 1 min, ramped again at 15 °C/min to 240 °C, held
for 6.5 min and ramped at 25 °C/min to 270 °C, ramped at 5 °C/min to a final
temperature of 280 °C and held for 4 min. The total analyses time was 29.33 min
that provided with a high resolution for detection of various volatile organic
compounds in the headspace over the culture plates. Once biomarkers were
identified for P. aeruginosa strains, a fast GC oven temperature program was used
to reduce the analyses time. The oven temperature started at 40 °C for 1 min, and
ramped to 115 °C at 15 °C/min and held for 1 min, and ramped to final temperature
of 280 °C at 25 °C/min and held for 3 min. The total analyses time was reduced to
16.6 min.
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Results
Identification of VOCs in the Headspace of P. aeruginosa
The VOCs present in the prototypic P. aeruginosa strain PAO1 were differentiated
from other bacteria, E. coli DH5α and C. violaceum, in this particular study and
characteristic VOCs were found in the P aeruginosa strains using the 1-min.
headspace sampling method. After 24 hours of incubation, the headspace of the
plates were sampled with the CMV for 1 min. 1-Undecene and 2aminoacetophenone (2-AA) were detected in P. aeruginosa, and indoles were
detected in E. coli (Figure A2.3). After 48 hours of incubation at room temperature,
limonene was also detected in both the P. aeruginosa and C. violaceum plates;
thus, limonene wasn’t chosen as a biomarker along with 1-undecene and 2-AA in
this research.
Differentiation of P. aeruginosa from Other Bacterial Species
The 1-min. headspace sampling using CMV resulted in the differentiation of the
199 plates containing P. aeruginosa strains from the 66 plates containing other
bacteria using blind sampling studies. The compounds 1-undecene and 2-AA were
found only in the headspace of the P. aeruginosa strains (see Table A2.3) and
these results are consistent with previous workers who also reported finding these
compounds as biomarkers of P. aeruginosa. Almost every plate containing the P.
aeruginosa strain resulted in the detection of one or both of these biomarkers.
Additionally, none of the plates containing the other bacteria resulted in the
presence of either or both of the biomarkers. A confusion matrix was built (Table
A2.3) in which the theoretical biomarker present is equivalent to P. aeruginosa
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plate and the theoretical biomarker absence is equivalent to a plate containing
other bacteria. Based on this confusion matrix, two observations can be made.
First, where the true negative rate equals to 1.00 indicates that the two biomarkers
chosen are not found in the other bacterial strains tested in this study. Second, the
false negative rate of 0.12 indicates that a few P. aeruginosa strains do not emit
either 1-undecene or 2-AA. Mucoid strains may be retaining the VOCs better than
the non-mucoid strains and therefore the biomarkers are more difficult to detect.
Detection of 2-AA and 1-undecene is specific for P. aeruginosa
To determine if this detection method is specific and sensitive, several
mixtures of species were made (Table A2.4). The headspace of each mixture was
also sampled and the chromatograms were overlaid (Figure A2.4). As predicted,
the two compounds, 1-undecene and 2-AA were detected in Group 1 (P.
aeruginosa, S. marcescens, and S. aureus) and 4 (P. aeruginosa alone), and
indole was found in Group 2 (E. coli, S. marcescens, and B. cereus UW85), 3 (E.
coli, S. marcescens, and S. aureus) and 5 (E.coli alone). Thus, the test method for
1 min fast dynamic sampling followed by analysis in GC-MS is suitable even when
a complex mixture is present.
Differentiation between mucoid and non-mucoid P. aeruginosa strains
P. aeruginosa strains often transition from acute to chronic infections in
patients with CF. The transition is marked by development of resistance to
antibiotics and conversion to mucoid phenotype. The mucoid phenotype is due to
overproduction of alginate (Figure A2.5). The mucoid strains are referred to as
Alg+. Thus we hypothesized that the transition will lead to concomitant change in
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odor the profile. To test this hypothesis, eight non-mucoid and 10 mucoid strains
were tested (Figure A2.6).
For the eight mucoid strains analyzed, 1-undecene was detected in all 83
plates (100% detection rate); while 2-AA was found in 80 plates (96.4% detection
rate) (Figure A2.6). The only strain that didn’t have 2-AA in headspace is strain
CDN118, which is a pan-resistant bacterimic isolate from Nigeria. The absence of
2-AA in this single strain needs further study.
The 2-AA biomarker was detected in 85 of 116 (73.3%) of the mucoid strains
(Figure 2A.6). The plates that failed to have detectable 2-AA in the headspace
included strain ZW77 (3 plates), PAO1 (3 plates), and PDO300 (17 plates). The 1undecene was detected in all of the non-mucoid (Alg-) strains whereas only 41.3
% of the mucoid isolates presented 1-undecene in the headspace (Figure 2A.6).
The mucoid strains may not produce appreciable amounts of 1-undecene. The
presence of 1-undecene in some of the plates could result from the presence of
non-mucoid strains in the plates due to their ability to transition during the
incubation process. In fact, the Alg+ phenotype of PDO300 is unstable and up to
80% of the isolates can revert to non-mucoid phenotype (Sautter et al., 2012). To
test this hypothesis, volatiles from three stable mucoid strains PA2192 (12 plates),
FRD39 (13 plates), were compared with the Alg- PAO1 (6 plates) strains. As
expected, only 2-AA was found in all 31 plates. The stable mucoid strains were
differentiated from the non-mucoid strains by only the presence of these two
biomarkers using the CMV headspace test described.
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was inserted into the small opening of a culture plate.

CMV device is connected to the handheld pump for 1 min sampling. (b) A CMV device

Figure A2.2. The dynamic headspace sampling process using CMV device. (a) A

182
of P. aeruginosa, wherea indole was detected in the headspace of E. coli.

C. violaceum were overlaid. 1-undecene and 2-AA were only found in the headspace

min dynamic sampling of LB plates with no bacteria, with E. coli, P. aeruginosa, and

Figure A2.3. Chromatograph of headspace samples. The chromatographs from 1
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found in the mixtures which contained P. aeruginosa strain.

strains. The two biomarkers used in the study, 2-AA and 1-undecene, were only

Figure A2.4. Overlaid chromatograms for plates contain multiple bacteria

Figure A2.5. Non-mucoid (Alg-) and mucoid (Alg+) P. aeruginosa. The
prototypic P. aeruginosa such as PAO1 are non-mucoid. The conversion seen
during chronic infection, especially in patients with cystic fibrosis is due to a
mutation in mucA encoding an anti-sigma factor. The mucoid phenotype reverts
back to non-mucoidy in the absence of selection due to second site suppressors
strain (Sautter et al., 2012).

Figure A2.6. The detection frequency of 1-undecene and 2-aminoacetophenone
(2-AA) in mucoid and non-mucoid P. aeruginosa strains. 1-Undecene was 100%
detectable in non-mucoid P. aeruginosa strains, while only 43% detectable in mucoid
strains. The significant drop in detection frequency led to the hypothesis of using 1undecene as a biomarker for separation of mucoid and non-mucoid strains.
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Table A2.2. Bacterial strains used in this study
Strain
Relevant characteristics
Background
P. aeruginosa strains
Alg-; Prototypic wild type, a
PAO1
PAO1
wound isolate
Alg+; PAOmucA22,
PDO300
PAO1
constitutively mucoid
Strain ID

PKM315

PAO1

PKM816

PDO300

PKM831

PDO300

PKM900

PAO1

PKM901

PAO1

PKM902

PAO1

CDN118

Alg-; PAO∆ampR
Alg-; PDO300 revertant, nonmucoid;
PAOlagO96 mucA22
Alg-; PDO300 revertant, nonmucoid; PAOmucP451 mucA22
Alg-; PAO∆mifR; in-frame
deletion of mifS
Alg-; PAO∆mifS; In-frame
deletion of mifS
Alg-; PAO∆mifSR; in-frame
deletion of mifS and mifR
Alg-; Panresistant clinical isolate
from Nigeria
Alg+; Mucoid cystic fibrosis (CF)
clinical isolate

PA2192

2192

FRD1

FRD1

Alg+; Mucoid CF clinical isolate

FRD39

FRD1

Alg+; Mucoid isolate

ZW77
ZW98
PT22
641 HD
PKM122

PAO1

Alg+; poxB15, CF throat swab,
London, UK, 1997
Alg-; CF throat swab, The
Hague, Netherlands, 1997
Alg-; Water, Mühlheim,
Germany, 1992
Alg-; poxB22; Water, Mühlheim,
Germany, 1992
Alg+; PAOmucA22; mucoid
strain isolated from PAO1
biofilm after PMN exposure
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Source
(Stover et al.,
2000)
(Mathee et al.,
1999)
(Balasubramania
n et al., 2012)
sap26; Mathee
Lab
sap21; Mathee
Lab
(Tatke et al.,
2015)
(Tatke et al.,
2015)
(Tatke et al.,
2015)
C.D. Nkwonta
(Pier et al., 1983)
(Ohman &
Chakrabarty,
1981)
(Ohman &
Chakrabarty,
1981)
(Kong et al.,
2005)
(Kong et al.,
2005)
(Kong et al.,
2005)
(Kong et al.,
2005)
(Mathee et al.,
1999)

PKM123

PAO1

Alg+; PAOmucA22; mucoid
strain isolated from PAO1
biofilm after PMN exposure

(Mathee et al.,
1999)

Bacillus strains
ATCC
B.
NRRL B4488 [HD73]
35866
thuringiensis
ATCC
B. subtilis
ind- tyr+
23857
ATCC
B. megaterium
14581
ATCC
B. cereus
53522
UW85
Other bacterial strains
Chromobacteriu
CV026
Violaceum negative mutant
m violaceum
F- Φ80lacZΔM15 Δ (lacZYAargF)U169 deoR recA1
DH5α
Escherichia coli endA1 hsdR17 (rk- mk+)
phoA supE44 λ- thi-1 gyrA96
relA1
ATCC
Serratia
Isolated from pond water
13880
marcescens
Staphylococcus
KM1000
Wild type
aureus

ATCC
ATCC
ATCC
ATCC

(Pier et al., 1983)
New England
Biolabs
ATCC
Mathee Lab

Table A2.3. Confusion matrix built upon the blind study.
Theoretical
Confusion Matrix

Biomarker
Present

Biomarker not
Present

Biomarker Present

176 (TP=0.88)

0 (FP=0)

Biomarker not
Present

23 (FN=0.12)

66 (TN=1.00)

Experimental

TP: True Positive Rate; FP: False Positive Rate; FN: False Negative Rate; TN:
True Negative Rate
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Table A2.4. Mixture of bacterial cultures
Strain Background

Strain IDs

P. aeruginosa

PAO1

S. marcescens

ATCC 13880

S. aureus

KM1000

E. coli

DH5α

S. marcescens

ATCC 13880

B. cereus UW85

ATCC 53522

E. coli

DH5α

S. marcescens

ATCC 13880

S. aureus

KM1000

Mixture 4

P. aeruginosa

PAO1

Mixture 5

E. coli

DH5α

Mixture 1

Mixture 2

Mixture 3
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Discussion
The rapid sampling technique using CMV devices coupled to GC-MS for
sample analysis is an effective method to differentiate P. aeruginosa strains from
the other bacterial pathogens. The two biomarkers used in this study, 2-AA and 1undecene, are only found in the headspace of P. aeruginosa strains, in comparison
to the headspace of several other pathogen strains. No significant levels of
biomarkers were found for the other bacterial pathogens except that indole was
found in the headspace of DH5α (E. coli). Beyond this, when multiple bacteria were
mixed together, the method doesn’t show any interference and is specific in
identifying the two biomarkers only from the mixtures that contained the P.
aeruginosa strains.
In addition, to differentiate P. aeruginosa strains from the other bacterial
pathogens, the method could also be used for separation of P. aeruginosa mucoid
and non-mucoid strains. In the analysis of 8 mucoid strains, the 1-undecene
detection rate dropped significantly from 100% to 41.3%, when compared to the
analysis of 10 non-mucoid strains. These results suggest that either the mucoid
strains do not produce 1-undecene in the headspace as a biomarker or the
mucoidy prevents the release (absorbs) the 1-undecene. The headspace analysis
of the three stable mucoid strains shows that 2-AA was the only biomarker
detected in the headspace. Previously, solid phase microextraction (SPME) has
been used for studying the headspace of P. aeruginosa (Scott-Thomas et al.,
2010, Savelev et al., 2011). Because of the static sampling nature of the SPME
device and its limited surface area and phase volume, the static sampling SPME
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methods required longer analysis times. In addition, the SPME glass fiber is very
fragile and thus not suitable for field applications. In this study, the newly
developed method is rugged, dynamic, fast, and has comparable or better
sensitivity as SPME. However, in the analysis of about 300 culture plates, a
relatively low true positive rate (88%) was found which resulted from three out of
eight mucoid strains. As discussed above, the mucoid strains may have the
polysaccharide cover to prevent the release of biomarkers into the headspace;
thus, culturing the plates under a condition to prevent conversion from mucoid to
non-mucoid might be useful for successful detection that can lead to a higher true
positive rate. Additionally, both stable and unstable mucoid strains should be
analyzed. Further experiments should also include quantitative analysis that
addresses the number of bacteria on the culture plate versus the headspace
biomarker signals. These studies may provide further insights into the
concentration of biomarker compounds that can differentiate the mucoid and
nonmucoid strains of P. aeruginosa.
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Conclusions
The newly reported CMV device for dynamic headspace sampling of VOCs
over bacteria culture plates provides for a simple and inexpensive extraction setup.
The 1 min sampling time significantly increases the sampling throughput and the
direct introduction of the CMV into a port of a GC-MS followed by thermal
desorption produces a VOC profile in ~ 17 min for each plate. 1-undecene and 2AA were identified as the biomarkers for P. aeruginosa in these studies. In further
screening test, 265 plates were sampled and no false positive was generated with
a total number of 66 other bacteria (not containing P. aeruginosa) plates analyzed.
In the analysis of non-mucoid strains, the clinical isolate CDN118 did not produce
2-AA in the headspace, but 1-undecene was found in all plates; thus, 1-undecene
can be used as the primary biomarker while 2-AA as a secondary marker for
confirmation. In addition, 1-undecene might be used as the biomarker to
differentiate mucoid and non-mucoid P. aeruginosa isolates. The method was also
successfully applied to the culture plates with multiple bacteria (mixtures). The
detection results showed the method is sensitive and effective even with a relative
complex matrix. In conclusion, the simple and fast sampling method developed in
this research is effective in screening bacteria culture plates to identify P.
aeruginosa strains. Additional developmental research may lead to rapid, noninvasive detection of P. aeruginosa in the breath of patients that are susceptible to
P. aeruginosa infection such as potential cystic fibrosis patients.
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